TW200914991A - Resist composition, method of forming resist pattern, compound and acid generator - Google Patents

Resist composition, method of forming resist pattern, compound and acid generator Download PDF

Info

Publication number
TW200914991A
TW200914991A TW097121845A TW97121845A TW200914991A TW 200914991 A TW200914991 A TW 200914991A TW 097121845 A TW097121845 A TW 097121845A TW 97121845 A TW97121845 A TW 97121845A TW 200914991 A TW200914991 A TW 200914991A
Authority
TW
Taiwan
Prior art keywords
group
acid
alkyl group
compound
component
Prior art date
Application number
TW097121845A
Other languages
Chinese (zh)
Other versions
TWI383252B (en
Inventor
Takeshi Iwai
Hideo Hada
Keita Ishiduka
Akiya Kawaue
Hiroaki Shimizu
Kyoko Ohshita
Tsuyoshi Nakamura
Komei Hirahara
Yuichi Suzuki
Takehiro Seshimo
Original Assignee
Tokyo Ohka Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Ohka Kogyo Co Ltd filed Critical Tokyo Ohka Kogyo Co Ltd
Publication of TW200914991A publication Critical patent/TW200914991A/en
Application granted granted Critical
Publication of TWI383252B publication Critical patent/TWI383252B/en

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/0045Photosensitive materials with organic non-macromolecular light-sensitive compounds not otherwise provided for, e.g. dissolution inhibitors
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/0047Photosensitive materials characterised by additives for obtaining a metallic or ceramic pattern, e.g. by firing

Abstract

A compound represented by general formula (b-14); and acid generator consisting of the compound; and a resist composition including a base component (A) which exhibits changed solubility in an alkali developing solution under action of acid and an acid-generator component (B) which generates acid upon exposure, the acid-generator component (B) including an acid generator (B1) consisting of a compound represented by general formula (b1-14): wherein R7" to R9" each independently represents an aryl group or an alkyl group, wherein two of R7" to R9" may be bonded to each other to form a ring with the sulfur atom, and at least one of R7" to R9" represents a substituted aryl group in which a portion or all of the hydrogen atoms are substituted with an alkoxyalkyloxy group or an alkoxycarbonylalkyloxy group; and X- represents an anion.

Description

200914991 九、發明說明 【發明所屬之技術領域】 本發明爲有關光阻組成物 '使用該光阻組成物之光阻 圖型之形成方法、適合作爲光阻組成物用酸產生劑之化合 物,及該化合物所成之酸產生劑。 本案爲基於2007年6月13日於日本特許廳所提出之 特願2007-156556號,與2007年11月13曰於日本特許 廳所提出之特願2007-294429號爲基礎主張優先權,本說 明書中係援用其内容。 【先前技術】 微影蝕刻技術中,例如於基板上形成由光阻材料所得 之光阻膜,並對於前述光阻膜,介由形成特定圖型之遮罩 ’以光、電子線等放射線進行選擇性曝光,經施以顯影處 理,使前述光阻膜形成具有特定形狀之光阻圖型之方式進 行。經曝光之部份變化爲具有溶解於顯影液之特性的光阻 材料稱爲正型,經曝光之部份變化爲具有不溶解於顯影液 之特性的光阻材料稱爲負型。 近年來,於半導體元件或液晶顯示元件之製造中,伴 隨微影蝕刻技術之進步而急速的推向圖型之微細化。 微細化之方法,一般而言,爲將曝光光源予以短波長 化之方式進行。具體而言爲,以往爲使用g線、i線爲代 表之紫外線。但現在則開始使用KrF準分子雷射、或ArF 準分子雷射以進行半導體元件之量産。又,對於前述準分 -6- 200914991 子雷射具有更短波長之F2準分子雷射、電子線、EUV (極 紫外線)或X線等亦已開始進行硏究。 光阻材料,則尋求對於前述曝光光源具有感度,具有 可重現微細尺寸圖型之解析性等微影蝕刻特性。可滿足前 述要求之光阻材料,一般常用含有基於酸之作用使鹼可溶 性產生變化之基礎樹脂,與經由曝光產生酸之酸產生劑之 化學增幅型光阻。例如正型之化學增幅型光阻,其爲含有 作爲基礎樹脂之基於酸之作用而增大鹼溶解性之樹脂,與 酸產生劑成份,其於光阻圖型形成時,經由曝光使酸產生 劑產生酸,而使曝光部形成鹼可溶性。 目前爲止,化學增幅型光阻之基礎樹脂爲使用對KrF 準分子雷射(248nm )具有高度透明性之聚羥基苯乙烯( PHS )或其被酸解離性之溶解抑制基所保護之樹脂(PHS 系樹脂)。但是,PHS系樹脂,因具有苯環等芳香環,故 對於24 8nm更短之波長,例如對於193nm之光線的透明 性仍不充分。因此,使用PHS系樹脂作爲基礎樹脂成份之 化學增幅型光阻,例如對於使用1 93 nm光線之製程,則仍 有解析性較低等缺點。 因此,目前,對於ArF準分子雷射微影蝕刻中所使用 之光阻的基礎樹脂,爲使其於1 9 3 nm附近具有優良透明性 ,故一般多使用主鏈具有以(甲基)丙烯酸酯所衍生之結 構單位之樹脂(丙烯酸系樹脂)。爲正型之情形,前述樹 脂主要爲使用包含含有脂肪族多環式基之三級烷酯型酸解 離性溶解抑制基之(甲基)丙烯酸酯所衍生之結構單位、 200914991 例如主要使用含有2-烷基-2-金剛烷基(甲基)丙烯酸酯 等所衍生之結構單位的樹脂(例如專利文獻1 )。 又’「(甲基)丙儲酸酯(acrylic acid ester)」係 指α位鍵結有氫原子之丙烯酸酯,與該〇;位鍵結甲基之甲 基丙烯酸酯之一或二者之意。「(甲基)丙烯酸酯( acrylate )」係指α位鍵結有氫原子之丙烯酸酯,與該α 位鍵結甲基之甲基丙烯酸酯之一或二者之意。「(甲基) 丙烯酸」係指α位鍵結有氫原子之丙烯酸,與該α位鍵結 甲基之甲基丙烯酸之一或二者之意。 又,化學增幅型光阻中所使用之酸產生劑,目前已有 各種各樣之物質被提出,例如碘鑰鹽或锍鹽等鎗鹽系酸產 生劑’肟磺酸酯系酸產生劑、重氮甲烷系酸產生劑、硝基 苄基磺酸酯系酸產生劑、亞胺基磺酸酯系酸產生劑、二砸 類系酸產生劑等多種已知化合物。目前酸產生劑已有使用 含有三苯基锍骨架、二萘基單苯基锍骨架等之酸產生劑。 (專利文獻2 )。 [專利文獻1 ]特開2 0 0 3 - 2 4 1 3 8 5號公報 [專利文獻2]特開2 0 0 5 - 3 7 8 8 8號公報 【發明內容】 近年來,伴隨光阻圖型之微細化,對於高解析性有著 更進一步之期待,進而有尋求各種微影蝕刻特性之提昇。 例如,形成光阻圖型之際,其圖型形狀或遮罩重現性 等’將隨著圖型的微細化其改善將更爲重要。遮罩誤差因200914991 IX. Description of the Invention [Technical Field] The present invention relates to a photoresist composition for forming a photoresist pattern using the photoresist composition, a compound suitable as an acid generator for a photoresist composition, and An acid generator formed by the compound. This case is based on the special wish 2007-156556 proposed by the Japan Patent Office on June 13, 2007, and the priority of 2007-294429, which was proposed by the Japan Patent Office on November 13, 2007. The contents are used in the manual. [Prior Art] In the lithography technique, for example, a photoresist film obtained from a photoresist material is formed on a substrate, and for the photoresist film, a mask of a specific pattern is formed by radiation such as light or electron lines. The selective exposure is carried out by applying a development treatment to form the photoresist film into a photoresist pattern having a specific shape. The portion of the exposure which is changed to have a characteristic of being dissolved in the developer is referred to as a positive type, and the portion of the photoresist which is exposed to have a property of not being dissolved in the developer is referred to as a negative type. In recent years, in the manufacture of semiconductor elements or liquid crystal display elements, with the advancement of the lithography technique, the pattern has been rapidly refined. The method of miniaturization is generally carried out in such a manner as to shorten the wavelength of the exposure light source. Specifically, ultraviolet rays which are represented by g-line and i-line are conventionally used. However, KrF excimer lasers or ArF excimer lasers are now being used for mass production of semiconductor components. Further, F2 excimer lasers, electron beams, EUV (ultraviolet rays) or X-rays having shorter wavelengths have been studied for the above-mentioned quasi-minutes -6-200914991 sub-lasers. The photoresist material is sought to have sensitivity to the aforementioned exposure light source, and has lithographic etching characteristics such as reproducibility of reproducible fine-size patterns. The photoresist material which satisfies the above requirements is generally used as a base resin containing a change in alkali solubility based on an acid action, and a chemically amplified photoresist which generates an acid generator by exposure. For example, a positive type chemically amplified photoresist is a resin containing an acid-based action as a base resin to increase alkali solubility, and an acid generator component which is formed by exposure to an acid when formed in a photoresist pattern. The agent generates an acid and causes the exposed portion to form an alkali solubility. The base resin of the chemically amplified photoresist is a polyhydroxystyrene (PHS) highly transparent to KrF excimer laser (248 nm) or a resin which is protected by an acid-dissociable dissolution inhibiting group (PHS). Resin). However, since the PHS-based resin has an aromatic ring such as a benzene ring, transparency to a shorter wavelength of 24 8 nm, for example, light of 193 nm is still insufficient. Therefore, a chemically amplified photoresist using a PHS resin as a base resin component has disadvantages such as low resolution for a process using a 93 nm light. Therefore, at present, for the base resin of the photoresist used in the ArF excimer laser lithography etching, in order to have excellent transparency near 193 nm, it is generally used to have a (meth)acrylic acid in the main chain. A resin (acrylic resin) of a structural unit derived from an ester. In the case of a positive type, the above-mentioned resin is mainly a structural unit derived from a (meth) acrylate containing a tertiary alkyl ester type acid dissociable dissolution inhibiting group containing an aliphatic polycyclic group, 200914991, for example, mainly used 2 A resin having a structural unit derived from an alkyl-2-adamantyl (meth) acrylate or the like (for example, Patent Document 1). Further, '(acrylic acid ester) means an acrylate having a hydrogen atom bonded to the α-position, and one or both of the methacrylate of the methyl group; meaning. "(Meth)acrylate" means an acrylate having a hydrogen atom bonded to the α-position and one or both of a methyl methacrylate bonded to the α-position. "(Meth)acrylic acid" means an acrylic acid having a hydrogen atom bonded to the α-position, and one or both of the methacrylic acid having a methyl group bonded to the α-position. Further, various acid generators have been proposed for use in chemically amplified photoresists, such as a gun salt acid generator such as an iodine salt or a phosphonium salt, and an oxime sulfonate acid generator. A variety of known compounds such as a diazomethane acid generator, a nitrobenzyl sulfonate acid generator, an imidosulfonate acid generator, and a diterpenoid acid generator. At present, an acid generator containing a triphenylsulfonium skeleton, a dinaphthylmonophenylphosphonium skeleton or the like has been used as the acid generator. (Patent Document 2). [Patent Document 1] Japanese Patent Publication No. 2 0 0 3 - 2 4 1 3 8 5 [Patent Document 2] JP-A-2000-A-37-8 No. 8 [Invention] In recent years, along with a photoresist pattern The miniaturization of the type has further expectations for high resolution, and further improvements in various lithographic etching characteristics have been sought. For example, when a photoresist pattern is formed, its pattern shape or mask reproducibility, etc., will be more important as the pattern is refined. Mask error

200914991 子(MEF )即爲表示前述特性的指標之一,护 下,固定間距之狀態下變化遮罩尺寸(線路萝 之線寬,接觸通孔圖型中爲通孔直徑)之際’ 寸下遮罩圖型如何忠實地重現(遮罩重現性) 提高微影蝕刻特性等目的上,改善前述圖型 等爲重要之因素,於使用新穎之酸產生劑時, 述之目的。 本發明即是鑒於上述情事所提出者,即t 合作爲光阻組成物用酸產生劑之新穎化合物、 形成之酸產生劑、含有該酸產生劑之光阻組成 該光阻組成物之光阻圖型之形成方法爲目的。 解決上述問題之本發明之第一實施態樣, 組成物,其爲含有經由酸之作用而對鹼顯影液 生變化之基材成份(A )及經由曝光而產生酸 成份(B )之光阻組成物,其特徵爲,前述酸 (B)爲含有下述通式(bl-14)所示之化合物 產生劑(B 1 ), 【化1】 (b 1 - 1 4) [式中’ R7”〜R9”各自獨立表示芳基或烷基; 意2個可相互鍵結與式中之硫原子共同形成 之中’至少1個爲氫原子之一部份或全部被 相同曝光量 空間圖型中 顯不不同尺 之參數。於 珍狀或 MEF 即可達成前 提出一種適 該化合物所 物、及使用 爲一種光阻 之溶解性產 之酸產生劑 產生劑成份 所形成之酸 「’〜R9”中任 ;R7”〜R9’ 氧院基氧基 -9- 200914991 或烷氧羰基烷基氧基所取代之取代芳基;χ·爲陰離子]。 又’本發明之第二實施態樣爲,包含使用上述本發明 之第一實施態樣的光阻組成物於支撐體上形成光阻膜之步 驟,使前述光阻膜曝光之步驟,及使前述光阻膜以鹼顯影 而形成光阻圖型之步驟的光阻圖型之形成方法。 此外’本發明之第三實施態樣爲上述通式(b 1 -1 4 ) 所示之化合物。 又’此外,本發明之第四實施態樣爲上述通式(b 1 -1 4 )所示之化合物所形成之酸產生劑。 又,本說明書及申請專利範圍中,「結構單位」係指 構成樹脂成份(聚合物)之單體單位(monomer unit)之 思 。 「曝光」係包含放射線之全般照射之槪念。 「烷基」,於無特別限定性,係包含直鏈狀、支鏈狀 及環狀之1價飽和烴基者。 「低級烷基」係指碳原子數1〜5之烷基之意。 「酸解離性基」係指經由酸之作用而解離之有機基。 本發明,爲提供一種光阻組成物,使用該光阻組成物 之光阻圖型之形成方法,作爲該光阻組成物用酸產生劑之 新穎化合物,及該化合物所形成之酸產生劑。 以下,將對本發明作更詳細之說明。 《第三實施態樣之化合物》 首先,將對本發明之第三實施態樣之化合物進行說明 -10- 200914991 。本發明之第二實施態樣之化合物’如前述通式(b 1 1 4 )所示者。 前述通式(bl-14)中,R 烷基。其中,R7’’〜R9”中至少 部被院氧院基氧基或院氧羯基 〜R各自獨立表示芳基或 1個爲氫原子之〜部份或全 院基氧s所取代之取代芳基 R7’’〜R9’’之芳基’並未有特別限制,例如,碳數6〜 2〇之芳基中’該芳基爲’其氫原子之一部份或全部被垸氧 院基氧基及院氧羰基垸基氧基以外之取代基,例如,院_ 、烷氧基、鹵素原子、羥基等所取代者亦可,未被取代者 亦可。前述芳基,就可廉價合成等觀點,以碳數6〜1〇之 芳基爲佳。具體而言例如,苯基、萘基等。 可取代目丨i述方基Μ原子的院基,以碳數1〜5之院基 爲佳’又以甲基、乙基、丙基、η-丁基、tert -丁基爲最佳 可取代前述芳基之氫原子的烷氧基,以碳數1〜5之 院氧基爲佳,又以甲氧基、乙氧基、η -丙氧基、iso_丙氧 基、η -丁氧基、tert -丁氧基爲最佳。 可取代前述芳基之氫原子的鹵素原子,以氟原子爲佳 R7’’〜R9’’之烷基並未有特別限制,例如可爲碳數1〜 1 0之直鏈狀、支鏈狀或環狀之烷基等。就具有優良解析度 等觀點,以碳數1〜5爲佳。具體而言例如,甲基、乙基 、η-丙基、異丙基、η· 丁基、異丁基、n_戊基、環戊基、 -11 - 200914991 己基、環己基、壬基 '癸基等,就具有優良解析度’且可 廉價地合成等觀點,例如爲甲基等。 R7〜R9中至少1個爲前述芳基之氫原子的一部份或 全J被k虱:ί:兀基氧基或烷氧羰基烷基氧基所取代之取代芳 基。R7〜R9中2個以上爲前述取代芳基者亦可,又以 R7’’〜R9”中任一個爲前述取代芳基者爲最佳。 前述取代芳基中之氫原子可被取代之烷氧烷基氧基, 例如’下述通式(bl4-l)所示之內容。 【化2】200914991 Sub-(MEF) is one of the indicators indicating the above characteristics. Under the condition of guarding the fixed pitch, the mask size (line width of the line and the diameter of the through hole in the contact pattern) is changed. How to faithfully reproduce the mask pattern (mask reproducibility) For the purpose of improving the lithography etching characteristics, etc., it is an important factor to improve the above-mentioned pattern and the like, and the purpose is described when a novel acid generator is used. The present invention has been made in view of the above circumstances, that is, a novel compound which is an acid generator for a photoresist composition, an acid generator formed, and a photoresist containing the acid generator to constitute a photoresist of the photoresist composition. The method of forming the pattern is for the purpose. A first embodiment of the present invention which solves the above problems, a composition comprising a substrate component (A) which is changed by an action of an acid to an alkali developing solution, and a photoresist which generates an acid component (B) by exposure. In the composition, the acid (B) is a compound generating agent (B 1 ) represented by the following formula (bl-14), and is a compound (B 1 - 1 4). "~R9" each independently represents an aryl group or an alkyl group; meaning that two groups may be bonded to each other to form a sulfur atom in the formula. 'At least one of the hydrogen atoms is partially or wholly the same exposure space pattern. There are different parameters in the middle. In the case of Yuzhen or MEF, an acid "'~R9" which is suitable for the compound and which is used as a resistive acid generator generator component; R7"~R9 'Oxygenyloxy-9-200914991 or a substituted aryl group substituted by an alkoxycarbonylalkyloxy group; χ· is an anion]. Further, a second embodiment of the present invention includes the use of the above-described invention The step of forming a photoresist film on the support by the photoresist composition of the embodiment, the step of exposing the photoresist film, and the photoresist pattern of the step of forming the photoresist pattern by alkali development of the photoresist film Further, the third embodiment of the present invention is a compound represented by the above formula (b 1 -1 4 ). Further, in addition, the fourth embodiment of the present invention is the above formula (b 1 -1 4 ) An acid generator formed by the compound shown. In the specification and the patent application, "structural unit" means a monomer unit constituting a resin component (polymer). "Exposure" is a tribute to the full illumination of radiation. The "alkyl group" is not particularly limited, and includes a linear, branched, and cyclic monovalent saturated hydrocarbon group. The "lower alkyl group" means an alkyl group having 1 to 5 carbon atoms. The "acid dissociable group" means an organic group which is dissociated by the action of an acid. The present invention provides a photoresist composition using a photoresist pattern of the photoresist composition, a novel compound as an acid generator for the photoresist composition, and an acid generator formed of the compound. Hereinafter, the present invention will be described in more detail. <<Compound of Third Embodiment>> First, a compound of the third embodiment of the present invention will be described - -10-200914991. The compound of the second embodiment of the present invention is as shown in the above formula (b 1 14 ). In the above formula (bl-14), R alkyl group. Wherein, at least a part of R7''~R9" is independently substituted by a oxy group or a oxyalkyl group to R, each independently representing an aryl group or a part of a hydrogen atom or a substitution of a whole hospital oxygen s The aryl group of the aryl group R7''~R9'' is not particularly limited. For example, in the aryl group having 6 to 2 Å, the aryl group is a part or all of the hydrogen atom. The substituent other than the oxy group and the oxycarbonyl fluorenyloxy group may be substituted, for example, a compound such as a siloxane, an alkoxy group, a halogen atom or a hydroxy group, and may be substituted. The aryl group may be inexpensive. From the viewpoint of synthesis and the like, an aryl group having 6 to 1 carbon atoms is preferred. Specifically, for example, a phenyl group, a naphthyl group, etc. may be substituted for the base of the atom of the atom, and the number of carbon atoms is 1 to 5 The base is preferably 'methyl, ethyl, propyl, η-butyl, tert-butyl is the alkoxy group which can replace the hydrogen atom of the above aryl group, and the alkyl group having a carbon number of 1 to 5 Preferably, methoxy, ethoxy, η-propoxy, iso-propoxy, η-butoxy, tert-butoxy are preferred. Halogen which can replace the hydrogen atom of the aforementioned aryl group atom, The alkyl group having a fluorine atom of preferably R7'' to R9'' is not particularly limited, and for example, it may be a linear, branched or cyclic alkyl group having a carbon number of 1 to 10, etc., and has excellent resolution. The viewpoint is preferably a carbon number of 1 to 5. Specifically, for example, a methyl group, an ethyl group, a η-propyl group, an isopropyl group, an η-butyl group, an isobutyl group, an n-pentyl group, a cyclopentyl group, -11 - 200914991 A hexyl group, a cyclohexyl group, a fluorenyl group, a fluorenyl group, etc., which have excellent resolution and can be synthesized inexpensively, for example, a methyl group, etc. At least one of R7 to R9 is a hydrogen atom of the above aryl group. a part or all of J is k虱: ί: a substituted aryl group substituted by a mercaptooxy group or an alkoxycarbonylalkyloxy group. Two or more of R7 to R9 may be the above substituted aryl group, and Any one of R7'' to R9" is preferably the above substituted aryl group. The alkoxyalkyloxy group in which the hydrogen atom in the above substituted aryl group may be substituted, for example, is represented by the following formula (bl4-l). [Chemical 2]

[式中’ R47及R4 8各自獨立爲氫原子或直鏈狀或支鏈狀之 烷基’ R49爲烷基,R48及R49可相互鍵結形成一個之環構 造亦可。其中’ R47及R48中至少1個爲氫原子]。 式中、R47及R48各自獨立爲氫原子或直鏈狀或支鏈 狀之烷基,其中,R47及R48中,至少1個爲氫原子。 R47、R48中,烷基之碳數較佳爲1〜5,又以乙基、甲 基爲佳,以甲基爲最佳。 又,R47及R48又以一者爲氫原子,另一者爲氫原子 或甲基者爲佳,以R47及R48任一皆爲氫原子爲最佳。 R49之烷基,較佳爲碳數1〜1 5,其可爲直鏈狀、支 鏈狀、環狀中任一者皆可。 R4 9中之直鏈狀、支鏈狀之烷基,以碳數爲1〜5者爲 -12- 200914991 佳,例如,甲基、乙基、丙基、η-丁基、tert-丁基等。 R49中之環狀之烷基,以碳數4〜15者爲佳,以碳數 4〜12者爲更佳,以碳數5〜10者爲最佳。 具體之內容,如可被碳數1〜5之烷基、氟原子或氟 化烷基所取代亦可,或未被取代亦可之單環鏈烷、二環鏈 烷 '三環鏈烷、四環鏈烷等多環鏈烷去除1個以上之氫原 子之基等。單環鏈烷例如環戊烷、環己烷等。多環鏈烷例 如金剛烷、降冰片烷、異冰片烷、三環癸烷、四環十二烷 等。其中又以金剛烷去除1個以上之氫原子之基爲佳。 R48及R49,可相互鍵結形成一個環構造亦可。此時, R48及R49,與R49所鍵結之氧原子,與該氧原子及R48所 鍵結之碳原子亦可形成環式基。該環式基,以4〜7員環 爲佳,以4〜6員環爲更佳。 前述取代芳基中,氫原子被取代之烷氧羰基烷基氧基 ,例如,下述通式(bl4-2 )所示之內容。 【化3】[wherein R47 and R4 8 are each independently a hydrogen atom or a linear or branched alkyl group, R49 is an alkyl group, and R48 and R49 may be bonded to each other to form a ring structure. Wherein at least one of 'R47 and R48 is a hydrogen atom>. In the formula, each of R47 and R48 is independently a hydrogen atom or a linear or branched alkyl group, and at least one of R47 and R48 is a hydrogen atom. In R47 and R48, the carbon number of the alkyl group is preferably from 1 to 5, more preferably ethyl or methyl, and most preferably methyl. Further, it is preferred that one of R47 and R48 is a hydrogen atom, and the other is a hydrogen atom or a methyl group, and any of R47 and R48 is preferably a hydrogen atom. The alkyl group of R49 is preferably a carbon number of 1 to 15, and may be any of a linear chain, a branched chain, and a cyclic chain. The linear or branched alkyl group in R4 9 is preferably -12-200914991 having a carbon number of 1 to 5, for example, methyl, ethyl, propyl, η-butyl, tert-butyl. Wait. The cyclic alkyl group in R49 is preferably a carbon number of 4 to 15, and more preferably a carbon number of 4 to 12, and most preferably a carbon number of 5 to 10. Specifically, for example, it may be substituted by an alkyl group having 1 to 5 carbon atoms, a fluorine atom or a fluorinated alkyl group, or a monocyclic alkane or a bicycloalkane 'tricycloalkane which may be unsubstituted. A polycyclic alkane such as a tetracycloalkane is removed from a group of one or more hydrogen atoms. A monocyclic alkane such as cyclopentane, cyclohexane or the like. Polycyclic alkanes are exemplified by adamantane, norbornane, isobornane, tricyclodecane, tetracyclododecane and the like. Among them, it is preferred that adamantane is used to remove one or more hydrogen atoms. R48 and R49 may be bonded to each other to form a ring structure. In this case, R48 and R49 may form a cyclic group with an oxygen atom bonded to R49 and a carbon atom bonded to the oxygen atom and R48. The ring base is preferably a 4 to 7 member ring, and a 4 to 6 member ring is preferred. In the above substituted aryl group, the alkoxycarbonylalkyloxy group in which the hydrogen atom is substituted is, for example, a content represented by the following formula (bl4-2). [化3]

[式中,R5°爲直鏈狀或支鏈狀之伸烷基,R51爲酸解離性 基]。 R5Q中之直鏈狀、支鏈狀之伸烷基,以碳數爲1〜5者 爲佳,例如,伸甲基、伸乙基、伸三曱基、伸四甲基、1 ,1 -二甲基伸乙基等。 -13- 200914991 R51中之酸解離性基’只要經由酸之作用而解離之有 機基則無特別之限定’其可爲環狀或鏈狀之三級院基醋型 酸解離性基;烷氧烷基等縮醛型酸解離性基等,其中又以 三級烷基酯型酸解離性基爲佳。具體而言例如,2-甲基-2-金剛院基、2 -乙基-2-金剛院基、i_甲基-1-環戊基、卜乙 基-1-環戊基、1-甲基-1-環己基、1-乙基-1-環己基、丨_( 1 -金剛烷基)-1 -甲基乙基、1 - ( 1 -金剛烷基)-1 -甲基丙基 、1- ( 1-金剛烷基)-1-甲基丁基、1- ( 1-金剛烷基)-1-甲 基戊基;1-(1-環戊基)-1-甲基乙基、1-(1-環戊基)-:ι-甲基丙基、l-(l-環戊基)-l-甲基丁基、l-(l-環戊基)-1-甲基戊基;1-(1-環己基)-1-甲基乙基、1-(1-環己基 )-1-甲基丙基、1-(1-環己基)-1-甲基丁基、環己 基)-1-甲基戊基、tert-丁基、tert-戊基、tert -己基等。 前述取代芳基中之氫原子被取代之烷氧烷基氧基或烷 氧羰基烷基氧基之數目,以2個以下爲佳,又以1個爲最 佳。 前述取代芳基以外之R7”〜R9’’,以分別爲苯基或萘基 者爲佳,又以苯基爲最佳。 r7’’〜R9”,以其中任意2個相互鍵結與式中之硫原子 共同形成環亦可。此時,以形成含有硫原子之3〜10員環 爲佳’又以形成5〜7員環者爲更佳。 前述通式(bl-14)中,X-爲陰離子。X-之陰離子 部並未有特別限制,其可適當使用鑰鹽系酸產生劑中已知 作爲陰離子部之物。例如,可使用通式「r14s〇3_(R14爲 -14- 200914991 直鏈狀、支鏈狀或環狀之烷基、鹵化烷基、芳基、或烯基 )j所示之陰離子。或通式「Ri-O-Y^SOsIR1爲1價之 脂肪族烴基、1價之芳香族有機基,或1價之羥烷基;Y1 爲可被氟取代之碳數1〜4之伸烷基)」所示之陰離子。 前述通式「R14S03—」中,R14爲直鏈狀、支鏈狀或環 狀之院基、齒化院基、芳基、或嫌基。 前述R14之直鏈或分支之烷基,以碳數1〜者爲佳 ,以碳數1〜8者爲更佳,以碳數1〜4者爲最佳。 前述R14之環狀烷基,以碳數4〜15者爲佳,以碳數 4〜10者爲更佳,以碳數6〜10者爲最佳。 前述R14之鹵化烷基,即,烷基中之氫原子的一部份 或全部被鹵素原子所取代者。其中,該烷基以碳數1至5 之低級烷基爲佳,其中又以直鏈狀或支鏈狀之烷基爲更佳 ,又以甲基、乙基、丙基、異丙基、η-丁基、tert-丁基、 tert-戊基或異戊基爲更佳。可取代氫原子之鹵素原子,例 如氟原子、氯原子、碘原子、溴原子等。鹵化烷基中,以 氫原子之全體個數的50〜100 %被鹵素原子所取代者爲佳 ,又以全部被取代者爲更佳。 其中,該鹵化烷基以氟化烷基爲佳。氟化烷基以碳數 1〜10者爲佳,以碳數1〜8者爲更佳,以碳數1〜4者爲 最佳。又,該氟化烷基之氟化率(相對於氟化前烷基中之 全部氫原子數,經氟化而取代之氟原子數之比例,以下相 同),較佳爲10〜100%,更佳爲50〜100%,特佳爲氫原 子全部被氟原子取代所得者,以其酸之強度增強而爲最佳 -15- 200914991 。前述較佳之氟化烷基,具體而言,例如三氟甲基、七 氟-η-丙基、九氟_n_ 丁基等。 則述R14之芳基,可具有取代基亦可,又以碳數6〜 20之芳基爲佳。可具有之取代基,例如鹵素原子、雜原子 、垸基等。取代基可具有複數個。 前述R14之烯基’其可具有取代基,又以碳數2〜1〇 之烯基爲佳。可具有之取代基’例如鹵素原子、雜原子、 院基等。取代基可具有複數個。 其中又以’則述R 1 4爲鹵化院基爲佳。 前述通式「R^O-Y^SOr」中,R1爲1價之脂肪族烴 基、1價之芳香族有機基、或1價之羥烷基;Y1爲可被氟 取代之碳數1〜4之伸烷基。 R1之1價之脂肪族烴基,例如,碳數1〜1 5之直鏈狀 、支鏈狀或環狀之1價之飽和烴基,或碳數2〜5之直鏈 狀或支鏈狀之1價之脂肪族不飽和烴基等。 直鏈狀之1價飽和烴基,例如,甲基、乙基、丙基、 丁基、戊基、己基、庚基、辛基、壬基、癸基等。 支鏈狀之1價飽和烴基,例如’ 1 -甲基乙基、1 -甲基 丙基、2 -甲基丙基、1-甲基丁基、2 -甲基丁基、3 -甲基丁 基、1-乙基丁基、2 -乙基丁基、1-甲基戊基、2 -甲基戊基 、3·甲基戊基、4_甲基戊基等。 環狀之1價飽和烴基,可爲多環式基、單環式基中任 一者皆可,例如,單環鏈烷 '二環鏈烷、三環鏈烷、四環 鏈烷等多環鏈烷去除1個氫原子所得之基等。更具體而言 -16- 200914991 ,例如,環戊烷、環己烷 '環庚烷、環辛烷等之單環鏈烷 ,或金剛院、降冰片院、異冰片院、三環癸院、四環十二 院等多環鏈院去除1個氫原子所得之基等。 直鏈狀之1價不飽和烴基,例如’乙烯基' 丙烯基( 烯丙基)、丁烯基等。 支鏈狀之1價不飽和烴基’例如,1-甲基丙烯基、2_ 甲基丙烯基等。 R之1價脂肪族烴基之碳數以2〜4爲佳,又以3爲 最佳。 R1之1價之芳香族有機基,例如苯基、聯苯基( biphenyl)、芴基(fluorenyi)、萘基、蒽基(anthryl) 基、菲繞啉基等之芳香族烴之環去除1個氫原子之基,及 構成即述芳基之環的碳原子之一部份被氧原子、硫原子、 氮原子等雜原子取代所得之雜芳基,苄基、苯乙基、丨_萘 甲基、2-萘甲基、卜萘乙基、2_萘乙基等芳烷基等。前述 方院基中之院鏈的碳數以1至4爲佳,以1至2爲更佳, 以1爲最佳。該些芳基、雜芳基、芳烷基,可具有碳數i 〜1 〇之烷基、鹵化烷基、烷氧基、羥基、鹵素原子等取代 基。該取代基中之烷基或鹵化烷基,以碳數1〜8者爲佳 ’又以碳數1〜4爲更佳。又’該鹵化烷基以氟化烷基爲 佳。該鹵素原子例如氟原子、氯原子、碘原子、溴原子等 ’又以氣原子爲佳。[wherein, R5° is a linear or branched alkyl group, and R51 is an acid dissociable group]. A linear or branched alkyl group in R5Q, preferably having a carbon number of 1 to 5, for example, a methyl group, an ethyl group, a trisyl group, a tetramethyl group, a 1,1 -2 group. Methyl extended ethyl and the like. -13- 200914991 The acid-dissociable group in R51 is not particularly limited as long as it is dissociated by the action of an acid. It may be a cyclic or chain-like tertiary-grade vinegar-type acid dissociable group; An acetal type acid dissociable group such as an alkyl group, and the like, and a third-stage alkyl ester type acid dissociable group is preferred. Specifically, for example, 2-methyl-2-goldenyl, 2-ethyl-2-goldenyl, i-methyl-1-cyclopentyl, ethyl-1-cyclopentyl, 1-methyl 1-cyclohexyl, 1-ethyl-1-cyclohexyl, 丨-(1-adamantyl)-1-methylethyl, 1-(1-adamantyl)-1-methylpropyl, 1-(1-adamantyl)-1-methylbutyl, 1-(1-adamantyl)-1-methylpentyl; 1-(1-cyclopentyl)-1-methylethyl , 1-(1-cyclopentyl)-:ι-methylpropyl, 1-(l-cyclopentyl)-l-methylbutyl, 1-(l-cyclopentyl)-1-methyl Butyl; 1-(1-cyclohexyl)-1-methylethyl, 1-(1-cyclohexyl)-1-methylpropyl, 1-(1-cyclohexyl)-1-methylbutyl , cyclohexyl)-1-methylpentyl, tert-butyl, tert-pentyl, tert-hexyl, and the like. The number of the alkoxyalkyloxy group or the alkoxycarbonylalkyloxy group in which the hydrogen atom in the substituted aryl group is substituted is preferably 2 or less, and more preferably one. R7" to R9'' other than the substituted aryl group is preferably a phenyl group or a naphthyl group, and preferably a phenyl group. r7''~R9", wherein any two of them are bonded to each other The sulfur atoms in the form together form a ring. In this case, it is preferable to form a 3 to 10 member ring containing a sulfur atom, and it is more preferable to form a 5 to 7 member ring. In the above formula (bl-14), X- is an anion. The anion portion of X- is not particularly limited, and those known as an anion portion of the key salt acid generator can be suitably used. For example, an anion represented by the formula "r14s〇3_(R14 is a linear, branched or cyclic alkyl group, a halogenated alkyl group, an aryl group, or an alkenyl group) j can be used. The formula "Ri-OY^SOsIR1 is a monovalent aliphatic hydrocarbon group, a monovalent aromatic organic group, or a monovalent hydroxyalkyl group; Y1 is an alkyl group having 1 to 4 carbon atoms which may be substituted by fluorine" Show anion. In the above formula "R14S03-", R14 is a linear, branched or ring-shaped yard base, a dentifrice base, an aryl group, or a suspect base. The linear or branched alkyl group of the above R14 is preferably one having a carbon number of 1 or less, more preferably having a carbon number of 1 to 8, and most preferably having a carbon number of 1 to 4. The cyclic alkyl group of R14 is preferably a carbon number of 4 to 15, more preferably a carbon number of 4 to 10, and most preferably a carbon number of 6 to 10. The above halogenated alkyl group of R14, that is, a part or all of a hydrogen atom in the alkyl group is substituted by a halogen atom. Wherein, the alkyl group is preferably a lower alkyl group having 1 to 5 carbon atoms, wherein a linear or branched alkyl group is more preferably a methyl group, an ethyl group, a propyl group or an isopropyl group. More preferably, η-butyl, tert-butyl, tert-pentyl or isopentyl. A halogen atom which may be substituted for a hydrogen atom, such as a fluorine atom, a chlorine atom, an iodine atom or a bromine atom. In the halogenated alkyl group, 50 to 100% of the total number of hydrogen atoms is preferably substituted by a halogen atom, and more preferably all of them are substituted. Among them, the halogenated alkyl group is preferably a fluorinated alkyl group. The fluorinated alkyl group is preferably a carbon number of 1 to 10, more preferably a carbon number of 1 to 8, and most preferably a carbon number of 1 to 4. Further, the fluorination ratio of the fluorinated alkyl group (the ratio of the number of fluorine atoms substituted by fluorination to the total number of hydrogen atoms in the fluorinated alkyl group is the same as the following) is preferably 10 to 100%. More preferably, it is 50 to 100%, and it is particularly preferred that all of the hydrogen atoms are replaced by fluorine atoms, and the strength of the acid is enhanced to be the best -15-200914991. The above preferred fluorinated alkyl group is specifically, for example, a trifluoromethyl group, a heptafluoro-η-propyl group, a nonafluoro-n-butyl group or the like. The aryl group of R14 may have a substituent, and preferably an aryl group having 6 to 20 carbon atoms. There may be a substituent such as a halogen atom, a hetero atom, a fluorenyl group or the like. The substituents may have a plurality of substituents. The above alkenyl group of R14 may have a substituent, and is preferably an alkenyl group having 2 to 1 carbon atoms. There may be a substituent such as a halogen atom, a hetero atom, a hospital base or the like. The substituents may have a plurality of substituents. Among them, it is better to say that R 1 4 is a halogenated hospital base. In the above formula "R^OY^SOr", R1 is a monovalent aliphatic hydrocarbon group, a monovalent aromatic organic group, or a monovalent hydroxyalkyl group; and Y1 is a carbon number 1 to 4 which may be substituted by fluorine. Alkyl. The monovalent aliphatic hydrocarbon group of R1, for example, a linear, branched or cyclic monovalent saturated hydrocarbon group having 1 to 15 carbon atoms, or a linear or branched carbon number of 2 to 5 A monovalent aliphatic unsaturated hydrocarbon group or the like. A linear monovalent saturated hydrocarbon group, for example, a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a decyl group, a decyl group or the like. Branched monovalent saturated hydrocarbon group, such as '1-methylethyl, 1-methylpropyl, 2-methylpropyl, 1-methylbutyl, 2-methylbutyl, 3-methyl Butyl, 1-ethylbutyl, 2-ethylbutyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, and the like. The cyclic monovalent saturated hydrocarbon group may be any of a polycyclic group or a monocyclic group, for example, a polycyclic ring such as a monocyclic alkane 'bicycloalkane, a tricycloalkane or a tetracycloalkane. The base obtained by removing one hydrogen atom from the alkane. More specifically,-16-200914991, for example, a monocyclic alkane such as cyclopentane, cyclohexane 'cycloheptane, cyclooctane, or the like, or a diamond plant, a noodle house, an ice sculpture, a three-ring brothel, The base obtained by removing one hydrogen atom from a multi-ring chain such as the Fourth Ring and the Fourth House. A linear monovalent unsaturated hydrocarbon group such as a 'vinyl' propylene group (allyl), a butenyl group or the like. A branched monovalent unsaturated hydrocarbon group 'e.g., a 1-methylpropenyl group, a 2-methacryl group, or the like. The carbon number of the monovalent aliphatic hydrocarbon group of R is preferably 2 to 4, and more preferably 3. Aromatic organic group of a valence of R1, for example, a ring of an aromatic hydrocarbon such as a phenyl group, a biphenyl group, a fluorenyi group, a naphthyl group, an anthryl group or a phenanthroline group; a heteroaryl group obtained by substituting a hydrogen atom or a part of a carbon atom constituting the ring of the aryl group with a hetero atom such as an oxygen atom, a sulfur atom or a nitrogen atom, benzyl, phenethyl or fluorene-naphthalene An aralkyl group such as a methyl group, a 2-naphthylmethyl group, a naphthylethyl group or a 2-naphthylethyl group. The carbon number of the chain in the aforementioned square yard is preferably from 1 to 4, more preferably from 1 to 2, and most preferably from 1. The aryl group, heteroaryl group or aralkyl group may have a substituent such as an alkyl group having a carbon number of i 〜1 〇, a halogenated alkyl group, an alkoxy group, a hydroxyl group or a halogen atom. The alkyl group or the halogenated alkyl group in the substituent is preferably a carbon number of 1 to 8 and more preferably a carbon number of 1 to 4. Further, the halogenated alkyl group is preferably a fluorinated alkyl group. The halogen atom such as a fluorine atom, a chlorine atom, an iodine atom, a bromine atom or the like is preferably a gas atom.

Rl之1價羥烷基’爲直鏈狀、支鏈狀或環狀之1價飽 和烴基中至少1個氫原子被羥基所取代者。又以直鏈狀或 -17- 200914991 支鏈狀之1價之飽和烴基中之1個或2個之氫原子被羥基 所取代者爲佳。具體而言,例如羥甲基、羥乙基、1 -羥丙 基、2-羥丙基、3-羥丙基、2,3-二羥丙基等。 R1之1價羥烷基之碳數以1〜1 0爲佳,以1〜8爲更 佳,以1〜6爲最佳,以1〜3爲特佳。 Y1之可被氟取代之碳數1〜4之伸烷基,例如-CF2-' -CF2CF2-、-CF2CF2CF2- ' -CF(CF3)CF2-、-CF(CF2CF3)- 、-c(cf3)2-、-cf2cf2cf2cf2-、-cf(cf3)cf2cf2-、 -CF2CF(CF3)CF2-、-CF(CF3)CF(CF3)-、-C(CF3)2CF2-、 -cf(cf2cf3)cf2-、-cf(cf2cf2cf3)-、-C(CF3)(CF2CF3)- ;-CHF- ' CH2CF2- ' -CH2CH2CF2- ' -CH2CF2CF2- ' -CH(CF3)CH2-、-CH(CF2CF3)-、-C(CH3)(CF3)·、 -CH2CH2CH2CF2-、-CH2CH2CF2CF2-、-CH(CF3)CH2CH2- 、-ch2ch(cf3)ch2-、-ch(cf3)ch(cf3)-、-c(cf3)2ch2-;-ch2-、-ch2ch2-、-ch2ch2ch2-、-ch(ch3)ch2-、 -CH(CH2CH3)-、-C(CH3)2-- -CH2CH2CH2CH2-、 -CH(CH3)CH2CH2-、-CH2CH(CH3)CH2-、 -CH(CH3)CH(CH3)-、-C(CH3)2CH2-、-CH(CH2CH3)CH2-、 -CH(CH2CH2CH3)-、-C(CH3)(CH2CH3)-等。 又,Y1之可被氟取代之碳數1〜4之伸烷基,以鍵結 於S之碳原子被氟化者爲佳,前述氟化伸烷基,例如 -CF2-、-CF2CF2- ' -CF2CF2CF2- ' -CF(CF3)CF2- ' •CF2CF2CF2CF2-、-CF(CF3)CF2CF2-、-CF2CF(CF3)CF2-、 -CF(CF3)CF(CF3)-、-C(CF3)2CF2-、-CF(CF2CF3)CF2-; -18- 200914991 -CH2CF2- ' -CH2CH2CF2- ' -CH2CF2CF2-; -CH2CH2CH2CF2-、-CH2CH2CF2CF2-、-CH2CF2CF2CF2-等 。其中又以-CF2CF2-、-CF2CF2CF2·,或 CH2CF2CF2-爲佳 ,以- CF2CF2·或- CF2CF2CF2 -爲更佳,以- CF2CF2 -爲最佳。 前述通式(bl-14 )中,X·可使用下述通式(b-3 )所 示之陰離子、下述通式(b-4)所示之陰離子等。 【化4】The monovalent hydroxyalkyl group of R1 is a linear, branched or cyclic monovalent saturated hydrocarbon group in which at least one hydrogen atom is replaced by a hydroxyl group. Further, one or two hydrogen atoms of a linear or -17-200914991 branched monovalent saturated hydrocarbon group are preferably replaced by a hydroxyl group. Specifically, for example, hydroxymethyl, hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 2,3-dihydroxypropyl and the like. The carbon number of the monovalent hydroxyalkyl group of R1 is preferably 1 to 10, more preferably 1 to 8, more preferably 1 to 6, and particularly preferably 1 to 3. Alkyl group of 1 to 4 carbon atoms which may be substituted by fluorine, such as -CF2-'-CF2CF2-, -CF2CF2CF2-'-CF(CF3)CF2-, -CF(CF2CF3)-, -c(cf3) 2-, -cf2cf2cf2cf2-, -cf(cf3)cf2cf2-, -CF2CF(CF3)CF2-, -CF(CF3)CF(CF3)-, -C(CF3)2CF2-, -cf(cf2cf3)cf2-, -cf(cf2cf2cf3)-, -C(CF3)(CF2CF3)-; -CHF- 'CH2CF2- ' -CH2CH2CF2- ' -CH2CF2CF2- ' -CH(CF3)CH2-, -CH(CF2CF3)-, -C( CH3)(CF3)·, -CH2CH2CH2CF2-, -CH2CH2CF2CF2-, -CH(CF3)CH2CH2-, -ch2ch(cf3)ch2-, -ch(cf3)ch(cf3)-, -c(cf3)2ch2-; -ch2-, -ch2ch2-, -ch2ch2ch2-, -ch(ch3)ch2-, -CH(CH2CH3)-, -C(CH3)2---CH2CH2CH2CH2-, -CH(CH3)CH2CH2-, -CH2CH( CH3)CH2-, -CH(CH3)CH(CH3)-, -C(CH3)2CH2-, -CH(CH2CH3)CH2-, -CH(CH2CH2CH3)-, -C(CH3)(CH2CH3)-, and the like. Further, the alkyl group of Y1 which may be substituted by fluorine and has a carbon number of 1 to 4 is preferably a fluorine atom bonded to the carbon atom of S, and the above-mentioned fluorinated alkyl group, for example, -CF2-, -CF2CF2-' -CF2CF2CF2- ' -CF(CF3)CF2- ' •CF2CF2CF2CF2-, -CF(CF3)CF2CF2-, -CF2CF(CF3)CF2-, -CF(CF3)CF(CF3)-, -C(CF3)2CF2- -CF(CF2CF3)CF2-; -18- 200914991 -CH2CF2- '-CH2CH2CF2- '-CH2CF2CF2-; -CH2CH2CH2CF2-, -CH2CH2CF2CF2-, -CH2CF2CF2CF2-, etc. Further, -CF2CF2-, -CF2CF2CF2., or CH2CF2CF2- is preferred, and -CF2CF2. or -CF2CF2CF2- is more preferred, and -CF2CF2- is preferred. In the above formula (bl-14), an anion represented by the following formula (b-3), an anion represented by the following formula (b-4), or the like can be used as X. 【化4】

…(b-3) 〇2S—Y&quot;...(b-3) 〇2S—Y&quot;

-••(b-4) [式中,X”爲至少1個氫原子被氟原子取代之碳數2至6 之伸烷基;Y”、2;”各自獨立爲至少1個氫原子被氟原子取 代之碳數〗至1〇之烷基]。 通式(b-3 )中,X”爲至少1個氫原子被氟原子取代 之直鏈狀或支鏈狀伸烷基,該伸烷基之碳數較佳爲2至6 ,更佳爲碳數3至5,最佳爲碳數3。 通式(b-4 )中,Y”、Z”各自獨立爲至少1個氫原子 被氟原子取代之直鏈狀或支鏈狀烷基,該烷基之碳數較佳 爲1至10,更佳爲碳數1至7,最佳爲碳數1至3。 X”之伸烷基之碳數或Y”、Z”之烷基的碳數於上述範圍 內時,基於對光阻溶劑具有優良溶解性等理由,以越小越 好。 又,X ’’之伸烷基或Y ”、Z ”之烷基中,被氟原子取代之 -19- 200914991 氫原 之筒 該伸 90 3 基或 中, 子、 如下 子數越多時,酸之強度越強’又,相對於200nm以下 能量光線或電子線時,以其可提高透明性而爲較佳。 烷基或烷基中之氟化率’較佳爲70至100%’更佳爲 E 1 00%,最佳爲全部氫原子被氟原子取代之全氟伸烷 全氟院基。 又,前述通式(bl-14)中,X-可爲鹵素陰離子。其 鹵素陰離子例如氟化物離子、氯化物離子、溴化物離 碘化物離子等。 本發明之第三實施態樣之化合物,較佳之具體例列舉 所示。 -20- 200914991-••(b-4) [wherein, X" is an alkylene group having 2 to 6 carbon atoms substituted with at least one hydrogen atom by a fluorine atom; Y", 2;" each independently is at least one hydrogen atom a carbon atom substituted by a fluorine atom to an alkyl group of 1 ]]. In the formula (b-3), X" is a linear or branched alkyl group in which at least one hydrogen atom is substituted by a fluorine atom, and the extension The alkyl group preferably has 2 to 6 carbon atoms, more preferably 3 to 5 carbon atoms, most preferably 3 carbon atoms. In the formula (b-4), Y" and Z" are each independently a linear or branched alkyl group in which at least one hydrogen atom is substituted by a fluorine atom, and the alkyl group preferably has 1 to 10 carbon atoms. More preferably, the carbon number is from 1 to 7, and the most preferred carbon number is from 1 to 3. When the carbon number of the alkyl group of X" or the carbon number of the alkyl group of Y" or Z" is in the above range, it is preferably as small as possible based on the solubility of the resist solvent, etc. Further, X '' In the alkyl group of the alkyl group or the Y", Z" group, which is replaced by a fluorine atom, the cylinder of the hydrogen atom is extended to 90 3 groups or in the middle, and the more the number of the following sub-numbers, the stronger the strength of the acid Further, it is preferable to increase the transparency with respect to an energy light or an electron beam of 200 nm or less. The fluorination rate in the alkyl group or the alkyl group is preferably 70 to 100%, more preferably E 1 00. % is preferably a perfluoroalkylene perfluorocarbon group in which all hydrogen atoms are replaced by fluorine atoms. Further, in the above formula (bl-14), X- may be a halogen anion. Its halogen anion such as fluoride ion or chlorine The compound ion, the bromide ion iodide ion, etc. The compound of the third embodiment of the present invention is preferably exemplified by a specific example. -20- 200914991

【化5 I[Chemical 5 I

-21 - 200914991 【化6】-21 - 200914991 [Chem. 6]

CH2OCF2CF2CF2SO3 (b 1 -1 4-20 1)CH2OCF2CF2CF2SO3 (b 1 -1 4-20 1)

(b 1 - 1 4-2 0 2)(b 1 - 1 4-2 0 2)

-22- 200914991 【化7】-22- 200914991 【化7】

-23- 200914991 【化8】-23- 200914991 【化8】

-24- 200914991-24- 200914991

-25- 200914991 【化1 0】-25- 200914991 【化1 0】

-26- 200914991-26- 200914991

ch2ocf2cf2cf2so;Ch2ocf2cf2cf2so;

(b 1 — 1 4 —3 1 6)(b 1 — 1 4 — 3 1 6)

-27- 200914991 【化1 2】-27- 200914991 【化1 2】

其中又以前述化學式(bl-14-101) 、 (bl-14-201) 、(bl-14-301) 、 (bl-14-401)及(bl-14-402)所示之 化合物爲佳。 -28- 200914991 &lt;第三實施態樣之化合物的製造方法&gt; 本發明之第三實施態樣的化合物(b卜14) ’例如’ 可依以下方式製造。即,於有機酸H + B- ( ,例如’甲烷 磺酸離子等,表示有機酸之陰離子部)之溶液中’加入下 述通式(bl-14-Ol)及(bl-14-〇2)所示之化合物使其進 行反應後,加入純水及有機溶劑(例如,二氯甲烷、四氫 呋喃等),將有機層回收,由該有機層中取得下述通式( bl-14-03 )所示之化合物。 其次,使通式(bl-14-03 )所示之化合物溶解於有機 溶劑(例如,二氯甲烷、四氫呋喃等)與水之混合溶劑中 ,再加入所期待之陰離子X_之鹼金屬鹽L + X_ ( L+,例如 ’鋰離子、鉀離子、鈉離子等所表示之鹼金屬陽離子)使 其反應’於進行分液及水洗後,由有機層中製得下述通式 (bl-l4-〇4 )所示之化合物。 其次’使通式(bl-14-04 )所示之化合物溶解於有機 溶劑(例如’二氯甲烷、四氫呋喃等)中,於水冷後,加 入驗(例如,氫化鈉等)’加入所期待之烷氧烷基或烷氧 幾院基之鹵化物(例如,通式「C1-C ( R47 ) ( R48 ) -〇- r49」、「c 1-R5〇-C ( = 0 ) -〇-R51」、「Br-R50-C ( = 〇 )-0-R51」等。其中,r47〜r51係與前述爲相同之內容) ’使-R1C) -OH之-OH基的氫原子與前述烷氧烷基或烷氧羰 烷基進行取代,而得化合物(b丨_丨4 )。 -29- 200914991 【化1 3】 Ο t r8,-s-r9&quot;Among them, compounds represented by the aforementioned chemical formulas (bl-14-101), (bl-14-201), (bl-14-301), (bl-14-401) and (bl-14-402) are preferred. . -28-200914991 &lt;Production Method of Compound of Third Embodiment&gt; The compound (b) of the third embodiment of the present invention can be produced, for example, in the following manner. That is, in the solution of the organic acid H + B- (for example, 'methanesulfonate ion, etc., indicating an anion portion of the organic acid), 'the following formula (bl-14-Ol) and (bl-14-〇2) are added. After the compound is reacted, pure water and an organic solvent (for example, dichloromethane, tetrahydrofuran, etc.) are added, and the organic layer is recovered, and the following formula (bl-14-03) is obtained from the organic layer. The compound shown. Next, the compound represented by the formula (bl-14-03) is dissolved in a mixed solvent of an organic solvent (for example, dichloromethane, tetrahydrofuran, etc.) and water, and then the alkali metal salt L of the desired anion X_ is added. + X_ (L+, for example, 'alkali metal cation represented by lithium ion, potassium ion, sodium ion, etc.) is allowed to react. After liquid separation and water washing, the following formula (bl-l4-) is obtained from the organic layer. 〇4) The compound shown. Next, 'the compound represented by the formula (bl-14-04) is dissolved in an organic solvent (for example, 'dichloromethane, tetrahydrofuran, etc.), and after water cooling, an addition test (for example, sodium hydride, etc.) is added to the desired a halide of an alkoxyalkyl or alkoxy group (for example, the formula "C1-C ( R47 ) ( R48 ) - 〇 - r49", "c 1-R5 〇 - C ( = 0 ) - 〇 - R51 "Br-R50-C (= 〇)-0-R51", etc., wherein r47 to r51 are the same as described above) - "-R1C" - the hydrogen atom of the -OH group of -OH and the alkoxy group described above The alkyl or alkoxycarbonylalkyl group is substituted to give the compound (b丨_丨4). -29- 200914991 【化1 3】 Ο t r8,-s-r9&quot;

H-R10-〇H (b 1 - 1 4-0 1 ) (b 1 - 1 4-0 2) OHR10&quot; H+B' R8—S+ B' (b 1 — 1 4-0 3)H-R10-〇H (b 1 - 1 4-0 1 ) (b 1 - 1 4-0 2) OHR10&quot; H+B' R8-S+ B' (b 1 — 1 4-0 3)

OH D10&quot; R8'二 S+ X-(b 1 - 1 4) L+X- x* ^ R9&quot; (b 1 - 1 4-0 4) [式中,R8”及R9,,係與前述通式(b卜丨^中之厌8及R爲 相同之內容;爲前述通式(w-14)中之芳基的尺7去 除1個氫原子所得之伸芳基;Β —爲有機酸之陰離子部’ L+爲鹼金屬陽離子;X·係與前述通式(bl_14)中之I 爲相同之內容。] 又,化合物(bl-14-03)之陰離子交換中’係可由 L + X.與反應之前使化合物(bl-14-03)之-R1(&gt;”-〇H的-0H 基之氫原子與前述烷氧烷基或烷氧羰烷基進行取代之方式 ,以進行陰離子交換,而可製得化合物(b卜1 4 )。 《第四實施態樣之酸產生劑》 本發明之第四實施態樣之酸產生劑(以下,亦稱爲酸 產生劑(B1)),係由前述通式(bl-14)所示之化合物 所形成。式中’ R7’’〜R9’’,X-係與上述本發明之第三實施 -30- 200914991 態樣的化合物中所列舉之化合物爲相同之內容。 《第一實施態樣之光阻組成物:》 ‘將對本發明之第一之實施態樣的光阻組成物進行說明 。本發明之第一實施態樣的光阻組成物,爲含有經由酸之 作用而對鹼顯影液之溶解性產生變化之基材成份(A )( 以下’亦稱爲(A)成份)及經由曝光而產生酸之酸產生 劑成份(B)(以下,亦稱爲(B)成份),又,前述(B )成份爲含有前述通式(bl-14)所示之化合物所形成之 酸產生劑(B 1 )。 本發明之光阻組成物中,(A )成份可使用經由酸之 作用而對鹼顯影液之溶解性產生變化之高分子材料,亦可 使用經由酸之作用而對鹼顯影液之溶解性產生變化之低分 子材料。 又’本發明之光阻組成物可爲負型光阻組成物,或爲 正型光阻組成物。 本發明之光阻組成物爲負型光阻組成物時,例如,( A )成份爲鹼可溶性樹脂,且該負型光阻組成物添加有交 聯劑(C )。 該負型光阻組成物,於形成光阻圖型時,經由曝光使 ' (B )成份產生酸時,曝光部經由該酸之作用而於鹼可溶 - 性樹脂與交聯劑之間形成交聯,而變化爲鹼不溶性。 鹼可溶性樹脂’以具有由ct -(羥烷基)丙烯酸酸、 或《 -(羥烷基)丙烯酸酸之低級烷基酯所選出之至少一 -31 - 200914991 個所衍生之單位的樹脂,可形成具有較少膨 '潤之良好光阻 圖型,而爲較佳。又,《 -(羥烷基)丙稀酸酸’爲鍵結 於羧基之(X位之碳原子鍵結氫原子所得之丙丨希__ ’與該 α位之碳原子鍵結羥烷基(較佳爲碳數1〜5之經丨完基) 所鍵結之α -羥烷基丙烯酸酸之一或二者之意° 交聯劑(c ),例如,通常使用具有羥甲基或院氧甲 基之甘脲等之胺基系交聯劑時,可形成具有較少膨潤之良 好光阻圖型,而爲較佳。交聯劑(c )之添加量,相對於 鹼可溶性樹脂1 〇〇質量份,以1〜5 0質量份爲佳。 本發明之光阻組成物爲正型光阻組成物時,(A )成 份,於曝光前對鹼顯影液爲不溶性,於形成光阻圖型時, 經由曝光使前述(B )成份產生之酸生作用時,而使酸解 離性溶解抑制基解離之方式,而增大(A )成份全體段鹼 顯影液之溶解性,使其由鹼不溶性變化爲鹼可溶性。因此 ,於光阻圖型之形成中,對將該正型光阻組成物塗佈於基 板上所得之光阻膜進行選擇性曝光時,曝光部於轉變爲鹼 可溶性的同時,未曝光部則爲鹼不溶性之未變化之狀態, 而可進行鹼顯影。 本發明之光阻組成物中,(A )成份以使用經由酸之 作用而增大對鹼顯影液之溶解性之基材成份爲佳。即,本 發明之光阻組成物以正型光阻組成物爲佳。又,(A )成 份以使用經由酸之作用而增大鹼溶解性之樹脂成份(A 1 ) (以下,亦稱爲(A1 )成份)爲更佳。 -32- 200914991 &lt; (A 1 )成份&gt; 該正型光阻組成物中較佳使用之(A 1 )成份’以具有 含酸解離性溶解抑制基之丙烯酸酯所衍生之結構單位(a 1 )爲佳。 又,前述(A1)成份以再含有具有含內酯之環式基的 丙烯酸酯所衍生之結構單位(a2 )爲佳。 又,前述(A1)成份以再含有具有含極性基之脂肪族 烴基的丙烯酸酯所衍生之結構單位(a3 )爲佳。 其中,本說明書與申請專利範圍中,「丙烯酸酯所衍 生之結構單位」係指丙烯酸酯之乙烯性雙鍵經開裂所構成 之結構單位之意。 「丙烯酸酯」,係指α位之碳原子除鍵結有氫原子之 丙烯酸酯以外,亦包含α位之碳原子鍵結有取代基(氫原 子以外之原子或基)之化合物之槪念。取代基,例如低級 烷基、鹵化低級烷基等。 又,丙烯酸酯所衍生之結構單位之ct位(α位之碳原 子),於未有特別限定下,係指鍵結於羰基之碳原子。 丙烯酸酯中,α位取代基之低級烷基,具體而言,例 如甲基、乙基、丙基、異丙基、η-丁基、異丁基、tert -丁 基、戊基、異戊基、新戊基等直鏈狀或支鏈狀之低級烷基 等。 又,鹵化低級院基’具體而言,以上述「α位取代基 之低級烷基」中之氫原子的一部份或全部被鹵素原子取代 所得之基等。該鹵素原子’例如氟原子、氯原子、溴原子 -33- 200914991 、磺原子等,特別是以氟原子爲佳。 本發明中,丙烯酸酯之α位所鍵結者,以氫原子、低 級烷基或鹵化低級烷基爲佳,又以氫原子、低級烷基或氟 化低級烷基爲更佳,就工業上容易取得等觀點,以氫原子 或甲基爲最佳。 •結構單位(a 1 ) 結構單位(a 1 ),爲含酸解離性溶解抑制基之丙烯酸 酯所衍生之結構單位。 結構單位(a 1 )中之酸解離性溶解抑制基,只要爲解 離前使(A 1 )成份全體具有鹼不溶性之鹼溶解抑制性的同 時,經由酸之解離後使此(A 1 )成份全體增大對鹼顯影液 之溶解性之基即可,其可使用目前爲止被提案作爲化學增 幅型光阻組成物用基礎樹脂之酸解離性溶解抑制基之物。 一般而言,已知者例如可與(甲基)丙烯酸中之羧基 形成環狀或鏈狀之三級烷基酯之基,或烷氧烷基等縮醛型 酸解離性溶解抑制基等。又,「(甲基)丙烯酸酯」係指 氫原子鍵結於α位之丙烯酸酯,與甲基鍵結於α位之甲基 丙烯酸酯中一或二者之意。 其中,「三級烷基酯」,例如羧基之氫原子被鏈狀或 環狀之烷基取代而形成酯,使該羰氧基(-C ( 0 ) -0-)末 端之氧原子,鍵結於前述鏈狀或環狀之烷基之三級碳原子 所得之結構。前述三級烷基酯中,經由酸之作用時,即可 切斷氧原子與三級碳原子之間的鍵結。 -34- 200914991 又,前述鏈狀或環狀之烷基可具有取代基。 以下,經由羧基與三級烷基酯所構成之具有酸解離性 之基,方便上將其稱爲「三級烷基酯型酸解離性溶解抑制 基」。 三級烷基酯型酸解離性溶解抑制基’例如脂肪族支鏈 狀酸解離性溶解抑制基、含有脂肪族環式基之酸解離性溶 解抑制基等。 其中,本申請專利範圍與說明書中所稱之「脂肪族」 ,係指相對於芳香族之相對槪念,即定義爲不具有芳香族 性之基、化合物等之意。 「脂肪族支鏈狀」係指不具有芳香族性之支鏈狀結構 之意。 「脂肪族支鏈狀酸解離性溶解抑制基」之結構,並未 限定爲由碳與氨所形成之基(烴基),但以烴基爲佳。 又,「烴基」可爲飽和或不飽和者皆可,一般以飽和 者爲佳。 脂肪族支鏈狀酸解離性溶解抑制基以碳數4至8之三 級烷基爲佳’具體而言,例如tert-丁基、tert-戊基、tert- 庚基等。 「脂肪族環式基」係指不具有芳香族性之單環式基或 多環式基。 結構單位(a 1 )中之「脂肪族環式基」,其可具有取 代基或未取有取代基皆可。取代基例如碳數1至5之低級 烷基、氟原子、被氟原子取代之碳數1至5之氟化低級烷 -35- 200914991 基、氧原子 「脂肪 未限定由碳 ,「烴基」 佳。「脂肪 脂肪族 或氟化烷基 鏈烷、三環 原子所得之 單環鏈烷或 環十二烷等 又,含 於環狀之烷 言,例如2 或例如下述 鍵結於羰氧 剛烷基、環 環十二烷基 原子之支鏈 (=〇)等。 族環式基」中去除 與氫所構成之基( 可爲飽和或不飽和 族環式基」以多環 環式基之具體例, 所取代者,或未取 鏈烷、四環鏈烷等 基等。更具體而言 ,金剛烷、降冰片 多環鏈烷中去除1 有脂肪族環式基之 基的環骨架上具有 -甲基-2-金剛烷基 通式(al”-l)〜 基(-C-(O) -0· 己基、環戊基、降 等之脂肪族環式基 狀伸烷基之基等。 取代基之基本的環結構,並 烴基),但以烴基爲佳。又 者皆可’一般又以飽和者爲 式基爲較佳。 例如可被低級烷基、氟原子 代亦可之由單環鏈烷、二環 多環鏈烷中去除1個以上氫 ,例如由環戊烷、環己烷等 烷、異菠烷、三環癸烷、四 個以上氫原子所得之基等。 酸解離性溶解抑制基,例如 三級碳原子之基等,具體而 ,或2-乙基-2-金剛烷基等。 (a 1 ” - 6 )所示結構單位中, )之氧原子之基般’具有金 冰片烷基、三環癸烷基、四 ,及與其鍵結之具有三級碳 -36- 200914991 【化1 4】OH D10&quot; R8'2 S+ X-(b 1 - 1 4) L+X- x* ^ R9&quot; (b 1 - 1 4-0 4) [wherein R8" and R9, with the above formula (b) 厌 中 8 and R are the same content; the aryl group obtained by removing one hydrogen atom from the ulnar 7 of the aryl group in the above formula (w-14); Β is an anion of an organic acid The moiety 'L+ is an alkali metal cation; the X. system is the same as I in the above formula (bl_14).) Further, in the anion exchange of the compound (bl-14-03), the system can be reacted by L + X. The hydrogen atom of the -H group of -R1(&gt;"-〇H of the compound (bl-14-03) is previously substituted with the alkoxyalkyl or alkoxycarbonylalkyl group to carry out anion exchange. The compound (b) can be obtained. The acid generator of the fourth embodiment of the present invention (hereinafter, also referred to as an acid generator (B1)) is composed of The compound represented by the above formula (bl-14) is formed. In the formula, the compounds listed in the formulas of 'R7'' to R9'', X-series and the above-mentioned third embodiment of the present invention -30-200914991 For the same content. A photoresist composition of the present invention: "The photoresist composition of the first embodiment of the present invention will be described. The photoresist composition of the first embodiment of the present invention contains a base for the action of an acid. The substrate component (A) (hereinafter referred to as (A) component) which changes the solubility of the developer, and the acid generator component (B) which generates an acid by exposure (hereinafter, also referred to as (B) component) Further, the component (B) is an acid generator (B 1 ) containing a compound represented by the above formula (bl-14). In the photoresist composition of the present invention, the component (A) can be used via an acid. As the polymer material which changes the solubility of the alkali developing solution, it is also possible to use a low molecular material which changes the solubility of the alkali developing solution by the action of an acid. Further, the photoresist composition of the present invention may be The negative photoresist composition or the positive photoresist composition. When the photoresist composition of the present invention is a negative photoresist composition, for example, the component (A) is an alkali-soluble resin, and the negative photoresist composition A crosslinking agent (C) is added to the material. The negative photoresist composition is in the form In the case of the resist pattern, when the acid is generated by the exposure of the component (B) by exposure, the exposed portion forms a crosslink between the alkali-soluble resin and the crosslinking agent via the action of the acid, and changes to alkali-insoluble. The soluble resin' can be formed by a resin having at least one -31 - 200914991 units selected from ct-(hydroxyalkyl)acrylic acid, or lower alkyl ester of -(hydroxyalkyl)acrylic acid It is better to have a good photoresist pattern of less swelling. Further, "-(hydroxyalkyl)acrylic acid' is bonded to the carboxyl group (the carbon atom at the X position is bonded to the hydrogen atom)丨 __ 'The meaning of one or both of the α-hydroxyalkyl acrylates bonded to the carbon atom of the α-position bonded to the hydroxyalkyl group (preferably the carbonic acid number 1 to 5) ° Crosslinking agent (c), for example, when an amine-based crosslinking agent having a methylol group or a methoxymethyl group such as glycoluril is usually used, a good photoresist pattern with less swelling can be formed, and good. The amount of the crosslinking agent (c) to be added is preferably 1 to 50 parts by mass based on 1 part by mass of the alkali-soluble resin. When the photoresist composition of the present invention is a positive photoresist composition, the component (A) is insoluble to the alkali developer before exposure, and the acid generated by the component (B) is formed by exposure when the photoresist pattern is formed. In the case of the action, the acid dissociable dissolution inhibiting group is dissociated, and the solubility of the alkali developing solution of the whole (A) component is increased to change from alkali insoluble to alkali soluble. Therefore, in the formation of the photoresist pattern, when the photoresist film obtained by applying the positive-type photoresist composition on the substrate is selectively exposed, the exposed portion is converted into alkali-soluble, and the unexposed portion is It is an alkali-insoluble, unaltered state, and alkali development is possible. In the resist composition of the present invention, the component (A) is preferably a substrate component which increases the solubility in an alkali developing solution by the action of an acid. That is, the photoresist composition of the present invention is preferably a positive photoresist composition. Further, the component (A) is preferably a resin component (A 1 ) (hereinafter also referred to as (A1) component) which increases the alkali solubility by the action of an acid. -32- 200914991 &lt; (A 1 ) Component&gt; The (A 1 ) component which is preferably used in the positive resist composition is a structural unit derived from an acrylate having an acid dissociable dissolution inhibiting group (a) 1) is better. Further, the component (A1) is preferably a structural unit (a2) derived from an acrylate having a cyclic group containing a lactone. Further, the component (A1) is preferably a structural unit (a3) derived from an acrylate further having an aliphatic hydrocarbon group having a polar group. In the present specification and the scope of the patent application, "the structural unit derived from acrylate" means the structural unit constituted by the cracking of the ethylenic double bond of the acrylate. The "acrylate" means a carbon atom of the α-position, in addition to an acrylate having a hydrogen atom bonded thereto, and a compound in which a carbon atom at the α-position is bonded with a substituent (atom or a group other than a hydrogen atom). The substituent is, for example, a lower alkyl group, a halogenated lower alkyl group or the like. Further, the ct position (carbon atom of the α-position) of the structural unit derived from the acrylate means a carbon atom bonded to the carbonyl group unless otherwise specified. In the acrylate, a lower alkyl group of the substituent at the α-position, specifically, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, an η-butyl group, an isobutyl group, a tert-butyl group, a pentyl group, an isoprene group A linear or branched lower alkyl group such as a benzyl group or a neopentyl group. Further, the halogenated lower-grade base group is specifically a group obtained by substituting a part or all of a hydrogen atom in the above-mentioned "lower alkyl group of the α-substituted substituent" with a halogen atom. The halogen atom 'e.g., a fluorine atom, a chlorine atom, a bromine atom -33-200914991, a sulfo atom or the like is particularly preferably a fluorine atom. In the present invention, the α-position of the acrylate is preferably a hydrogen atom, a lower alkyl group or a halogenated lower alkyl group, and more preferably a hydrogen atom, a lower alkyl group or a fluorinated lower alkyl group. It is easy to obtain a viewpoint such as a hydrogen atom or a methyl group. • Structural unit (a 1 ) The structural unit (a 1 ) is a structural unit derived from an acrylate containing an acid dissociable dissolution inhibiting group. The acid dissociable dissolution inhibiting group in the structural unit (a 1 ) is such that, as long as the (A 1 ) component has an alkali-insoluble alkali dissolution inhibiting property before dissociation, the (A 1 ) component is obtained by dissociation of the acid. It is sufficient to increase the solubility in the alkali developing solution, and it is possible to use an acid dissociable dissolution inhibiting group which has been proposed as a base resin for a chemically amplified resist composition. In general, for example, a carboxyl group in (meth)acrylic acid may form a cyclic or chain tertiary alkyl ester group, or an acetal acid dissociable dissolution inhibiting group such as an alkoxyalkyl group. Further, "(meth) acrylate" means one or both of a acrylate having a hydrogen atom bonded to the α-position and a methyl acrylate having a methyl group bonded to the α-position. Here, the "trialkyl ester", for example, a hydrogen atom of a carboxyl group is substituted with a chain or a cyclic alkyl group to form an ester, and an oxygen atom at the terminal of the carbonyloxy group (-C(0)-0-) is bonded. A structure obtained by the tertiary carbon atom of the above-mentioned chain or cyclic alkyl group. In the above tertiary alkyl ester, the bond between the oxygen atom and the tertiary carbon atom can be interrupted by the action of an acid. Further, the chain or cyclic alkyl group may have a substituent. Hereinafter, the acid dissociable group composed of a carboxyl group and a tertiary alkyl ester is conveniently referred to as a "triester alkyl ester type acid dissociable dissolution inhibiting group". The tertiary alkyl ester type acid dissociable dissolution inhibiting group, for example, an aliphatic branched acid dissociable dissolution inhibiting group, an acid dissociable dissolution inhibiting group containing an aliphatic cyclic group, and the like. Here, the term "aliphatic" as used in the scope of the present application and the specification refers to the relative complication with respect to aromatics, that is, the meaning of a group or a compound having no aromaticity. "Aliphatic branched" means a branched structure having no aromaticity. The structure of the "aliphatic branched acid dissociable dissolution inhibiting group" is not limited to a group (hydrocarbon group) formed of carbon and ammonia, but a hydrocarbon group is preferred. Further, the "hydrocarbon group" may be either saturated or unsaturated, and it is generally preferred to saturate. The aliphatic branched acid dissociable dissolution inhibiting group is preferably a tertiary alkyl group having 4 to 8 carbon atoms. Specifically, for example, tert-butyl, tert-pentyl, tert-heptyl or the like. The "aliphatic cyclic group" means a monocyclic or polycyclic group having no aromaticity. The "aliphatic cyclic group" in the structural unit (a 1 ) may have a substituent or may not have a substituent. The substituent is, for example, a lower alkyl group having 1 to 5 carbon atoms, a fluorine atom, a fluorinated lower alkane having a carbon number of 1 to 5 substituted by a fluorine atom, and an oxygen atom. "The fat is not limited by carbon, and the "hydrocarbon group" is preferably . "A fatty aliphatic or fluorinated alkylalkane, a monocyclic alkane or a cyclododecane obtained by a tricyclic atom, and the like, are contained in a cyclic alkyl group, for example, 2 or, for example, bonded to a carbonyloxantane as described below. a group of a ring or a cyclododecyl atom (=〇), etc. a group consisting of a hydrogen group and a hydrogen group (which may be a saturated or unsaturated ring group) is a polycyclic ring group. Specific examples, the substituted, or a group such as an alkane or a tetracycloalkane, etc., more specifically, an adamantane or a norbornane polycyclic alkane is removed from the ring skeleton having an aliphatic cyclic group. a radical having a -methyl-2-adamantyl formula (al"-l)-yl (-C-(O)-0.hexyl, cyclopentyl, descending aliphatic cyclic alkyl group Etc. The basic ring structure of the substituent, and a hydrocarbon group), but preferably a hydrocarbon group. Alternatively, it is preferred to use a saturated group as a base. For example, it can be substituted by a lower alkyl group or a fluorine atom. One or more hydrogens are removed from a monocyclic alkane or a bicyclic polycyclic alkane, for example, an alkane such as cyclopentane or cyclohexane, iso-araconine, tricyclodecane, or more than four hydrogen atoms. An acid dissociable dissolution inhibiting group, for example, a group of a tertiary carbon atom, or the like, or a 2-ethyl-2-adamantyl group or the like. In the structural unit represented by (a 1 ′ - 6 ), The base of the oxygen atom is 'having a gold borneol, a tricyclodecyl group, a tetra, and a triple carbon bonded thereto-36-200914991 [Chem. 1 4]

[式中,R爲氫原子、低級烷基或鹵化低級烷基之意;R1&quot; 、R16爲烷基(可爲直鏈、支鏈狀皆可’較佳爲碳數1至 5 ) ]° 通式(al,,-l)〜(al,’-6)中,R之低級烷基或鹵化 低級烷基,例如與上述可鍵結於丙烯酸酯之α位之低級院 基或齒化低級烷基爲相同之內容。 「縮醛型酸解離性溶解抑制基」一般爲鍵結於取代羧 基、羥基等之鹼可溶性基末端之氫原子的氧原子。因此’ 經由曝光產生酸時,經由該酸之作用,而切斷縮醛型酸解 離性溶解抑制基與該縮醛型酸解離性溶解抑制基所鍵結之 氧原子之間的鍵結。 縮醛型酸解離性溶解抑制基,例如,下述通式(Ρ 1 ) 所示之基等。 -37- 200914991 【化1 5】Wherein R is a hydrogen atom, a lower alkyl group or a halogenated lower alkyl group; R1&quot; and R16 are alkyl groups (may be linear or branched, preferably 'carbon number 1 to 5)]° In the general formula (al,, -l)~(al, '-6), the lower alkyl group of R or the halogenated lower alkyl group, for example, is lower than the above-mentioned lower-grade or low-toothed base which can be bonded to the α-position of the acrylate. The alkyl group is the same content. The "acetal type acid dissociable dissolution inhibiting group" is generally an oxygen atom bonded to a hydrogen atom at the terminal of an alkali-soluble group which substitutes a carboxyl group or a hydroxyl group. Therefore, when an acid is generated by exposure, the bond between the acetal type acid dissociable dissolution inhibiting group and the oxygen atom to which the acetal type acid dissociable dissolution inhibiting group is bonded is cut by the action of the acid. The acetal type acid dissociable dissolution inhibiting group is, for example, a group represented by the following formula (Ρ 1 ). -37- 200914991 [Chem. 1 5]

—C-〇-fcH2)-Y—C-〇-fcH2)-Y

[式中、R1’,R2’各自獨立爲氫原子或低級烷基,n爲0至 3之整數,Υ爲低級烷基或脂肪族環式基]。 上述式中,η以0至2之整數爲佳,以0或1爲更佳 ,以〇爲最佳。 R1 ’、R2’之低級烷基,例如與上述R之低級烷基爲相 同之內容,又以甲基或乙基爲佳,以甲基爲最佳。 本發明中,以R1’、R2’中至少1個爲氫原子者爲佳。 即,酸解離性溶解抑制基(ρ 1 )以下述通式(ρ 1 -1 )所示 之基爲佳。 【化1 6】[wherein, R1' and R2' are each independently a hydrogen atom or a lower alkyl group, n is an integer of 0 to 3, and hydrazine is a lower alkyl group or an aliphatic cyclic group]. In the above formula, η is preferably an integer of 0 to 2, more preferably 0 or 1, and most preferably 〇. The lower alkyl group of R1' and R2' is, for example, the same as the lower alkyl group of the above R, and preferably a methyl group or an ethyl group, and a methyl group is most preferable. In the present invention, it is preferred that at least one of R1' and R2' is a hydrogen atom. Namely, the acid dissociable dissolution inhibiting group (ρ 1 ) is preferably a group represented by the following formula (ρ 1 -1 ). 【化1 6】

• · ( ρ 1 — 1 ) [式中、R1’、η、Υ係與上述內容爲相同之內容。] Υ之低級烷基,例如與上述R之低級烷基爲相同之內 容。 Υ之脂肪族環式基,例如可由以往於ArF光阻等之中 ’被多次提案之單環或多環式脂肪族環式基之中適當地選 擇使用’例如與上述「脂肪族環式基」爲相同之內容。 -38- 200914991 又,縮醛型酸解離性溶解抑制基,例如下述通式(p2 )所示之基等。 【化1 7】 r -C—Ο—R19 r18 · * (p 2) [式中、R17、R18各自獨立爲直鏈狀或支鏈狀之烷基或氫 原子,R19爲直鏈狀、支鏈狀或環狀之烷基,或R17與R19 各自獨立爲直鏈狀或支鏈狀之伸烷基,R17之末端與R19 之末端鍵結形成環亦可]。 R17、R18中,烷基之碳數較佳爲1至15,其可爲直鏈 狀或支鏈狀皆可,又以乙基、甲基爲佳,以甲基爲最佳。 特別是以R17、R18中之任一者爲氫原子,另一者爲甲 基爲最佳。 R19爲直鏈狀、支鏈狀或環狀之烷基時,碳數較佳爲 1至15,其可爲直鏈狀、支鏈狀或環狀中任一者皆可。 R19爲直鏈狀或支鏈狀時,碳數以1至5爲佳,又以 乙基、甲基爲更佳,以乙基爲最佳。 R19爲環狀時,以碳數4至15爲佳,以碳數4至12 爲更佳’以碳數5至10爲最佳。具體而言,其可被氟原 子或氟化烷基取代,或未被取代皆可之單環鏈烷、二環鏈 烷、三環鏈烷、四環鏈烷等多環鏈烷中去除1個以上氫原 子之基等。具體而言,例如環戊烷、環己烷等單環鏈院, 或金剛烷、降冰片烷、異菠烷、三環癸院、四環十二院等 -39- 200914991 多環鏈烷中去除1個以上氫原子之基等。其中又以金剛烷 去除1個以上氫原子所得之基爲佳。 又,上述通式中,R17與R18各自獨立爲直鏈狀或支 鏈狀之伸烷基(較佳爲碳數1至5之伸烷基),且R19之 末端可與R17之末端鍵結亦可。 此時,R17與R19,與鍵結於R19之氧原子,與該氧原 子與鍵結於R17之碳原子形成環式基。該環式基,以4至 7員環爲佳,以4至6員環爲更佳。該環式基之具體例, 例如四氫吡喃基、四氫呋喃基等。 結構單位(a 1 ),以使用由下述式(a 1 - 0 -1 )所示結 構單位,與下述式(al-0-2 )所示結構單位所成群中所選 出之1種以上爲佳。• ( ρ 1 — 1 ) [wherein, R1', η, and Υ are the same as the above. The lower alkyl group of hydrazine is, for example, the same as the lower alkyl group of the above R. The aliphatic cyclic group of hydrazine can be appropriately selected from the monocyclic or polycyclic aliphatic cyclic group which has been proposed many times in the conventional ArF photoresist, for example, and the above-mentioned "aliphatic ring type". The base is the same content. Further, the acetal type acid dissociable dissolution inhibiting group is, for example, a group represented by the following formula (p2). [Chemical Formula 1] r -C-Ο-R19 r18 · * (p 2) [wherein, R17 and R18 are each independently a linear or branched alkyl group or a hydrogen atom, and R19 is a linear chain or a branch. A chain or a cyclic alkyl group, or R17 and R19 are each independently a linear or branched alkyl group, and the terminal of R17 is bonded to the end of R19 to form a ring]. In R17 and R18, the alkyl group preferably has 1 to 15 carbon atoms, and may be linear or branched, preferably ethyl or methyl, and most preferably methyl. In particular, it is preferred that either of R17 and R18 is a hydrogen atom and the other is a methyl group. When R19 is a linear, branched or cyclic alkyl group, the number of carbon atoms is preferably from 1 to 15, and it may be any of a linear chain, a branched chain or a cyclic chain. When R19 is linear or branched, the carbon number is preferably from 1 to 5, more preferably ethyl or methyl, and most preferably ethyl. When R19 is a ring, it is preferably 4 to 15 carbon atoms, more preferably 4 to 12 carbon atoms, and most preferably 5 to 10 carbon atoms. Specifically, it may be substituted by a fluorine atom or a fluorinated alkyl group, or may be removed by a polycyclic alkane such as a monocyclic alkane, a bicycloalkane, a tricycloalkane or a tetracycloalkane which is not substituted. More than one hydrogen atom or the like. Specifically, for example, a monocyclic chain such as cyclopentane or cyclohexane, or adamantane, norbornane, isopentane, a tricyclic brothel, a four-ring, twelve-yard, etc. -39-200914991 polycyclic alkane The base of one or more hydrogen atoms is removed. Among them, a group obtained by removing one or more hydrogen atoms from adamantane is preferred. Further, in the above formula, R17 and R18 are each independently a linear or branched alkyl group (preferably an alkyl group having 1 to 5 carbon atoms), and the terminal of R19 may be bonded to the end of R17. Also. At this time, R17 and R19 are bonded to the oxygen atom bonded to R19, and the oxygen atom forms a cyclic group with the carbon atom bonded to R17. The ring base is preferably a 4 to 7 member ring, and a 4 to 6 member ring is preferred. Specific examples of the cyclic group include, for example, a tetrahydropyranyl group, a tetrahydrofuranyl group and the like. The structural unit (a 1 ) is one selected from the group consisting of the structural unit represented by the following formula (a 1 - 0 -1 ) and the structural unit represented by the following formula (al-0-2 ). The above is better.

【化1 8】 [式中,R爲氫原子、鹵素原子、低級烷基或鹵化低級烷基 ;X1爲酸解離性溶解抑制基]。 -40- 200914991[In the formula, R is a hydrogen atom, a halogen atom, a lower alkyl group or a halogenated lower alkyl group; and X1 is an acid dissociable dissolution inhibiting group]. -40- 200914991

【化1 9】 [式中,R爲氫原子、鹵素原子、低級烷基或鹵化低級烷基 ;X2爲酸解離性溶解抑制基;Y2爲伸烷基或脂肪族環式 基]。 式(al-0-l)中,R之鹵素原子、低級院基或鹵化低 級烷基,係與上述可鍵結於丙烯酸酯之α位之鹵素原子、 低級烷基、鹵化低級烷基爲相同之意義。 X 1,只要爲酸解離性溶解抑制基時則未有特別限定, 例如可爲三級烷基酯型酸解離性溶解抑制基、縮醛型酸解 離性溶解抑制基等,又以三級烷基酯型酸解離性溶解抑制 基爲佳。 式(al-0_2)中,R具有與上述相同之意義。 X2則與式(al-0-1 )中之X1爲相同之內容。 Y2較佳爲碳數1至1 〇之伸烷基或2價之脂肪族環式 基。該脂肪族環式基時,除使用去除2個以上氫原子之基 以外,例如可使用與前述「脂肪族環式基」之說明爲相同 之內容。 -41 - 200914991 結構單位(al)中,更具體而言,例如下述通式( al-Ι )至(al-4 )所示之結構單位。 【化2 0】[In the formula, R is a hydrogen atom, a halogen atom, a lower alkyl group or a halogenated lower alkyl group; X2 is an acid dissociable dissolution inhibiting group; and Y2 is an alkylene group or an aliphatic cyclic group]. In the formula (al-0-l), the halogen atom of R, the lower-grade or the halogenated lower alkyl group is the same as the above-mentioned halogen atom, lower alkyl group, or halogenated lower alkyl group which may be bonded to the α-position of the acrylate. The meaning. X1 is not particularly limited as long as it is an acid dissociable dissolution inhibiting group, and may be, for example, a tertiary alkyl ester type acid dissociable dissolution inhibiting group or an acetal type acid dissociating dissolution inhibiting group, and a tertiary alkyl group. The ester-type acid dissociable dissolution inhibiting group is preferred. In the formula (al-0_2), R has the same meaning as described above. X2 is the same as X1 in the formula (al-0-1). Y2 is preferably an alkylene group having a carbon number of 1 to 1 Torr or a divalent aliphatic ring group. In the case of the aliphatic cyclic group, the same as the above description of the "aliphatic cyclic group" can be used, except for the use of a group in which two or more hydrogen atoms are removed. -41 - 200914991 In the structural unit (al), more specifically, for example, the structural unit represented by the following general formula (al-Ι) to (al-4). [化2 0]

[上述式中’ X ’爲三級烷基酯型酸解離性溶解抑制基;Y 爲碳數1至5之低級垸基,或脂肪族環式基;η爲〇至3 之整數;Υ2爲伸院基或脂肪族環式基;R具有與上述相同 之意義;R1’、R2’各自獨立爲氫原子或碳數1至5之低級 烷基]。 前述R1’、R2’中較佳爲至少1個爲氫原子,更佳爲同 時爲氫原子。η較佳爲0或1。 X ’係與前述X 1中所例示之環狀之三級烷基酯型酸解 離性溶解抑制基爲相同之內容。 Υ之脂肪族環式基,例如與上述「脂肪族環式基」之 說明中所例示之內容爲相同之內容。 Υ2較佳爲碳數1〜10之伸烷基或2價之脂肪族環式基 -42- 200914991 ’該脂肪族環式基可使用去除2個以上氫原子所得之基以 外,亦可使用與前述「脂肪族環式基」說明爲相同之基。 γ2爲碳數1〜1 〇之伸烷基時,以碳數1〜6者爲更佳,以 碳數1〜4爲最佳,以碳數1〜3爲特佳。Y2爲2價之脂肪 族環式基時’以由環戊垸、環己院、降冰片院、異冰片院 、金剛烷、三環癸烷、四環十二烷中去除2個以上氫原子 所得之基爲最佳。 以下爲上述通式(al-Ι)至(al-4)所示之結構單位 之具體例, -43- 200914991 lit 2 1 ch3 -fcH2—C-V。心' 0=1 © &lt; ch2-ch[In the above formula, 'X' is a tertiary alkyl ester type acid dissociable dissolution inhibiting group; Y is a lower fluorenyl group having a carbon number of 1 to 5, or an aliphatic cyclic group; η is an integer of 〇 to 3; Υ 2 is The excipient or aliphatic cyclic group; R has the same meaning as above; R1', R2' are each independently a hydrogen atom or a lower alkyl group having 1 to 5 carbon atoms]. It is preferable that at least one of R1' and R2' is a hydrogen atom, and more preferably a hydrogen atom. η is preferably 0 or 1. X' is the same as the cyclic tertiary alkyl ester type acid dissociable dissolution inhibiting group exemplified in the above X 1 . The aliphatic cyclic group of hydrazine is, for example, the same as those exemplified in the description of the above "aliphatic cyclic group". Υ2 is preferably an alkylene group having a carbon number of 1 to 10 or a divalent aliphatic cyclic group-42-200914991 'The aliphatic cyclic group may be used in addition to the group obtained by removing two or more hydrogen atoms, and may also be used. The above "aliphatic cyclic group" is illustrated as the same group. When γ2 is an alkylene group having 1 to 1 carbon atoms, it is more preferably 1 to 6 carbon atoms, most preferably 1 to 4 carbon atoms, and particularly preferably 1 to 3 carbon atoms. When Y2 is a divalent aliphatic ring-based group, two or more hydrogen atoms are removed from cyclopentanium, cyclohexyl, norbornene, isoborn, adamantane, tricyclodecane, and tetracyclododecane. The basis obtained is the best. The following are specific examples of the structural unit represented by the above formula (al-Ι) to (al-4), -43- 200914991 lit 2 1 ch3 -fcH2 - C-V. Heart ' 0=1 © &lt; ch2-ch

CHCH

(a1-1-2)(a1-1-2)

^h2-chV ,^h2-chV ,

CHCH

Cat-1-8) (CH2)3CH3 (a1-1-7)Cat-1-8) (CH2)3CH3 (a1-1-7)

(a1-1-9) CHf (al-1-10) ch3(a1-1-9) CHf (al-1-10) ch3

CH3 &quot;CH2—c-A- -ch2—c-^~ 0==\ CH3 〇、^CH3 &quot;CH2—c-A- -ch2—c-^~ 0==\ CH3 〇,^

(a1-1-13)(a1-1-13)

(a 1-1-14) 〇4 〇2h50、 CH2—ch} °=( C2H5 -44 - 200914991 【化2 2】(a 1-1-14) 〇4 〇2h50, CH2—ch} °=( C2H5 -44 - 200914991 [Chem. 2 2]

(a1-1-21) (a1-1-22) (a1-1-23)(a1-1-21) (a1-1-22) (a1-1-23)

3 (al+27) (a1 十 28) (a1~1~25) (a 1 —Ή26)3 (al+27) (a1 10 28) (a1~1~25) (a 1 —Ή26)

(a1-1-31) (a1-1-32) -45- 200914991 【化2 3】(a1-1-31) (a1-1-32) -45- 200914991 [Chem. 2 3]

-ch2—chV -/-CHr-Q_L-ch2—chV -/-CHr-Q_L

CH2—CH^~CH2—CH^~

(a1—1-41)(a1—1-41)

。4 i。4. 4 i. 4

〇=A mr :ir 【化2 4】〇=A mr :ir 【化2 4】

ch3 ~(ch2-c-)-Ch3 ~(ch2-c-)-

(a1-2-4)(a1-2-4)

(a1-2-5)(a1-2-5)

-46- 200914991 【化2 5 ch3 十2| 0=&lt; 〇、 (a 1-2*7) -fcH2-CHV-〇4^ (a1'2—10) ch3 —(ch2-c-)- O^- (a1-2-13) -(ch2-ch)- &gt;=k ch3 —(ch2-c4- 〇4 〇= 〇.-46- 200914991 [Chemical 2 5 ch3 10 2 | 0=&lt; 〇, (a 1-2*7) -fcH2-CHV-〇4^ (a1'2-10) ch3 —(ch2-c-)- O^- (a1-2-13) -(ch2-ch)- &gt;=k ch3 —(ch2-c4- 〇4 〇= 〇.

Cal-2-16) —fcH2-c)— 〇〜 (al-2-19) o 〇· (a1-2-9) ch3 —f〇H2-c)— ΊΘ 〇4° ° -fcH2-CHV- 〇 一 (a1-2-12) ,0 -^CH2-ch)-名(:::¾Cal-2-16) —fcH2-c)— 〇~ (al-2-19) o 〇· (a1-2-9) ch3 —f〇H2-c)— ΊΘ 〇4° ° -fcH2-CHV- 〇一(a1-2-12) , 0 -^CH2-ch)-Name (:::3⁄4

,0,0

o- (al-2-14)f3 -(ch2-〒十 -o 〇4 (a1-2-17),i2Z .〇 O-w (a1-2-20) ch3 —(-ch2-c^— 〇、 (a 1-2-15) f3 —(ch2-c-)- 〇、O- (al-2-14)f3 -(ch2-〒十-o 〇4 (a1-2-17), i2Z .〇Ow (a1-2-20) ch3 —(-ch2-c^- 〇, (a 1-2-15) f3 —(ch2-c-)- 〇,

p (a1—2-18) :°¾ -47- 200914991 【化2 6 ch3 / ί \ —(ch2-c-)- 0=^〇ν〇ΤΊ (a1-2-21) -(ch2-ch)- -{ch2—ch)〇4 0、 (a1-2-22) ch3 I、 ch2-c4— 〇4 0、 〜T&gt; (a 1-2-24) (a1 -2-25) —(ch2-c-)— 飞、 Γ3 —(ch2-c4- 。 。4X) °- (a 1 -2-27) (a 1-2-28) 〇p (a1—2-18) :°3⁄4 -47- 200914991 【化2 6 ch3 / ί \ —(ch2-c-)- 0=^〇ν〇ΤΊ (a1-2-21) -(ch2-ch ) - -{ch2—ch)〇4 0, (a1-2-22) ch3 I, ch2-c4—〇4 0, ~T&gt; (a 1-2-24) (a1 -2-25) —( Ch2-c-)—fly, Γ3—(ch2-c4-. .4X) °- (a 1 -2-27) (a 1-2-28) 〇

ch3 -(ch2-c·)- (a1-2-31) ch3 〇〜 (a1-2-23) -(ch2-ch 卜 T)。4。〜 \^___/ (31-2-26) cf3 —(-ch2-c^— 0=l &quot;O (。〜Ch3 -(ch2-c·)- (a1-2-31) ch3 〇~ (a1-2-23) -(ch2-ch 卜 T). 4. ~ \^___/ (31-2-26) cf3 —(-ch2-c^— 0=l &quot;O (.~

;O •0 -48- 200914991 【化2 7】;O •0 -48- 200914991 [Chem. 2 7]

(al-2-32) (a1-2-33) (a1-2-34)(al-2-32) (a1-2-33) (a1-2-34)

(a1-2-35) (a1-2-36)(a1-2-35) (a1-2-36)

-49- 200914991 【化2 8】-49- 200914991 [Chem. 2 8]

Cal-3-1) (a1-3-2) Ca 1-3-3)Cal-3-1) (a1-3-2) Ca 1-3-3)

Cat-3~5)Cat-3~5)

Cal-3-β)Cal-3-β)

Ca1-3-1〇) (at-3-Jl) (ai-3-t2)Ca1-3-1〇) (at-3-Jl) (ai-3-t2)

50- 200914991 【化2 9】50- 200914991 [Chem. 2 9]

-51 - 200914991-51 - 200914991

【化3 Ο】 CH ch3 ?H3 ch3 -(CH2-C-)- ~(CH2^h)- -f cH2-C-)- -(-CH2-Ch)- -(*CH2-^f 〇10 ,° /° 0 -°气。%气為O广 0、 Q Γ°[化3 Ο] CH ch3 ?H3 ch3 -(CH2-C-)- ~(CH2^h)- -f cH2-C-)- -(-CH2-Ch)- -(*CH2-^f 〇10 , ° / ° 0 - ° gas.% gas is O Guang 0, Q Γ °

ο Ο Ο )οο Ο Ο )ο

ο ; Q (a1-4~1) (at-4-2)ο ; Q (a1-4~1) (at-4-2)

Ca 1-4-4) ?η3Ca 1-4-4) ?η3

Ca1-4-3)Ca1-4-3)

Ca 1-4-5) CH 9Η3 -^-CH2-CH}- -^CH2-C-)--(-CH2-C^--(CH2-C-3- -(-CH2-CH)— i i i i i i (a 1-4-0) t δ (a1-4-7) (a 1-4-8) (al-4-9) (a1-4-10) (al-4-11)Ca 1-4-5) CH 9Η3 -^-CH2-CH}- -^CH2-C-)--(-CH2-C^--(CH2-C-3--(-CH2-CH)- iiiiii (a 1-4-0) t δ (a1-4-7) (a 1-4-8) (al-4-9) (a1-4-10) (al-4-11)

•CH ch3 ch3 l2&quot;*cH]h -(-ch2-ch) (-ch2—c-)— &quot;f ch2—9二 r\ 一 二。°&gt; 〇=&lt;〇 〇&gt; °&gt; 〇、 ό ο• CH ch3 ch3 l2&quot;*cH]h -(-ch2-ch) (-ch2-c-)— &quot;f ch2—9 two r\ one. °&gt;〇=&lt;〇〇&gt;°&gt; 〇, ό ο

,0,0

.〇 〇尸。 .0.〇 〇 。. .0

-CH;ο-CH;ο

CH3 .〇 PCH3 .〇 P

q〇 〇&gt;〇Q〇 〇&gt;〇

Ca 1-4-12) Ca1-4'13) (at-4-14) 0. 0 (al-4-15) h (a1-4-16) (al-4-17) 52- 200914991 【化3 1 CH.H0十^十H卜咩f十十+十 ? ? \ \ °\ 。4Ca 1-4-12) Ca1-4'13) (at-4-14) 0. 0 (al-4-15) h (a1-4-16) (al-4-17) 52- 200914991 3 1 CH.H0 ten ^ ten H 咩 咩 f ten + ten? ? \ \ °\. 4

0 ) 〇 Ο 0 &gt; 〇 ) U) (al-4-18) (al-4^19) (al-4-20) (a1-4-21) (al-4-22)0) 〇 Ο 0 &gt; 〇 ) U) (al-4-18) (al-4^19) (al-4-20) (a1-4-21) (al-4-22)

-CH2。·^ 十H。^子十卡 H士卡Η ^字 f CH^_ _/° P P ρ 〇 〇 (al-4-24)-CH2. ·^ Ten H. ^子十卡 H士卡Η ^Word f CH^_ _/° P P ρ 〇 〇 (al-4-24)

Ο \Ο \

〇 ;=0 〇v 0、〇 ;=0 〇v 0,

Ο ο οΟ ο ο

(8l'4'2S) (8,'4&quot;2W (a,+27)⑷-4-2« Cat-4-29) (al-4-30) .、 H3C 十ch2 h3c o =〇(8l'4'2S) (8, '4&quot;2W (a,+27)(4)-4-2« Cat-4-29) (al-4-30) ., H3C ten ch2 h3c o =〇

Cal-4-31) 1Θ (at-4-33) (a1-4-32) 、 . H3? 0=\ °\ 0==^ (料34) ________ (el-4-35)Cal-4-31) 1Θ (at-4-33) (a1-4-32) , . H3? 0=\ °\ 0==^ (Material 34) ________ (el-4-35)

Cat-4-36) 才 f f CH才 + f CH 念 ffCH 由H+ f CH这 Hf f CH》- /° / p °&gt; 〇 b 〇Λ S 彳 S ( S 〇 bCat-4-36) 才 f f CH才 + f CH 念 ffCH by H+ f CH Hf f CH"- /° / p °&gt; 〇 b 〇Λ S 彳 S ( S 〇 b

(al-4-37) (at-4-39) (at-4-38) Cal-4-40) ⑷-4-41)(al-4-37) (at-4-39) (at-4-38) Cal-4-40) (4)-4-41)

Cat-4-42) 結構單位(a 1 ) ’可單獨使用1種,或將2種以上組 合使用亦可。 -53- 200914991 其中又以式(a 1 -1 )所示之結構單位爲佳。具體而言 ,以使用由式(al-1-l)至(al-1-6)及式(al-1-35)至 (a 1 -1 - 4 1 )所成群中所選出之至少1種爲最佳。 又,結構單位(al )特別是以包含式(al-l-l )至( al_;!_4 )之結構單位的下述通式(31_卜01 )所示之單位’ 或包含式(al-1-35)至(al-:l-41)之結構單位的下述通 式(al_l-02)者爲佳。 【化3 2】Cat-4-42) The structural unit (a 1 ) ' may be used singly or in combination of two or more. -53- 200914991 Among them, the structural unit represented by the formula (a 1 -1 ) is preferred. Specifically, at least one selected from the group consisting of the formulae (al-1-l) to (al-1-6) and the formula (al-1-35) to (a 1 -1 - 4 1 ) One is the best. Further, the structural unit (al) is, in particular, a unit ' or a formula (al-1) represented by the following general formula (31_b 01) containing structural units of the formula (al-ll) to (al_; !_4) The following formula (al_l-02) of the structural unit of -35) to (al-:l-41) is preferred. [化3 2]

[式中,R爲氫原子、低級烷基或鹵化低級烷基,R11爲低 級烷基]° 【化3 3】Wherein R is a hydrogen atom, a lower alkyl group or a halogenated lower alkyl group, and R11 is a lower alkyl group] [Chemical 3 3]

c=oc=o

-54- 200914991 [式中,R爲氫原子、低級烷基或鹵化低級烷基,R12爲低 級院基,h爲1至3之整數]。 式(al-1-Ol)中,R具有與上述相同之內容。R11之 低級烷基係與R所示之低級烷基爲相同之內容,又以甲基 或乙基爲佳。 式(al-l-〇2)中,R具有與上述相同之內容。R12之 低級院基係與前述R所示之低級院基爲相同之內容,又以 甲基或乙基爲佳,又以乙基爲最佳。h以1或2爲佳,又 以2爲最佳。 (A 1 )中,結構單位(a 1 )之比例,相對於構成(A1 )成份之全體結構單位而言,以1 0至8 0莫耳。/。爲佳,以 2 0至7 0莫耳%爲更佳,以2 5至5 0莫耳%爲最佳。於下限 値以上時,於作爲正型光阻組成物時可容易形成圖型,於 上限値以下時,可與其他結構單位達成平衡。 •結構單位(a2 ) 本發明中’結構單位(a2 ),爲具有含內酯之環式基 之丙烯酸酯所衍生之結構單位。 其中,含內酯之環式基,爲含有- O- C(O)-結構之一 個環(內酯環)之環式基。並以內酯環作爲一個環單位進 行計數,僅爲內酯環之情形爲單環式基,若尙具有其他環 結構時,無論其結構爲何’皆稱爲多環式基。 結構單位(a2)之內酯環式基,於作爲(A1)成份用 於形成光阻膜之情形中,可有效提高光阻膜對基板之密著 -55- 200914991 性,並可有效地提高與含有水之顯影液的親和性。 其中,結構單位(a2 ),未有任何限定而可使用任意 之單位。 具體而言,含內酯之單環式基’例如丁內酯去除1 個氫原子所得之基等。又,含內酯之多環式基’例如由具 有內酯環之二環鏈烷、三環鏈烷、四環鏈烷去除1個氫原 子所得之基等。 結構單位(a2 )之例示中’更具體而言’例如下述通 式(a2-l )至(a2-5 )所示結構單位等。 【化3 4】-54- 200914991 [wherein R is a hydrogen atom, a lower alkyl group or a halogenated lower alkyl group, and R12 is a lower-grade hospital group, and h is an integer of 1 to 3]. In the formula (al-1-Ol), R has the same content as described above. The lower alkyl group of R11 is the same as the lower alkyl group represented by R, and a methyl group or an ethyl group is preferred. In the formula (al-l-〇2), R has the same content as described above. The lower-grade yard base of R12 is the same as the lower-grade yard base shown by R above, and is preferably methyl or ethyl, and ethyl is preferred. h is preferably 1 or 2, and 2 is the best. In (A 1 ), the ratio of the structural unit (a 1 ) is from 10 to 80 mol with respect to the entire structural unit constituting the component (A1). /. Preferably, it is preferably from 20 to 70% by mole, and preferably from 25 to 50% by mole. When the lower limit is 値 or more, the pattern can be easily formed when it is a positive resist composition, and it can be balanced with other structural units when it is below the upper limit 値. • Structural unit (a2) In the present invention, the structural unit (a2) is a structural unit derived from an acrylate having a cyclic group containing a lactone. Here, the cyclic group containing a lactone is a cyclic group containing one ring (lactone ring) of the -O-C(O)- structure. The lactone ring is counted as a ring unit, and the monocyclic group is only a lactone ring. If the ring has other ring structures, regardless of its structure, it is called a polycyclic group. The lactone ring group of the structural unit (a2) can effectively improve the adhesion of the photoresist film to the substrate in the case where the (A1) component is used to form the photoresist film, and can effectively improve Affinity with a developer containing water. Among them, the structural unit (a2) can be used in any unit without any limitation. Specifically, a lactone-containing monocyclic group such as butyrolactone is obtained by removing one hydrogen atom. Further, the polycyclic group having a lactone is, for example, a group obtained by removing one hydrogen atom from a bicycloalkane having a lactone ring, a tricycloalkane or a tetracycloalkane. In the exemplification of the structural unit (a2), 'more specifically' is, for example, a structural unit represented by the following general formulas (a2-l) to (a2-5). [化3 4]

[式中,R爲氫原子、低級院基或鹵化低級院基,R,爲氫原 子、低級烷基,或碳數1至5之烷氧基,„!爲〇或1之整 數,A爲碳數1至5之伸烷基或氧原子]。 式(a2-l)至(a2-5)中’ R具有與上述結構單位( al)中之R相同之內容。 R’之低級烷基’具有與上述結構單位(a 1 )中之R的 低級烷基爲相同之內容。 A之碳數1至5之伸烷基’具體而言,例如伸甲基、 伸乙基、η -伸丙基、異伸丙基等。 -56- 200914991 式(a2-l)至(a2-5)中,R’就工業上容易取得等觀 點而言,以氫原子爲佳。 以下爲前述通式(a2-l )至(a2-5 )之具體結構單位 之例示。 【化3 5】Wherein R is a hydrogen atom, a lower-grade or a halogenated lower-grade, R is a hydrogen atom, a lower alkyl group, or an alkoxy group having a carbon number of 1 to 5, and „! is an integer of 〇 or 1, and A is The alkyl group having 1 to 5 carbon atoms or the oxygen atom]. In the formulae (a2-l) to (a2-5), 'R has the same content as R in the above structural unit (al). Lower alkyl group of R' 'having the same content as the lower alkyl group of R in the above structural unit (a 1 ). The alkyl group having a carbon number of 1 to 5', specifically, for example, methyl group, ethyl group, η-extension In the formulae (a2-l) to (a2-5), R' is preferably a hydrogen atom from the viewpoint of industrial availability. An example of a specific structural unit of (a2-l) to (a2-5). [Chemical 3 5]

-57- 200914991 【化3 6】 ch3 ™fCH2一C·)—〇4 -(ch2-ch)-°=\ ch3 ch3 -fCH2—c-)- -(CH2-C·)- ' o o.-57- 200914991 [Chemical 3 6] ch3 TMfCH2-C·)-〇4 -(ch2-ch)-°=\ ch3 ch3 -fCH2-c-)- -(CH2-C·)- ' o o.

(a2-2-1) 〇(a2-2-1) 〇

(a2-2-2) ch3 B〇〆0 (a2-2-6) (a2-2-3)(a2-2-2) ch3 B〇〆0 (a2-2-6) (a2-2-3)

O ch3O ch3

O (32-2-4) CH3O (32-2-4) CH3

O (a2-2-7) O, ch3O (a2-2-7) O, ch3

(32-2-10) 58 200914991 【化3 7】 ch3 -(cH2-c)- -(cHj-CH、〇、a ^ 0.(32-2-10) 58 200914991 [Chemical 3 7] ch3 -(cH2-c)- -(cHj-CH, 〇, a ^ 0.

㈨列 〇 (32^-2) 0 ch3 -{ch2-c·)- -{ch2-ch〇&lt; 〇4 o, o(9) Column 〇 (32^-2) 0 ch3 -{ch2-c·)- -{ch2-ch〇&lt; 〇4 o, o

o.o.

ch3 O ch3 0 (a2-3-4) (a2-W)Ch3 O ch3 0 (a2-3-4) (a2-W)

(a2-3-6) ch3 -(ch2-c^- -(ch2-ch^- 0==( 0=(a2-3-6) ch3 -(ch2-c^- -(ch2-ch^- 0==( 0=

~(ch2-ch}- 0=4~(ch2-ch}- 0=4

0 (a2-3-1〇)0 (a2-3-1〇)

-59- 200914991 【化3 8】-59- 200914991 [Chem. 3 8]

(a2-4-7) (a2*4-8) (a2-4-9) -{ch2-ch&gt;- ch3 p H3C, - H3C (32-4-11) (a2-4-12) 。^。说祕 -60- 200914991 【化3 9】(a2-4-7) (a2*4-8) (a2-4-9) -{ch2-ch&gt;- ch3 p H3C, - H3C (32-4-11) (a2-4-12). ^. Speaking secret -60- 200914991 [Chemical 3 9]

H3C (a2·*-5) (aZ-5-6) 其中,又以使用由式(a2-l )至(a2-3 )所示結構單 位所選出之至少1種爲佳,又以由式(a2-l )至(a2-3 ) 所選出之至少1種以上爲更佳。具體而言,以使用由式( a2-1 -1 ) 、 ( a2-1-2 ) 、 ( a2-2- 1 ) 、 ( a2-2-2 ) 、 ( a2-3- 1 ) 、( a2-3-2) 、( a2-3-9)與(a2-3-10)所選出之 1 種 以上者爲最佳。 (A 1 )成份中,結構單位(a2 ),可單獨使用1種, 或將2種以上組合使用亦可。 (A1 )成份中之結構單位(a2 )的比例,以對構成( -61 - 200914991 A1 )成份之全體結構單位之合計,以5至60莫耳%爲佳 ,以1 0至5 0莫耳%爲較佳,以2 0至5 0莫耳%爲最佳。 於下限値以上時,含有結構單位(a2 )時可充分達到效果 ,於上限値以下時,可得到與其他結構單位之平衡。 •結構單位(a3) 結構單位(a3 ),爲具有含極性基之脂肪族烴基之丙 烯酸酯所衍生之結構單位。 (A1)成份具有結構單位(a3)時,可提高(A)成 份之親水性,而提高與顯影液之親和性,進而提昇曝光部 之鹼溶解性,而可期待解析度之提昇。 極性基,例如羥基、氰基、羧基、烷基中一部份氫原 子被氟原子取代之羥烷基等,又以羥基爲最佳。 脂肪族烴基’例如碳數1至1 0之直鏈狀或支鏈狀烴 基(較佳爲伸烷基),或多環式之脂肪族烴基(多環式基 )等。該多環式基,例如可由ArF準分子雷射用光阻組成 物用之樹脂中,由多數提案內容中作適當選擇使用。該多 環式基的碳數爲7〜30較佳。 其中,又以含有羥基、氰基、羧基、或含有烷基中氫 原子之一部份被氟原子取代之羥烷基的脂肪族多環式基之 丙烯酸酯所衍生之結構單位爲更佳。該多環式基,例如由 二環鏈烷、三環鏈烷、四環鏈烷中去除2個以上之氫原子 所得之基寺。具體而固’例如由金剛院、降冰片院、異疲 院、三環癸院、四環十二院等多環鏈院中去除2個以上氫 -62- 200914991 原子所得之基等。前述多環式基中,又以金剛烷去除2個 以上氫原子之基、降冰片烷去除2個以上氫原子之基、四 環十二烷去除2個以上氫原子之基等更適合工業上使用。 結構單位(a3 )中,於含有極性基之脂肪族烴基中之 烴基爲碳數1至1〇之直鏈狀或支鏈狀烴基時’以由丙烯 酸之羥乙基醋所衍生之結構單位爲佳,該烴基爲多環式基 時,例如下式(a 3 -1 )所示結構單位、(a 3 · 2 )所示結構 單位' (a3-3 )所示結構單位等爲佳。 【化4 0】H3C (a2·*-5) (aZ-5-6) wherein, at least one selected from the structural units represented by the formulas (a2-l) to (a2-3) is preferred, and It is more preferable that at least one or more selected from (a2-l) to (a2-3). Specifically, the equations (a2-1 -1), (a2-1-2), (a2-2- 1 ), (a2-2-2), (a2-3-1), (a2) are used. One or more selected from -3-2), (a2-3-9) and (a2-3-10) are preferred. In the component (A1), the structural unit (a2) may be used singly or in combination of two or more. The ratio of the structural unit (a2) in the component (A1) is preferably 5 to 60 mol%, and 10 to 50 mol%, based on the total of the structural units constituting the component (-61 - 200914991 A1). % is preferred, preferably 20 to 50% by mole. When it is more than the lower limit 値, the effect can be sufficiently obtained when the structural unit (a2) is contained, and when it is less than the upper limit 値, the balance with other structural units can be obtained. • Structural unit (a3) The structural unit (a3) is a structural unit derived from an acrylate having an aliphatic hydrocarbon group containing a polar group. When the component (A3) has a structural unit (a3), the hydrophilicity of the component (A) can be improved, and the affinity with the developer can be improved, and the alkali solubility of the exposed portion can be improved, and the resolution can be expected to be improved. A polar group such as a hydroxyl group, a cyano group, a carboxyl group, a hydroxyalkyl group in which a part of hydrogen atoms in the alkyl group is substituted by a fluorine atom, and the like are preferably a hydroxyl group. The aliphatic hydrocarbon group 'e.e., a linear or branched hydrocarbon group having 1 to 10 carbon atoms (preferably an alkylene group), or a polycyclic aliphatic hydrocarbon group (polycyclic group) or the like. The polycyclic group is, for example, a resin which can be used for a composition for a photoresist for an ArF excimer laser, and is appropriately selected from the contents of most proposals. The polycyclic group preferably has a carbon number of from 7 to 30. Further, a structural unit derived from an acrylate having a hydroxyl group, a cyano group, a carboxyl group, or an aliphatic polycyclic group containing a hydroxyalkyl group in which a part of hydrogen atoms in the alkyl group is substituted by a fluorine atom is more preferable. The polycyclic group is, for example, a base temple obtained by removing two or more hydrogen atoms from a bicycloalkane, a tricycloalkane or a tetracycloalkane. Specifically, it is solidified by, for example, a multi-ring chain such as the King Kong Institute, the Nori Institute, the Weak House, the Third Ring Hospital, and the Fourth Ring and the 12th Institute, and the base obtained by removing two or more hydrogen atoms - 62 - 200914991 atoms. In the polycyclic group, it is more suitable for industrially to remove two or more hydrogen atoms from adamantane, to remove two or more hydrogen atoms from norbornane, and to remove two or more hydrogen atoms from tetracyclododecane. use. In the structural unit (a3), when the hydrocarbon group in the aliphatic hydrocarbon group having a polar group is a linear or branched hydrocarbon group having 1 to 1 carbon atoms, the structural unit derived from hydroxyethyl acrylate of acrylic acid is When the hydrocarbon group is a polycyclic group, for example, a structural unit represented by the following formula (a 3 -1 ), a structural unit represented by (a 3 · 2 ), and a structural unit represented by (a3-3) are preferable. [化4 0]

OH (a3-3) [式中’ R具有與前述相同之意義,j爲丨至3之整數,k 爲1至3之整數,t’爲1至3之整數,1爲1至5之整數 ,S爲1至3之整數]。 通式(a3-l)中’j以】或2爲佳’又以1爲更佳。j 爲2之情形中,以經基鍵結於金剛燒基之3位與5位者爲 更佳。j爲1之情形中’特別是以羥基鍵結於金剛院基之 -63- 200914991 3位爲最佳。 又以j爲1爲佳,特別是羥基鍵結於金剛院基之3位 者爲最佳。 式(a3-2)中,以k爲1者爲佳。又以氰基鍵結於降 冰片烷基之5位或6位者爲佳。 式(a3-3)中,以t’爲1者爲佳,以1爲1者爲佳’ 以s爲1者爲佳。以前述丙烯酸之羧基的末端鍵結2_降冰 片院基或3 -降冰片院基之化合物爲佳。氟化院基醇以鍵結 於降冰片烷基之5或6位者爲佳。 (A 1 )成份中’結構單位(a3 )可單獨使用1種’或 將2種以上組合使用亦可。 (A 1 )成份中之結構單位(a3 )之比例,相對於構成 (A 1 )成份之全體結構單位,以5至5 0莫耳%爲佳,以5 至40莫耳%爲更佳,以5至25莫耳%爲最佳。於下限値 以上時,可充分得到含有結構單位(a3 )之效果,於上限 値以下時可得到與其他結構單位之平衡性。 •結構單位(a4 ) (A1)成份’於不損害本發明之效果之範圍中,可再 含有上述結構單位(a 1 )至(a3 )以外之其他結構單位( a4 ) 〇 結構單位(a4 )只要爲未分類於前述結構單位(a!) 至(a3 )以外之結構單位時’並無特別限定。其可使用 ArF準分子雷射用、KrF準分子雷射用(較佳爲ArF準分 -64 - 200914991 子雷射用)等光阻組成物所使用之以往已知之多數結構單 位。 結構單位(a4 ),例如含有非酸解離性之脂肪族多環 式基的丙烯酸酯所衍生之結構單位等爲佳。該多環式基, 例如爲與前述結構單位(a 1 )時所例示之相同例示內容, 其可使用ArF準分子雷射用、KrF準分子雷射用(較佳爲 ArF準分子雷射用)等光阻組成物之樹脂成份所使用之以 往已知之多數結構單位。 特別是由三環癸烷基、金剛烷基、四環十二烷基、異 菠烷基、降冰片烷基所選出之至少1種以上時,以工業上 容易取得而爲較佳。前述多環式基,可被碳數1至5之直 鏈狀或支鏈狀之烷基取代亦可。 結構單位(a4),具體而言,例如下述通式(a4-l) 至(a4-5 )所示結構單位等。 【化4 1】OH (a3-3) [wherein R has the same meaning as described above, j is an integer from 丨 to 3, k is an integer from 1 to 3, t' is an integer from 1 to 3, and 1 is an integer from 1 to 5. , S is an integer from 1 to 3.]. In the formula (a3-l), 'j is preferably 2 or more and more preferably 1 is used. In the case where j is 2, it is more preferable that the base group is bonded to the 3 and 5 positions of the diamond base. In the case where j is 1, 'especially hydroxy-bonded to the base of the King Kong Institute -63-200914991 3 is the best. It is also preferable that j is 1 and it is preferable that the hydroxyl group is bonded to the base of the King Kong. In the formula (a3-2), it is preferred that k is one. Further, it is preferred that the cyano group is bonded to the 5- or 6-position of the norbornyl group. In the formula (a3-3), it is preferable that t' is one, and that one is one, and it is preferable that s is one. It is preferred that the terminal of the carboxyl group of the above-mentioned acrylic acid is bonded to the compound of the 2 -norborn or 3-norborn. Preferably, the fluorinated alcohol is bonded to the 5 or 6 position of the norbornyl group. In the component (A 1 ), the structural unit (a3) may be used singly or in combination of two or more. The ratio of the structural unit (a3) in the component (A 1 ) is preferably from 5 to 50 mol%, more preferably from 5 to 40 mol%, based on the entire structural unit constituting the component (A 1 ). The best is 5 to 25 mol%. When the lower limit is 値 or more, the effect of containing the structural unit (a3) can be sufficiently obtained, and when it is less than the upper limit 値, the balance with other structural units can be obtained. • Structural unit (a4) (A1) component 'in the range not impairing the effects of the present invention, may further contain other structural units (a4) 〇 structural unit (a4) other than the above structural units (a 1 ) to (a3) It is not particularly limited as long as it is a structural unit that is not classified into the above structural units (a!) to (a3). It is possible to use a conventionally known plurality of structural units used for a photoresist composition such as an ArF excimer laser or a KrF excimer laser (preferably for ArF sub-fraction -64 - 200914991 sub-laser). The structural unit (a4), for example, a structural unit derived from an acrylate having a non-acid dissociable aliphatic polycyclic group is preferred. The polycyclic group is, for example, the same as exemplified in the above structural unit (a 1 ), and can be used for ArF excimer laser or KrF excimer laser (preferably for ArF excimer laser). Most of the conventionally known structural units used for the resin component of the photoresist composition. In particular, when at least one selected from the group consisting of a tricyclodecylalkyl group, an adamantyl group, a tetracyclododecyl group, an isobornyl group, and a norbornyl group is industrially preferable, it is preferably obtained. The polycyclic group may be substituted by a linear or branched alkyl group having 1 to 5 carbon atoms. The structural unit (a4) is specifically, for example, a structural unit represented by the following general formulae (a4-l) to (a4-5). [化4 1]

[式中’ R具有與前述相同之內容]。 前述結構單位(a4 )包含於(A丨)成份中之際,結構 單位(a4 )之比例,相對於構成(A 1 )成份之全體結構單 -65- 200914991 位之合計,以含有1至3 0莫耳%爲佳,又以含有1 〇至20 莫耳%爲更佳。 本發明中,(Α1)成份爲基於酸之作用而增大對鹼顯 影液之可溶性之樹脂成份(聚合物),適合作爲該樹脂成 份(聚合物)之單位’例如具有結構單位(a 1 )、結構單 位(a2 )、及結構單位(a3 )之共聚物’前述共聚合物, 例如由結構單位(a 1 ) 、 ( a2 )、及(a3 )所得之共聚物 ,結構單位(a 1 ) 、 ( a2 ) 、 ( a3 )及(a4 )所得之共聚 物等。 (A1 )成份’可卓獨使用1種,或將2種以上合併使 用亦可。 本發明中,(A1)成份特別是以含有由下述通式( A 1 -1 )〜(A 1 - 3 )所示般結構單位之組合的共聚合物( A1-1)〜(A1-3)爲佳。[wherein R has the same content as described above]. When the structural unit (a4) is contained in the (A丨) component, the ratio of the structural unit (a4) to the total structure of the constituents of the (A1) component is -65 to 200914991, to 1 to 3 0% by mole is preferred, and more preferably 1% to 20% by mole. In the present invention, the (Α1) component is a resin component (polymer) which increases the solubility to the alkali developer based on the action of an acid, and is suitable as a unit of the resin component (polymer), for example, having a structural unit (a 1 ). , structural unit (a2), and copolymer of structural unit (a3) 'the aforementioned copolymer, for example, a copolymer obtained from structural units (a 1 ), ( a2 ), and (a3 ), structural unit (a 1 ) And the copolymer obtained by (a2), (a3) and (a4). (A1) The component ' can be used alone or in combination of two or more. In the present invention, the component (A1) is, in particular, a copolymer (A1-1) to (A1) containing a combination of structural units represented by the following formula (A 1 -1 ) to (A 1 - 3 ). 3) is better.

-66- 200914991 [式中,R具有與前述相同之內容,複數之R分別可爲相 同或相異皆可。R2 0爲低級烷基]。 式中,R具有與前述相同之內容。其中,又以氫原子 或甲基爲最佳。 式中’ R2Q爲低級烷基,其中又以甲基或乙基爲佳。 (A)成份中之共聚合物(A1-1)〜(A1-3)可單獨 使用1種,或將2種以上合倂使用亦可。 又’共聚合物(A1-1)〜(A1-3)中之2種以上組合 使用時’較佳爲共聚合物之組合內容中,例如共聚合物( A 1 - 2 )與(A 1 - 3 )之組合等。 (A)成份中之共聚合物(A1-1)〜(A1-3)之含量 ’以7 0質量%以上爲佳’以8 0質量%以上爲更佳,亦可 爲100質量% ’其中又以100質量%爲最佳。於該範圍之 下限値以上時,作爲正型光阻組成物時,可使微影微影蝕 刻特性再向上提昇。 (A 1 )成份,例如可將各結構單位所衍生之單體,例 如使用偶氮一異丁腈(AIBN)等偶氮系自由基聚合起始 劑依公知之自由基聚合等聚合反應而製得。 又,(A 1 )成份,於上述聚合之際,例如可倂用H S -CH2-CH2-CH2-C(CF3)2-OH等鏈移轉劑,而於末端導入-c(cf3)2-oh基。如此,可得到導入有烷基中氫原子之一部 份被氟原子取代之羥烷基的共聚物,因而可有效降低缺陷 或降低LER ( Line Edge Roughness :線路側壁具有不均勻 凹凸)之效果。 -67- 200914991 (A1)成份之質量平均分子量(Mw)(凝膠滲透色 層分析法之聚苯乙烯換算量)並未有特別限定,一般以 2,000至 50,000爲佳,以 3,000至 30,000爲更佳,以 4,000至20,000爲最佳,以5,000至20,000爲特佳。於此 範圍內時,作爲光阻使用時對光阻溶劑可得到充分之溶解 性,且可得到良好之耐乾蝕刻性或光阻圖型之截面形狀。 又,分散度(Mw/Μη )以1 · 0至5 · 0之範圍爲佳,以 1.0至3.0爲更佳,以1.2至2.5爲最佳。又,Μη爲數平 均分子量。 又,(A 1 )成份,除共聚合物(A 1 -1 )〜(A 1 - 3 )以 外之鹼可溶性樹脂成份,例如可使用以往正型光阻組成物 所使用之其他高分子化合物等。 本發明之正型光阻組成物,其(A 1 )成份之含量,可 配合所欲形成之光阻膜厚度作適當之製作即可。 &lt; (B )成份&gt; 本發明之光阻組成物中,(B)成份爲含有上述通式 (b 1 - 1 4 )所示之化合物所形成之酸產生劑(B 1 )(以下 ,亦稱爲(B1)成份)者。 式中’ R7 ”〜R9 ”、X _係與上述本發明之第三實施態樣 之化合物中所列舉者爲相同之內容6 (B )成份,於含有該(B 1 )成份時,於形成光阻圖 型之際可提昇遮罩重現性,例如’形成連接孔(C / Η )圖 型之際可提昇該通孔之正圓性、直徑(CD )之均勻性( -68- 200914991 CDU ) ’使遮罩誤差因子(MEF )得到改善,具有優良之 C/H圖型抜取性等,而提高微影蝕刻特性。又,形成線路 與空間之光阻圖型(L/S圖型)之際,因MEF得到改善等 ,故可提局微影餘刻特性。 隨後,本發明之光阻組成物,於含有浸潤式曝光步驟 之光阻圖型形成方法中,極適合作爲浸潤式曝光用光阻組 成物使用,而可得到良好之微影蝕刻特性,又,於含有形 成3層光阻層合物之步驟的光阻圖型形成方法中,亦適合 作爲形成上層光阻膜用之正型光阻組成物,而可得到良好 之微影蝕刻特性。 (B1)成份中,又以使用陰離子部爲前述通式「 R14S〇T」或「R^o-Y^sor」所示之陰離子,或前述通式 (b-3 )或(b-4 )所示之陰離子者爲佳。又,以使用通式 「R14S03_」或「Ri-O-Y^SOr」所示之陰離子爲更佳。 (B)成份,可使用1種或將2種以上混合使用。 本發明之光阻組成物中,(B)成份全體中之(B1) 成份的含量,以40質量%以上爲佳,以60質量%以上爲 更佳,亦可爲1 00質量%。於該範圍之下限値以上時,可 得到良好之光阻圖型形狀。特別是使用浸潤式曝光用光阻 組成物,或上層光阻膜形成用光阻組成物以形成光阻圖型 之際,可提高微影蝕刻特性。形成3層光阻層合體之際, 以其與光阻之下層膜具有良好之密合性,可抑制光阻圖型 之邊緣捲曲(footing)等而爲較佳。 又,本發明之光阻組成物中,(B1 )成份之含量,相 -69- 200914991 對於前述(A)成份之100質量份,以使用1〜30質量份 爲佳,以3〜18質量份爲更佳,以5〜16質量份爲特佳。 於該範圍之下限値以上時,特別是使用浸潤式曝光用光阻 組成物,或上層光阻膜形成用光阻組成物以形成光阻圖型 之際,可提高微影蝕刻特性。又,於上限値以下時,可得 到良好之保存安定性。 (B )成份中,前述(B 1 )成份以外之酸產生劑(B 2 )(以下亦稱爲(B2 )成份)亦可倂用前述(B 1 )成份。 (B2 )成份,只要爲前述(B 1 )成份成份以外之成份 時並未有特別限定,其可使用目前爲止被提案作爲化學增 幅型光阻用之酸產生劑的成份。 前述酸產生劑,目前爲止例如碘鎗鹽或鏑鹽等鎗鹽系 酸產生劑,肟磺酸酯系酸產生劑、雙烷基或雙芳基磺醯基 重氮甲烷類、聚(雙磺醯基)重氮甲烷類等重氮甲烷系酸 產生劑、硝基苄磺酸酯類系酸產生劑、亞胺基磺酸酯系酸 產生劑、二颯類系酸產生劑等多種已知化合物。 鑰鹽系酸產生劑,例如可使用下述式(b -1 )或(b - 2 )所示化合物。 【化4 3】-66- 200914991 [wherein R has the same content as described above, and the plural R may be the same or different. R20 is a lower alkyl group]. In the formula, R has the same content as described above. Among them, hydrogen atom or methyl group is preferred. Wherein 'R2Q is a lower alkyl group, of which methyl or ethyl is preferred. The copolymers (A1-1) to (A1-3) in the component (A) may be used singly or in combination of two or more. Further, when two or more of the 'copolymers (A1-1) to (A1-3) are used in combination, it is preferable to use a combination of copolymers such as a copolymer (A 1 - 2 ) and (A 1). - 3) combinations, etc. The content of the copolymer (A1-1) to (A1-3) in the component (A) is preferably 70% by mass or more, and more preferably 80% by mass or more, and may be 100% by mass. It is also preferably 100% by mass. When the lower limit 値 or more of the range is used, when the positive resist composition is used, the lithographic microetching characteristics can be further improved. (A1) component, for example, a monomer derived from each structural unit, for example, an azo-based radical polymerization initiator such as azo-isobutyronitrile (AIBN) can be produced by a polymerization reaction such as radical polymerization. Got it. Further, in the above-mentioned polymerization, the (A 1 ) component may be, for example, a chain transfer agent such as HS-CH2-CH2-CH2-C(CF3)2-OH, and -c(cf3)2- may be introduced at the end. Oh base. Thus, a copolymer having a hydroxyalkyl group in which one of the hydrogen atoms in the alkyl group is substituted with a fluorine atom can be obtained, whereby the defect can be effectively reduced or the LER (Line Edge Roughness) can be effectively reduced. -67- 200914991 (A1) The mass average molecular weight (Mw) of the component (polystyrene equivalent amount of gel permeation chromatography) is not particularly limited, and is generally preferably 2,000 to 50,000, and more preferably 3,000 to 30,000. Good, 4,000 to 20,000 is the best, and 5,000 to 20,000 is the best. In the above range, when used as a photoresist, sufficient solubility is obtained for the resist solvent, and a good dry etching resistance or a resist pattern cross-sectional shape can be obtained. Further, the degree of dispersion (Mw / Μη) is preferably in the range of 1 · 0 to 5 · 0, more preferably 1.0 to 3.0, and most preferably 1.2 to 2.5. Further, Μη is a number average molecular weight. Further, as the (A 1 ) component, in addition to the alkali-soluble resin component other than the copolymer (A 1 -1 ) to (A 1 - 3 ), for example, other polymer compounds used in the conventional positive-type resist composition can be used. . In the positive resist composition of the present invention, the content of the (A 1 ) component may be appropriately prepared in accordance with the thickness of the photoresist film to be formed. &lt; (B) Component&gt; In the photoresist composition of the present invention, the component (B) is an acid generator (B 1 ) containing a compound represented by the above formula (b 1 - 14 ) (hereinafter, Also known as (B1) ingredients. In the formula, 'R7' to R9' and X_ are the same as those listed in the above-mentioned third embodiment of the present invention, and the content of the component (B) is formed when the (B 1 ) component is contained. The photoresist pattern can improve the reproducibility of the mask, for example, when forming the connection hole (C / Η) pattern, the roundness and diameter (CD) uniformity of the through hole can be improved (-68- 200914991) CDU) 'Improve the mask error factor (MEF), have excellent C/H pattern pick-up, etc., and improve the lithography etching characteristics. Further, when the line and space resist pattern (L/S pattern) is formed, the MEF is improved, and the lithography residual characteristics can be improved. Subsequently, the photoresist composition of the present invention is excellently used as a photoresist composition for immersion exposure in a photoresist pattern forming method including an immersion exposure step, and good lithographic etching characteristics can be obtained. In the photoresist pattern forming method including the step of forming a three-layer photoresist layer, it is also suitable as a positive-type photoresist composition for forming an upper photoresist film, and good lithographic etching characteristics can be obtained. In the component (B1), the anion moiety is an anion represented by the above formula "R14S〇T" or "R^oY^sor", or the above formula (b-3) or (b-4) The anion is better. Further, it is more preferable to use an anion represented by the formula "R14S03_" or "Ri-O-Y^SOr". (B) The components may be used alone or in combination of two or more. In the photoresist composition of the present invention, the content of the component (B1) in the entire component (B) is preferably 40% by mass or more, more preferably 60% by mass or more, and may be 100% by mass. When the lower limit of the range is above ,, a good photoresist pattern shape can be obtained. In particular, when the photoresist composition for immersion exposure or the photoresist composition for forming an upper photoresist film is used to form a photoresist pattern, the lithography characteristics can be improved. When the three-layer photoresist layer is formed, it is preferable because it has good adhesion to the underlayer film of the photoresist, and it is possible to suppress edge curling of the photoresist pattern. Further, in the photoresist composition of the present invention, the content of the component (B1), phase -69 to 200914991 is preferably from 1 to 30 parts by mass, based on 100 parts by mass of the above component (A), and is from 3 to 18 parts by mass. For better, it is particularly good for 5 to 16 parts by mass. When the lower limit of the range is 値 or more, in particular, when the photoresist composition for immersion exposure or the photoresist composition for forming an upper photoresist film is used to form a photoresist pattern, the lithography characteristics can be improved. Also, when the upper limit is less than 値, good preservation stability can be obtained. In the component (B), the acid generator (B 2 ) other than the component (B 1 ) (hereinafter also referred to as the component (B2)) may be the same as the component (B 1 ). The component (B2) is not particularly limited as long as it is a component other than the component (B1), and a component which has been proposed as an acid generator for a chemically amplified photoresist has been used. The acid generator is, for example, a gun salt acid generator such as an iodine salt or a phosphonium salt, an oxime sulfonate acid generator, a dialkyl or bisarylsulfonyldiazomethane, or a polysulfonate. Hydrazine-based diazomethane-based acid generator, nitrobenzyl sulfonate-based acid generator, iminosulfonate-based acid generator, diterpenoid acid generator, etc. Compound. As the key salt acid generator, for example, a compound represented by the following formula (b-1) or (b-2) can be used. [化4 3]

Rif r4,.s〇-3 …㈣ /l+ R4S〇3 — (b-2) R6&quot; [式中’ R1”至R3’’、R5’’至R6”,各自獨立爲芳基或烷基; -70- 200914991 式(b-l )中之R至R3’’中,任意2個可相互鍵結並與式 中之硫原子共同形成環亦可;R4”爲直鏈狀、支鏈狀或環 狀烷基或氟化烷基·’ R1’’至R3,’中至少1個爲芳基,R5”至 R6”中至少1個爲芳基]。 式(b-l )中,1^’’至R3”除烷氧烷基羰基或烷氧羰基 烷氧基不能作爲氫原子被取代之取代基以外,其他皆與通 式(b-14)中之式R7’’至R9”爲相同之內容。 又,R1”至R3”中,至少丨個爲芳基。Rl ”至R3”中以2 個以上爲芳基者爲佳,又以Rl”至R3”全部爲芳基者爲最佳 0 其中又以R1’’至R3’’之分別爲苯基或萘基者爲最佳。 R4爲直鏈狀、支鏈狀或環狀之院基,或氟化院基。 前述直鏈狀或支鏈狀之烷基,以碳數〗至10者爲佳 ,以碳數1至8者爲更佳,以碳數1至4者爲最佳。 前述環狀之烷基,係如前述R 1 ”所示環式基,其以碳 數4至15者爲佳,以碳數4至1〇者爲更佳,以碳數6至 1 〇者爲最佳。 前述氟化烷基,以碳數1至1〇者爲佳,以碳數1至8 者爲更佳’以碳數1至4者爲最佳。又,該氟化烷基之氟 化率(烷基中氟原子之比例)較佳爲1 〇至1 〇 〇 %,更佳爲 50至1 0 0% ’特別是氫原子全部被氟原子取代所得者,以 其酸之強度更強而爲更佳。 R4 ’以直鏈狀或環狀之院基,或氣化院基者爲最佳 -71 - 200914991 式(b-2 )中’ R5”至R6”各自獨立爲芳基或烷基;R5’ 至R6’’中至少1個爲芳基,R5”至R6”中以全部爲芳基者爲 最佳。 R5’’至R6”之芳基,例如與R1”至R3”之芳基爲相同之內 容。 R5”至R6”之烷基,例如與R1”至R3”之院基爲相同之內 容。 其中又以R5’’至R6”之二者同時爲苯基者爲最佳。 前述式(b-2)中之R4”與(b-Ι)中之R4”爲相同之內 容。 式(b-1 ) 、 ( b-2 )所示鎗鹽系酸產生劑之具體例如 ’二苯基碘鑰之三氟甲烷磺酸酯或九氟丁烷磺酸酯、雙( 4-tert-丁基苯基)碘鎗之三氟甲烷磺酸酯或九氟丁烷磺酸 酯、三苯基锍之三氟甲烷磺酸酯、其七氟丙烷磺酸酯或其 九氟1 丁丨兀5貝酸醋、二(4 -甲基苯基)鏡之二氣甲院磺酸醋 、其七氟丙烷磺酸酯或其九氟丁烷磺酸酯、二甲基(4-羥 基萘基)锍之三氟甲烷磺酸酯、其七氟丙烷磺酸酯或其九 氟丁烷磺酸酯、單苯基二甲基毓之三氟甲烷磺酸酯、其七 氟丙烷磺酸酯或其九氟丁烷磺酸酯、二苯基單甲基锍之三 氟甲烷磺酸酯、其七氟丙烷磺酸酯或其九氟丁烷磺酸酯、 (4-甲基苯基)二苯基锍之三氟甲烷磺酸酯、其七氟丙院 磺酸酯或其九氟丁烷磺酸酯、(4-甲氧基苯基)二苯基锍 之三氟甲烷磺酸酯、其七氟丙烷磺酸酯或其九氟丁烷磺酸 酯、三(4-tert-丁基)苯基銃之三氟甲烷磺酸酯、其七氟 -72- 200914991 丙烷磺酸酯或其九氟丁烷磺酸酯、二苯基(1-( 4-甲氧基 )萘基)鏑之三氟甲烷磺酸酯、其七氟丙烷磺酸酯或其九 氟丁烷磺酸酯、二(1-萘基)苯基锍之三氟甲烷磺酸酯、 其七氟丙烷磺酸酯或其九氟丁烷磺酸酯、1-苯基四氫噻吩 鑰之三氟甲烷磺酸酯、其七氟丙烷磺酸酯或其九氟丁烷磺 酸酯、1 - ( 4-甲基苯基)四氫噻吩鐵之三氟甲烷磺酸酯' 其七氟丙烷磺酸酯或其九氟丁烷磺酸酯、1-( 3,5-二甲基-4-羥苯基)四氫噻吩鑰之三氟甲烷磺酸酯、其七氟丙烷磺 酸酯或其九氟丁烷磺酸酯、1-(4·甲氧基萘-1-基)四氫噻 吩鑰之三氟甲烷磺酸酯、其七氟丙烷磺酸酯或其九氟丁烷 磺酸酯、1-(4-乙氧基萘-1-基)四氫噻吩鎗之三氟甲烷磺 酸酯、其七氟丙烷磺酸酯或其九氟丁烷磺酸酯、l-(4-n-丁氧基萘-卜基)四氫噻吩鑰之三氟甲烷磺酸酯、其七氟丙 烷磺酸酯或其九氟丁烷磺酸酯、1-苯基四氫噻喃鑰之三氟 甲烷磺酸酯、其七氟丙烷磺酸酯或其九氟丁烷磺酸酯、1-(4 -羥苯基)四氫噻喃鑰之三氟甲烷磺酸酯、其七氟丙烷 磺酸酯或其九氟丁烷磺酸酯、1-(3,5-二甲基-4-羥苯基) 四氫噻喃鐡之三氟甲烷磺酸酯、其七氟丙烷磺酸酯或其九 氟丁烷磺酸酯、〗-(4_甲基苯基)四氫噻喃錙之三氟甲烷 磺酸酯、其七氟丙烷磺酸酯或其九氟丁烷磺酸酯等。 又,可使用前述鐵鹽之陰離子部被甲烷磺酸酯、η-丙 烷磺酸酯、η-丁烷磺酸酯、η-辛烷磺酸酯所取代之鑰鹽。 又,亦可使用前述式(b-Ι)或(b-2)中,陰離子部 被下述式(b-3 )或(b-4 )所示陰離子部取代所得之鐵鹽 -73- 200914991 系酸產生劑亦可(陽離子部係與前述式(b_})或(b_2) 相同)。 又’亦可使用具有下述通式(b-5)或(b_6)所表示 之陽離子部之錡鹽作爲鎗鹽系酸產生劑使用。 【化4 4】Rif r4,.s〇-3 (4) /l+ R4S〇3 — (b-2) R6&quot; [wherein 'R1' to R3'', R5'' to R6", each independently being an aryl or alkyl group; -70- 200914991 In the formula (b1), R to R3'', any two of them may be bonded to each other and form a ring together with a sulfur atom in the formula; R4" is linear, branched or cyclic. At least one of the alkyl group or the fluorinated alkyl group 'R1'' to R3,' is an aryl group, and at least one of R5" to R6" is an aryl group. In the formula (bl), 1^'' to R3 The same applies to the formulas R7'' to R9" in the formula (b-14) except that the alkoxyalkylcarbonyl group or the alkoxycarbonylalkoxy group is not a substituent which is substituted as a hydrogen atom. Among R1" to R3", at least one of them is an aryl group. Among R1" to R3", it is preferable to use two or more aryl groups, and it is preferable that all of R1" to R3" are aryl groups. It is preferred that R1'' to R3'' are respectively phenyl or naphthyl. R4 is a linear, branched or cyclic group, or a fluorinated base. The aforementioned linear or branched chain Alkyl group, preferably with carbon number 1-10 to 10, with carbon number 1 to 8 being more Preferably, the cyclic alkyl group is a cyclic group represented by the above R 1 ", and preferably has a carbon number of 4 to 15 and a carbon number of 4 to 1 Å. For better, the best carbon number is 6 to 1 。. The above-mentioned fluorinated alkyl group is preferably one having a carbon number of 1 to 1 Torr, more preferably having a carbon number of 1 to 8 and preferably having a carbon number of 1 to 4. Further, the fluorination ratio of the fluorinated alkyl group (the ratio of the fluorine atom in the alkyl group) is preferably from 1 Torr to 1% by weight, more preferably from 50 to 100%. In particular, all of the hydrogen atoms are replaced by fluorine atoms. The winner is better because the strength of the acid is stronger. R4 'is linear or ring-based, or gasification yard base is best -71 - 200914991 Formula (b-2) 'R5" to R6" are each independently aryl or alkyl; R5' At least one of R6'' is an aryl group, and all of R5" to R6" are preferably an aryl group. The aryl group of R5'' to R6" is, for example, the same as the aryl group of R1" to R3". The alkyl group of R5" to R6" is, for example, the same as the group of R1" to R3". It is also preferred that both of R5'' to R6" are phenyl groups at the same time. R4" in the above formula (b-2) and R4" in (b-Ι) are the same contents. Specific examples of the gun salt acid generators represented by the formulae (b-1) and (b-2), such as 'diphenyliodide trifluoromethanesulfonate or nonafluorobutanesulfonate, bis (4-tert) -butylphenyl) iodine gun trifluoromethane sulfonate or nonafluorobutane sulfonate, triphenyl sulfonium trifluoromethane sulfonate, its heptafluoropropane sulfonate or its nonafluoro 1 butyl sulfonate 5 Bayeine vinegar, bis(4-methylphenyl) mirror of digastric sulfonic acid vinegar, heptafluoropropane sulfonate or its nonafluorobutane sulfonate, dimethyl (4-hydroxynaphthyl) anthracene Trifluoromethanesulfonate, its heptafluoropropane sulfonate or its nonafluorobutane sulfonate, triphenylmethanesulfonate monophenyldimethylhydrazine, its heptafluoropropane sulfonate or its nonafluorobutane sulfonic acid Ethyl ester, triphenylmethanesulfonate of diphenylmonomethylhydrazine, its heptafluoropropane sulfonate or its nonafluorobutane sulfonate, trifluoromethanesulfonic acid of (4-methylphenyl)diphenylphosphonium Ester, its heptafluoropropane sulfonate or its nonafluorobutane sulfonate, (4-methoxyphenyl)diphenylphosphonium trifluoromethanesulfonate, its heptafluoropropane sulfonate or its nonafluoro Butane sulfonate, three (4-tert- Phenylhydrazine trifluoromethanesulfonate, heptafluoro-72- 200914991 propane sulfonate or its nonafluorobutane sulfonate, diphenyl (1-(4-methoxy)naphthyl) Trifluoromethanesulfonate, its heptafluoropropane sulfonate or its nonafluorobutane sulfonate, di(1-naphthyl)phenylphosphonium trifluoromethanesulfonate, heptafluoropropane sulfonate or its nine Fluorobutane sulfonate, 1-phenyltetrahydrothiophene key trifluoromethane sulfonate, heptafluoropropane sulfonate or its nonafluorobutane sulfonate, 1-(4-methylphenyl)tetrahydrogen Thiophene iron trifluoromethane sulfonate's heptafluoropropane sulfonate or its nonafluorobutane sulfonate, 1-(3,5-dimethyl-4-hydroxyphenyl)tetrahydrothiophene-trifluoromethane a sulfonate, a heptafluoropropane sulfonate or a nonafluorobutane sulfonate thereof, a trifluoromethanesulfonate of 1-(4.methoxynaphthalen-1-yl)tetrahydrothiophene, and a heptafluoropropane sulfonate thereof Or a nonafluorobutane sulfonate, a trifluoromethanesulfonate of 1-(4-ethoxynaphthalen-1-yl)tetrahydrothiophene, a heptafluoropropane sulfonate or a nonafluorobutane sulfonate thereof , l-(4-n-butoxynaphthalene-buyl) tetrahydrothiophene Methanesulfonate, its heptafluoropropane sulfonate or its nonafluorobutane sulfonate, 1-phenyltetrahydrothienyl trifluoromethanesulfonate, heptafluoropropane sulfonate or its nonafluorobutane sulfonic acid Ester, 1-(4-hydroxyphenyl)tetrahydrothienyl trifluoromethanesulfonate, heptafluoropropane sulfonate or its nonafluorobutane sulfonate, 1-(3,5-dimethyl- 4-hydroxyphenyl) tetrahydrothiopyranium trifluoromethanesulfonate, heptafluoropropane sulfonate or its nonafluorobutane sulfonate, 4-(4-phenylphenyl)tetrahydrothiopyran Trifluoromethanesulfonate, heptafluoropropane sulfonate or nonafluorobutane sulfonate thereof. Further, a key salt in which the anion portion of the iron salt is replaced by a methanesulfonate, η-propanesulfonate, η-butanesulfonate or η-octanesulfonate can be used. Further, in the above formula (b-Ι) or (b-2), the anion portion may be substituted with an anion portion represented by the following formula (b-3) or (b-4) to obtain an iron salt-73-200914991. The acid generator may also be (the cationic moiety is the same as the above formula (b_}) or (b_2)). Further, a sulfonium salt having a cation portion represented by the following formula (b-5) or (b-6) may be used as a gun salt acid generator. [4 4]

[式中,R41〜R40爲各自獨立之烷基、乙醯基、烷氧基、 羧基、羥基或羥烷基;〜〜ns爲各自獨立之〇〜3之整數 ’ n6爲0〜2之整數]。 R41〜R46中,烷基以碳數1〜5之烷基爲佳,其中又 以直鏈狀或分支鏈狀之烷基爲更佳,以甲基、乙基、丙基 、異丙基、η-丁基、或tert-丁基爲特佳。 院氧基以碳數1〜5之垸氧基爲佳,其中又以直鏈狀 或分支鏈狀之垸氧基爲更佳,以甲氧基、乙氧基爲特佳。 經院基以上述院基中之一個或多數個之氫原子被經基 所取代之基爲佳,例如羥甲基 '羥乙基、羥丙基等。 R41〜R46所附加之符號ηι〜n6爲2以上之整數時,該 複數之R41〜R46各自可爲相同或相異皆可。 -74- 200914991 ηι較佳爲〇〜2,更佳爲〇或1,最佳爲〇。 Π2及η3,較佳爲爲各自獨立之〇或1,更佳爲〇。 η4較佳爲〇〜2,更佳爲〇或1。 η5較佳爲0或1,更佳爲0。 η6較佳爲〇或1,更佳爲1。 具有式(b-5 )或(b-6 )所表示之陽離子部之毓鹽的 陰離子部,並未有特別限定,其可使用與目前提案作爲鑰 鹽系酸產生劑之陰離子部爲相同之陰離子部。該陰離子部 ,例如上述通式(b-Ι )或(b-2 )所表示之鎗鹽系酸產生 劑之陰離子部(R4’’S03·)等氟化烷基磺酸離子;上述通式 (b-3 )或(b-4 )所表示之陰離子部等。其中,又以氟化 烷基磺酸離子爲佳,以碳數1〜4之氟化烷基磺酸離子爲 更佳,以碳數1〜4之直鏈狀之全氟烷基磺酸離子爲最佳 。具體例如三氟甲基磺酸離子、七氟-η-丙基磺酸離子、九 氟-η-丁基磺酸離子等。 本說明書中,肟磺酸酯系酸產生劑例如至少具有1個 下述式(Β -1 )所示之基之化合物’其具有經由放射線照 射可產生酸之特性。前述肟磺酸酯系酸產生劑,常用於化 學增幅型光阻組成物使用’本發明可任意進行選擇使用。 【化4 5】 -C=N—Ο—S〇2—R31 p32 1 · * (Β - 1 ) [式(Β-!)中,R3L r32各自獨立爲有機基]。 -75- 200914991 R31、R3 2之有機基爲含有碳原子之基,但其亦可含有 碳原子以外之原子(例如氫原子、氧原子、氮原子、硫原 子、鹵素原子(氟原子、氯原子等)等)。 R31之有機基,以直鏈狀、分支狀或環狀烷基或芳基 爲佳。前述烷基、芳基可具有取代基。該取代基並未有任 何限制,例如可爲氟原子、碳數1至6之直鏈狀、分支狀 或環狀烷基等。其中’ 「具有取代基」係指烷基或芳基之 氫原子中至少1個被取代基所取代之意。 烷基以碳數1至20爲佳,以碳數1至1〇爲較佳,以 碳數1至8爲更佳’以碳數〗至6爲最佳,以碳數1至4 爲特佳。其中’烷基’特別是以部份或完全被鹵化所得之 院基(以下’亦稱爲鹵化烷基)爲佳。又,部份鹵化之烷 基’係指氫原子之一部份被鹵素原子所取代之烷基,完全 鹵化之院基,係指氫原子全部被鹵素原子所取代之烷基之 意。前述歯素原子’例如氟原子、氯原子、溴原子、碘原 子等’特別是以氟原子爲佳。即,鹵化烷基以氟化烷基爲 佳。 芳基以碳數4至20者爲佳,以碳數4至10者爲較佳 ’以碳數6至1 〇者爲更佳。芳基特別是以部份或全部被 鹵化所彳守之方基爲佳。又’部份鹵化之芳基,係指氫原子 之一部份被鹵素原子所取代之芳基’完全鹵化之芳基,係 指氫原子全部被鹵素原子所取代之芳基之意。 R31特別是以不具有取代基之碳數1至4之烷基,或 碳數1至4之氟化烷基爲佳。 -76- 200914991 R32之有機基’以直鏈狀、支鏈狀或環狀烷基、芳基 或氰基爲佳。R 3 2之院基、方基,例如與前述R3 1所列舉 之烷基、芳基爲相同之內容。 R32特別是爲氰基、不具有取代基之碳數1至8之烷 基,或碳數1至8之氟化院基爲佳。 肟磺酸酯系酸產生劑’更佳者例如下述式(B-2)或 (B-3 )所示化合物等。 【化4 6】 R34—C==N—Ο-S02—R35 R33 · · · · (B一 2) [式(B-2)中,R33爲氰基、不具有取代基之烷基或鹵化 烷基;R34爲芳基;R35爲不具有取代基之烷基或鹵化烷基 【化4 7】Wherein R41 to R40 are each independently an alkyl group, an ethyl sulfonyl group, an alkoxy group, a carboxyl group, a hydroxy group or a hydroxyalkyl group; and ~ ns are independent integers of 33, and n6 is an integer of 0 to 2 ]. In R41 to R46, the alkyl group is preferably an alkyl group having 1 to 5 carbon atoms, and more preferably a linear or branched alkyl group, and a methyl group, an ethyl group, a propyl group, an isopropyl group, or the like. Η-butyl or tert-butyl is particularly preferred. The oxy group is preferably a methoxy group having 1 to 5 carbon atoms, more preferably a linear or branched decyloxy group, and particularly preferably a methoxy group or an ethoxy group. It is preferred that the base of the hospital is substituted with a hydrogen atom of one or more of the above-mentioned bases, such as a hydroxymethyl 'hydroxyethyl group, a hydroxypropyl group or the like. When the symbols ηι to n6 to be added to R41 to R46 are integers of 2 or more, the plural numbers R41 to R46 may be the same or different. -74- 200914991 ηι is preferably 〇~2, more preferably 〇 or 1, preferably 〇. Preferably, Π2 and η3 are independently 〇 or 1, more preferably 〇. Η4 is preferably 〇~2, more preferably 〇 or 1. Η5 is preferably 0 or 1, more preferably 0. Η6 is preferably 〇 or 1, more preferably 1. The anion portion having the sulfonium salt of the cation portion represented by the formula (b-5) or (b-6) is not particularly limited, and it can be used in the same manner as the anion portion currently proposed as the key salt acid generator. Anion part. The anion portion is, for example, a fluorinated alkylsulfonic acid ion such as an anion portion (R4''S03·) of a gun salt acid generator represented by the above formula (b-Ι) or (b-2); An anion portion or the like represented by (b-3) or (b-4). Among them, a fluorinated alkylsulfonic acid ion is preferred, and a fluorinated alkylsulfonic acid ion having a carbon number of 1 to 4 is more preferred, and a linear perfluoroalkylsulfonate ion having a carbon number of 1 to 4 is used. For the best. Specifically, for example, a trifluoromethanesulfonic acid ion, a heptafluoro-?-propylsulfonic acid ion, a nonafluoro-?-butylsulfonic acid ion or the like. In the present specification, an oxime sulfonate-based acid generator, for example, a compound having at least one group represented by the following formula (Β -1 ) has a property of generating an acid via radiation irradiation. The above-mentioned oxime sulfonate-based acid generator is commonly used in the chemically amplified photoresist composition. The present invention can be optionally used. [Chemical 4 5] -C=N—Ο—S〇2—R31 p32 1 · * (Β - 1 ) [In the formula (Β-!), R3L r32 is independently an organic group]. -75- 200914991 The organic group of R31 and R3 2 is a group containing a carbon atom, but it may also contain an atom other than a carbon atom (for example, a hydrogen atom, an oxygen atom, a nitrogen atom, a sulfur atom, a halogen atom (a fluorine atom, a chlorine atom). and many more). The organic group of R31 is preferably a linear, branched or cyclic alkyl or aryl group. The aforementioned alkyl group or aryl group may have a substituent. The substituent is not particularly limited and may, for example, be a fluorine atom, a linear one having a carbon number of 1 to 6, a branched or a cyclic alkyl group or the like. Wherein "having a substituent" means that at least one of the hydrogen atoms of the alkyl group or the aryl group is substituted with a substituent. The alkyl group is preferably a carbon number of 1 to 20, preferably a carbon number of 1 to 1 Torr, a carbon number of 1 to 8 or more, preferably a carbon number of 6 to 6 and a carbon number of 1 to 4. good. The 'alkyl group' is particularly preferably a hospital base (hereinafter also referred to as a halogenated alkyl group) obtained by partial or complete halogenation. Further, the partially halogenated alkyl group means an alkyl group in which a part of a hydrogen atom is substituted by a halogen atom, and a wholly halogenated group means an alkyl group in which a hydrogen atom is entirely substituted by a halogen atom. The halogen atom "e.g., fluorine atom, chlorine atom, bromine atom, iodine atom, etc." is particularly preferably a fluorine atom. Namely, the halogenated alkyl group is preferably a fluorinated alkyl group. The aryl group is preferably a carbon number of 4 to 20, preferably a carbon number of 4 to 10, and more preferably a carbon number of 6 to 1 Å. The aryl group is particularly preferably a square group which is partially or wholly halogenated. Further, the "partially halogenated aryl group" means an aryl group which is completely halogenated by an aryl group in which a part of a hydrogen atom is replaced by a halogen atom, and means an aryl group in which all hydrogen atoms are replaced by a halogen atom. R31 is particularly preferably an alkyl group having 1 to 4 carbon atoms which has no substituent, or a fluorinated alkyl group having 1 to 4 carbon atoms. -76- 200914991 The organic group of R32 is preferably a linear, branched or cyclic alkyl, aryl or cyano group. The base group and the square group of R 3 2 are, for example, the same as those of the alkyl group and the aryl group exemplified in the above R3 1 . R32 is particularly preferably a cyano group, an alkyl group having 1 to 8 carbon atoms which has no substituent, or a fluorinated group having 1 to 8 carbon atoms. The oxime sulfonate-based acid generator is more preferably a compound represented by the following formula (B-2) or (B-3). [Chemical 4 6] R34—C==N—Ο-S02—R35 R33 · · · · (B-2) [In the formula (B-2), R33 is a cyano group, an alkyl group having no substituent or halogenation An alkyl group; R34 is an aryl group; R35 is an alkyl group having no substituent or a halogenated alkyl group [Chemical 4 7]

[式(B-3 )中’ R36爲氰基、不具有取代基之烷基或鹵化 烷基;R3 7爲2或3價之芳香族烴基;R3 8爲不具有取代基 之烷基或鹵化烷基,P”爲2或3]。 前述式(B-2 )中,R33之不具有取代基之烷基或鹵化 烷基,以碳數1至10爲佳,以碳數1至8爲更佳,以碳 數1至6爲最佳。 -77- 200914991 R3 3以鹵化烷基爲佳,又以氟化院基爲更佳。 R33中之氟化烷基,其烷基中氫原子以5〇%以上被氟 化者爲佳,更佳爲70 %以上,又以90%以上被氟化者爲最 佳。 R34之芳基,例如苯基或聯苯基(biphenyl)、芴基( fluorenyl )、萘基、蒽基(anthryl )基、菲繞啉基等之芳 香族烴之環去除1個氫原子之基,及構成前述基之環的碳 原子之一部份被氧原子、硫原子、氮原子等雜原子取代所 得之雜芳基等。其中又以芴基爲更佳。 R34之芳基,可具有碳數1至10之烷基、鹵化烷基、 院氧基等取代基亦可。該取代基中之院基或鹵化院基,以 碳數1至8爲佳,以碳數1至4爲更佳。又,該鹵化烷基 以氟化烷基爲更佳。 R35之不具有取代基之烷基或鹵化烷基,以碳數1至 10爲佳,以碳數1至8爲更佳,以碳數1至6爲最佳。 R3 5以鹵化烷基爲佳,以氟化烷基爲更佳。 R35中之氟化烷基,其烷基中氫原子以50%以上被氟 化者爲佳,更佳爲70%以上,又以90%以上被氟化時,可 提高所產生之酸而爲更佳。最佳者則爲氫原子1 00%被氟 取代之全氟化烷基。 前述式(B-3 )中,R36之不具有取代基之烷基或鹵化 烷基,例如與上述R33所示之不具有取代基之烷基或鹵化 烷基爲相同之內容。 R37之2或3價之芳香族烴基,例如由上述R34之芳 -78- 200914991 基中再去除1或2個氨原子所得之基等。 R38之.不具有取代基之烷基或鹵化烷基,例如與 R35所示之不具有取代基之烷基或鹵化烷基爲相同之 〇 P”較佳爲2。 肟磺酸酯系酸產生劑之具體例,如α-(ρ-甲苯磺 亞胺基)·节基氰化物(cyanide) 、α-(ρ -氯基苯磺 亞胺基)-苄基氰化物、α - ( 4-硝基苯磺醯氧亞胺基: 基氰化物、α - ( 4 -硝基-2 ·三氟甲基苯磺醯氧亞胺基: 基氰化物、α-(苯磺醯氧亞胺基)-4-氯基苄基氰化 α-(苯磺醯氧亞胺基)-2,4-二氯基苄基氰化物、α -磺醯氧亞胺基)-2,6-二氯基苄基氰化物、α-(苯磺 亞胺基)-4-甲氧基苄基氰化物、α-(2-氯基苯磺醯 胺基)-4 -甲氧基千基氰化物、α -(苯磺醯氧亞胺基: 嗯-2 -基乙腈、α - ( 4 -十二烷基苯磺醯氧亞胺基)-苄 化物、〇: -[( ρ-甲苯磺醯氧亞胺基)-4-甲氧基苯基] 、〇:-[(十二烷基苯磺醯氧亞胺基)-4-甲氧基苯基] 、α -(對甲苯磺醯氧亞胺基)-4-噻嗯基氰化物、《 · 基磺醯氧亞胺基)-1-環戊烯基乙腈、α_(甲基磺酿 胺基)-1-環己烯基乙腈、α-(甲基磺醯氧亞胺基)-庚烯基乙腈、α -(甲基磺醯氧亞胺基)-1-環辛嫌基 、〇:-(三氟甲基磺醯氧亞胺基)-卜環戊烯基乙腈、〔 三氟甲基磺醯氧亞胺基)_環己基乙腈、乙基磺 亞胺基)-乙基乙腈、α -(丙基磺醯氧亞胺基)-丙基 上述 內容 醯氧 驢氧 )-苄 )-苄 物、 (苯 醯氧 氧亞 &gt; -噻 基氰 乙腈 乙腈 (甲 氧亞 1 -環 乙腈 τ -( 酿氧 乙腈 -79- 200914991 、α-(環己基磺醯氧亞胺基)-環戊基乙腈、α-(環己基 磺醯氧亞胺基)-環己基乙腈、α-(環己基磺醯氧亞胺基 )-1-環戊烯基乙腈、α-(乙基磺醯氧亞胺基)-1-環戊烯 基乙腈、α -(異丙基磺醯氧亞胺基)-1 -環戊烯基乙腈、 a - ( η_丁基磺醯氧亞胺基)-1-環戊烯基乙腈、a -(乙基 磺醯氧亞胺基)-1-環己烯基乙腈、α-(異丙基磺醯氧亞 胺基)-1-環己烯基乙腈、α-(η-丁基磺醯氧亞胺基)-1-環己烯基乙腈、α -(甲基磺醯氧亞胺基)-苯基乙腈、α -(甲基磺醯氧亞胺基)-Ρ -甲氧基苯基乙腈、α-(三氟甲 基磺醯氧亞胺基)-苯基乙腈、α-(三氟甲基磺醯氧亞胺 基)-Ρ-甲氧基苯基乙腈、α-(乙基磺醯氧亞胺基)-Ρ-甲 氧基苯基乙腈、〇:-(丙基磺醯氧亞胺基)-Ρ-甲基苯基乙 腈、α -(甲基磺醯氧亞胺基)-Ρ-溴基苯基乙腈等。 又,特開平9-20 8 5 54號公報(段落[0012]至[0014]之 [化 1 8]至[化 19])所揭示之肟磺酸酯系酸產生劑, W02004/074242A2 ( 65 至 8 5 頁之 Example 1 至 40 )所揭 示之肟磺酸酯系酸產生劑亦可配合需要使用。 又,較適當者例如下述所示之化合物等。 【化4 8】[In the formula (B-3), R36 is a cyano group, an alkyl group having no substituent or a halogenated alkyl group; R3 7 is a 2 or 3 valent aromatic hydrocarbon group; and R3 8 is an alkyl group having no substituent or halogenation. The alkyl group, P" is 2 or 3]. In the above formula (B-2), the alkyl group or the halogenated alkyl group having no substituent of R33 is preferably a carbon number of 1 to 10 and a carbon number of 1 to 8. More preferably, the carbon number is preferably from 1 to 6. -77- 200914991 R3 3 is preferably a halogenated alkyl group, and more preferably a fluorinated group. The fluorinated alkyl group in R33 has a hydrogen atom in the alkyl group. It is preferably 5% or more of fluorinated, more preferably 70% or more, and more preferably 90% or more of fluorinated. R34 aryl, such as phenyl or biphenyl, fluorenyl a ring of an aromatic hydrocarbon such as a fluorenyl group, a naphthyl group, an anthyl group or an phenanthroline group, which removes one hydrogen atom, and a part of a carbon atom constituting the ring of the above group is an oxygen atom, The heteroaryl group such as a sulfur atom or a nitrogen atom is substituted with a heteroaryl group or the like, and a fluorenyl group is more preferable. The aryl group of R34 may have an alkyl group having 1 to 10 carbon atoms, a halogenated alkyl group, or an alkoxy group. Base group. The substituent The base or halogenated yard base preferably has a carbon number of 1 to 8, preferably a carbon number of 1 to 4. Further, the halogenated alkyl group is more preferably a fluorinated alkyl group. The alkyl group or the halogenated alkyl group is preferably a carbon number of 1 to 10, more preferably a carbon number of 1 to 8, and most preferably a carbon number of 1 to 6. R3 5 is preferably a halogenated alkyl group or a fluorinated alkyl group. More preferably, the fluorinated alkyl group in R35 is preferably one in which the hydrogen atom in the alkyl group is fluorinated by 50% or more, more preferably 70% or more, and more preferably 90% or more. More preferably, it is a perfluorinated alkyl group in which 100% of hydrogen atoms are substituted by fluorine. In the above formula (B-3), an alkyl group or a halogenated alkyl group having no substituent of R36, for example It is the same as the alkyl group or the halogenated alkyl group having no substituent represented by the above R33. The 2 or 3 valent aromatic hydrocarbon group of R37 is, for example, 1 or 2 removed from the aryl-78-200914991 group of the above R34. The group obtained by the amino atom, etc. R. The alkyl group or the halogenated alkyl group having no substituent, for example, the same as the alkyl group or the halogenated alkyl group having no substituent represented by R35, preferably 2 . Specific examples of the sulfonate-based acid generator, such as α-(ρ-toluenesulfonyl)·cyanide, α-(ρ-chlorophenylsulfonimido)-benzyl cyanide Compound, α-(4-nitrophenylsulfonyloxyimido: cyano cyanide, α-(4-nitro-2·trifluoromethylbenzenesulfonyloxyimido: phenyl cyanide, α-( Phenylsulfonyloxyimido)-4-chlorobenzyl cyanated α-(phenylsulfonyloxyimino)-2,4-dichlorobenzyl cyanide, α-sulfonyloxyimido) -2,6-dichlorobenzyl cyanide, α-(phenylsulfonimido)-4-methoxybenzyl cyanide, α-(2-chlorophenylsulfonylamino)-4- Alkyl cyano cyanide, α-(phenylsulfonyloxyimido group: um-2-ylacetonitrile, α-(4-dodecylbenzenesulfonyloxyimino)-benzylate, hydrazine: -[ (ρ-toluenesulfonyloxyimido)-4-methoxyphenyl], hydrazine: -[(dodecylbenzenesulfonyloxyimino)-4-methoxyphenyl], α - (p-toluenesulfonyloxyimido)-4-thienyl cyanide, "·sulfonyloxyimino]-1-cyclopentenylacetonitrile, α_(methylsulfonylamino)-1- Cyclohexenylacetonitrile, α-(methylsulfonyloxyimido - heptyl acetonitrile, α-(methylsulfonyloxyimino)-1-cyclooctyl, 〇:-(trifluoromethylsulfonyloxyimido)-bucyclopentenylacetonitrile, Trifluoromethylsulfonyloxyimido)-cyclohexylacetonitrile, ethylsulfonimido)-ethylacetonitrile, α-(propylsulfonyloxyimino)-propyl, the above content, oxygen, oxygen -benzyl)-benzyl, (benzophenoxyoxy)&gt;-thylthioacetonitrile acetonitrile (methoxy- 1 -cycloacetonitrile τ-(glycolic acetonitrile-79-200914991, α-(cyclohexylsulfonate) -cyclopentylacetonitrile, α-(cyclohexylsulfonyloxyimino)-cyclohexylacetonitrile, α-(cyclohexylsulfonyloxyimino)-1-cyclopentenylacetonitrile, α-(B Alkylsulfonyloxyimido)-1-cyclopentenylacetonitrile, α-(isopropylsulfonyloxyimino)-1 -cyclopentenylacetonitrile, a - (η_butylsulfonyloxy) Amino)-1-cyclopentenylacetonitrile, a-(ethylsulfonyloxyimino)-1-cyclohexenylacetonitrile, α-(isopropylsulfonyloxyimino)-1-cyclo Hexenylacetonitrile, α-(η-butylsulfonyloxyimido)-1-cyclohexenylacetonitrile, α-(methylsulfonyloxyimino)-phenylacetonitrile, α -( Alkylsulfonyloxyimido)-fluorene-methoxyphenylacetonitrile, α-(trifluoromethylsulfonyloxyimino)-phenylacetonitrile, α-(trifluoromethylsulfonyloxyimino) )-Ρ-methoxyphenylacetonitrile, α-(ethylsulfonyloxyimido)-fluorene-methoxyphenylacetonitrile, hydrazine:-(propylsulfonyloxyimino)-indole-A Phenyl phenyl acetonitrile, α-(methylsulfonyloxyimido)-fluorene-bromophenylacetonitrile, etc. Further, Japanese Laid-Open Patent Publication No. Hei 9-20 8 5 54 (paragraphs [0012] to [0014] The oxime sulfonate-based acid generator disclosed in WO 8/A to [Chem. 19], W02004/074242A2 (Examples 1 to 40 of pages 65 to 85) may also be used. Need to use with the cooperation. Further, for example, a compound shown below or the like is suitable. [化4 8]

H3° 一?=N—~os〇2-(ch2)3ch3H3° A?=N-~os〇2-(ch2)3ch3

HsC C=N-〇s〇2-(CH2)3CH3 -80- 200914991 【化4 9】ch3O~ C*=N一Ο—S〇2—CF3 |cF2)6—ΗHsC C=N-〇s〇2-(CH2)3CH3 -80- 200914991 [化4 9]ch3O~ C*=N一Ο—S〇2—CF3 |cF2)6—Η

C=N—O—S02—CF3 C3F7C=N—O—S02—CF3 C3F7

ch3o C*=N一O—S〇2—CF3 (CF2)6-HCh3o C*=N-O-S〇2—CF3 (CF2)6-H

C—N一Ο—S〇2—CF3 C2F6C—N一Ο—S〇2—CF3 C2F6

C3F7 C=N—〇—S〇2~C4F9 (CF2)6—HC3F7 C=N—〇—S〇2~C4F9 (CF2)6—H

&lt;CF2&gt;4-H 上述例示化合物中又以下述4個化合物爲佳等。 -81 - 200914991 【化5 0】&lt;CF2&gt; 4-H The above four compounds are preferably the following four compounds. -81 - 200914991 【化5 0】

H3C—C=N—〇s〇2-(CH2)3CH3 h3c-C=N-OS02-(〇Η2)3〇Η3H3C—C=N—〇s〇2-(CH2)3CH3 h3c-C=N-OS02-(〇Η2)3〇Η3

C-=N—O—S〇2—C4F9 (CF2}6-HC-=N—O—S〇2—C4F9 (CF2}6-H

C=N—O—S02—C4F9 (CF2)4-H 重氮甲烷系酸產生劑中,雙烷基或雙芳基磺醯基重氮 甲烷類之具體例,如雙(異丙基磺醯基)重氮甲烷、雙( P-甲苯磺醯基)重氮甲烷、雙(ι,ι -二甲基乙基磺醯基) 重氮甲烷、雙(環己基磺醯基)重氮甲烷、雙(2,4-二甲 基苯基磺醯基)重氮甲烷等。 又,亦適合使用特開平1 1 -03 5 5 5 1號公報、特開平 1 1 - 0 3 5 5 5 2號公報、特開平1 1 -03 5 5 7 3號公報所揭示之重 氮甲烷系酸產生劑。 又,聚(雙磺醯基)重氮甲烷類,例如特開平11-3 22 7 07號公報所揭示之1,3-雙(苯基磺醯基重氮甲基磺醯 基)丙烷、1,4-雙(苯基磺醯基重氮甲基磺醯基)丁烷、 1,6-雙(苯基磺醯基重氮甲基磺醯基)己烷、1,10-雙(苯 基磺醯基重氮甲基磺醯基)癸烷、1,2-雙(環己基磺醯基 重氮甲基磺醯基)乙烷、1,3 -雙(環己基磺醯基重氮甲基 磺醯基)丙烷、1,6-雙(環己基磺醯基重氮甲基磺醯基) 己烷、1,1 〇-雙(環己基磺醯基重氮甲基磺醯基)癸烷等。 (B2 )成份可單獨使用1種前述酸產生劑,或將2種 -82 - 200914991 以上組合使用亦可。 本發明之光阻組成物中’ (B )成份之含量,對(A ) 成份1〇〇質量份爲使用0.5至30質量份,較佳爲使用1 至20質量份。於上述範圍時,可充分形成圖型。且可得 到均勻之溶液,與良好之保存安定性。 &lt; (D )成份&gt; 本發明之光阻組成物中,爲提昇光阻圖型形狀、保存 安定性(post exposure stability of the latent image formed by the pattern-wise exposure of the resist layer) 時,可再添加任意成份之含氮有機化合物(D )(以下亦 稱爲(D )成份)。 此(D )成份,目前已有多種化合物之提案,其亦可 使用公知之任意成份,其中又以脂肪族胺、特別是二級脂 肪族胺或三級脂肪族胺爲佳。其中,本發明說明書及申請 專利範圍中,「脂肪族」係爲相對於芳香族性之槪念,即 定義爲不具有芳香族性之基、化合物等之意。 「脂肪族環式基」係定義爲不具有芳香族性之單環式 基或多環式基之意。脂肪族胺係指具有1個以上之脂肪族 基之胺,且該脂肪族基係以碳數爲1〜1 2爲佳。 脂肪族胺,例如氨NH3中之至少1個氫原子被碳數 1 2以下之烷基或羥烷基取代所得之胺(烷基胺或烷醇胺) 或環式胺等。 烷基胺與烷醇胺之具體例如η-己基胺、η-庚基胺、n- -83- 200914991 辛基胺、η -壬基胺、n -癸基胺等單烷基胺;二乙基 η -丙基胺、二-η -庚基胺、二_η_辛基胺、二環己基 院基胺;三甲基胺、三乙基胺 '三-η -丙基胺、二 胺、三-η -己基胺、三-η -戊基胺、三-η -庚基胺、二 胺、二-η -壬基胺、三-η -癸基胺、三-η -十一丨兀基月女 基胺;二乙醇胺、三乙醇胺、二異丙醇胺、三異丙 二-η-辛醇胺、三-η-辛醇胺等烷醇胺。其中又以碳! 10之三烷基胺爲佳,以三-η-戊基胺、三-η-辛基胺 ,以三- η-戊基胺最佳。 環式胺,例如含有作爲雜原子之氮原子的雜環 等。該雜環化合物,可爲單環式之化合物(脂肪族 胺),或多環式之化合物(脂肪族多環式胺)亦可 脂肪族單環式胺,具體而言,例如哌陡、 piperazine )等。 脂肪族多環式胺,以碳數6至1 〇者爲佳’具 ,例如1,5 -二氮雜二環[4.3.0]-5 -壬烯、1,8 -二氮 [5.4.0]-7--(——碳烯、六伸甲基四胺、丨,4·二氮 [2.2.2 ]辛烷等。 其可單獨使用或將2種以上組合使用皆可。 (D)成份對(A)成份1〇〇質量份’一般 0.01至5.0質量份之範圍。 &lt;任意成份&gt; [(E )成份] 又,本發明之光阻組成物,爲防止感度 胺、二- 胺等二 -η-丁基 -η-辛基 等三烷 醇胺、 敗5至 爲更佳 化合物 單環式 〇 峨嗪( 體而言 雜二環 雜二環 爲使用 劣化( -84- 200914991Specific examples of the dialkyl or bisarylsulfonyldiazomethane in the C=N—O—S02—C4F9 (CF2)4-H diazomethane acid generator, such as bis(isopropylsulfonate) Diazomethane, bis(P-toluenesulfonyl)diazomethane, bis(ι,ι-dimethylethylsulfonyl)diazomethane, bis(cyclohexylsulfonyl)diazomethane, Bis(2,4-dimethylphenylsulfonyl)diazomethane or the like. Further, it is also suitable to use the diazomethane disclosed in Japanese Unexamined Patent Publication No. Hei No. Hei. No. Hei. No. 1 1 -03 5 5 5 No. 1 and JP-A No. 1 1 - 0 3 5 5 5 2 An acid generator. Further, poly(disulfonyl)diazomethane, for example, 1,3-bis(phenylsulfonyldiazomethylsulfonyl)propane disclosed in JP-A No. 11-3 22 07 07, , 4-bis(phenylsulfonyldiazomethylsulfonyl)butane, 1,6-bis(phenylsulfonyldiazomethylsulfonyl)hexane, 1,10-bis(benzene Sulfhydrazinyldiazomethylsulfonyl)decane, 1,2-bis(cyclohexylsulfonyldiazomethylsulfonyl)ethane, 1,3 -bis(cyclohexylsulfonyldiazo Methylsulfonyl)propane, 1,6-bis(cyclohexylsulfonyldiazomethylsulfonyl)hexane, 1,1 fluorene-bis(cyclohexylsulfonyldiazomethylsulfonyl) Decane and so on. (B2) The component may be used alone or in combination of two or more kinds of -82 - 200914991 or more. The content of the component (B) in the photoresist composition of the present invention is from 0.5 to 30 parts by mass, preferably from 1 to 20 parts by mass, per part by mass of the component (A). In the above range, the pattern can be sufficiently formed. A uniform solution is obtained with good preservation stability. &lt; (D) Component&gt; In the photoresist composition of the present invention, in the case of post exposure stability of the latent image formed by the pattern-wise exposure of the resist layer, Any other component of the nitrogen-containing organic compound (D) (hereinafter also referred to as (D) component) may be further added. As the component (D), there have been proposals for various compounds, and any of the known components may be used, and among them, an aliphatic amine, particularly a secondary aliphatic amine or a tertiary aliphatic amine is preferred. In the specification and the scope of the patent application, the "aliphatic" is a concept related to aromaticity, that is, it is defined as a group or a compound having no aromaticity. The "aliphatic cyclic group" is defined as a monocyclic group or a polycyclic group having no aromaticity. The aliphatic amine means an amine having one or more aliphatic groups, and the aliphatic group preferably has a carbon number of from 1 to 12. An aliphatic amine such as an amine (alkylamine or alkanolamine) or a cyclic amine obtained by substituting at least one hydrogen atom of ammonia NH3 with an alkyl group having 1 or less carbon atoms or a hydroxyalkyl group. Specific alkylamines and alkanolamines such as η-hexylamine, η-heptylamine, n--83-200914991 octylamine, η-decylamine, n-decylamine, etc.; N-propylamine, di-η-heptylamine, di-n-octylamine, dicyclohexylamine amine; trimethylamine, triethylamine 'tri-n-propylamine, diamine , tri-n-hexylamine, tri-n-pentylamine, tri-n-heptylamine, diamine, di-n-decylamine, tri-n-decylamine, tri-n-anthracene Alkenylamine, such as diethanolamine, triethanolamine, diisopropanolamine, triisopropyldi-n-octanolamine, tri-n-octanolamine. Which is carbon again! The trialkylamine is preferably a tri-n-pentylamine or a tri-n-octylamine, and the tri-n-pentylamine is most preferred. The cyclic amine is, for example, a heterocyclic ring containing a nitrogen atom as a hetero atom. The heterocyclic compound may be a monocyclic compound (aliphatic amine), or a polycyclic compound (aliphatic polycyclic amine) or an aliphatic monocyclic amine, specifically, for example, piperazine, piperazine )Wait. Aliphatic polycyclic amines, preferably having a carbon number of 6 to 1 ,, such as 1,5-diazabicyclo[4.3.0]-5-nonene, 1,8-diaza [5.4. 0]-7--(-carbene, hexamethylenetetramine, hydrazine, 4 diaza [2.2.2] octane, etc., which may be used singly or in combination of two or more. The component (A) component is in the range of generally 0.01 to 5.0 parts by mass. <Optional component> [(E) component] Further, the photoresist composition of the present invention is for preventing sensitivity amine, - a trialkanolamine such as an amine such as di-η-butyl-η-octyl, or a compound of a monocyclic pyridazine which is a better compound (the heterobicyclic heterobicycle is degraded in use) (-84- 200914991

Deterioration in sensitivity),或提昇光阻圖型形狀 '保 存安定性(P〇st exposure stability of the latent image formed by the pattern-wise exposure of the resist layer ) 等目的上,可再添加任意成份之有機羧酸或磷之含氧酸或 其衍生物所成之群所選出之至少1種化合物(E )(以下 亦稱爲(E )成份)。 有機羧酸,例如乙酸、丙二酸、檸檬酸、蘋果酸、琥 珀酸、苯甲酸、水楊酸等爲佳。 磷之含氧酸,例如磷酸、膦酸(Phosphonic acid)、 次膦酸(Phosphinicacid)等,其中又以膦酸爲佳。 磷酸之含氧酸衍生物,例如前述含氧酸之氫原子被烴 基取代所得之酯基等,前述烴基,例如碳數1〜5之烷基 ,碳數6〜15之芳基等。 磷酸衍生物例如磷酸二-η-丁酯、磷酸二苯酯等磷酸酯 等。 膦酸(Phosphonic acid )衍生物例如膦酸二甲酯、膦 酸-二-η· 丁酯 '苯基膦酸、膦酸二苯酯、膦酸二苄酯等膦 酸酯等。 次膦酸(Phosphinic acid)衍生物例如,苯基次膦酸 等次膦酸酯。 (E)成份可單獨使用1種,或將2種以上合倂使用 亦可。 (E )成份,以有機羧酸爲佳,特別是以水楊酸爲更 佳。 -85 - 200914991 (E)成份對(A)成份100質量份而言,一般爲使用 〇·〇1至5.0質量份之範圍。 本發明之光阻組成物,可再配合需要適當添加具有混 合性之添加劑,例如可改良光阻膜性能之加成樹脂,提昇 塗覆性之界面活性劑、溶解抑制劑、可塑劑、安定劑、著 色劑、光暈防止劑、染料等。 [(S )成份] 本發明之第1實施態樣之光阻組成物,可將材料溶解 於有機溶劑(以下亦稱爲(S )成份)之方式製造。 (S )成份’只要可溶解所使用之各成份而形成均勻 之溶液即可,例如可由以往作爲化學增幅型光阻溶劑之公 知ί谷劑中’適當的選擇1種或2種以上使用。 例如r-丁內酯等內酯類,丙酮、甲基乙基酮、環己 酮、甲基-η-戊酮、甲基異戊酮、2_庚酮等酮類;乙二醇、 二乙二醇、丙二醇、二丙二醇等多元醇類;乙二醇單乙酸 酯、二乙二醇單乙酸酯、丙二醇單乙酸酯、或二丙二醇單 乙酸醋等具有酯鍵結之化合物;前述多元醇類或前述具有 酯鍵結之化合物的單甲基醚、單乙基醚、單丙基醚、單丁 基醚等單院基醚或單苯基醚等具有醚鍵結之化合物等之多 元醇類之衍生物[其中,又以丙二醇單甲基醚乙酸酯( PGMEA )、丙二醇單甲基醚(PGME)爲佳];二噁烷等環 狀醚類;或乳酸甲酯、乳酸乙酯(EL)、乙酸甲酯、乙酸 乙醋、乙酸丁醋、丙酮酸甲酯、丙酮酸乙酯、甲氧基丙酸 -86- 200914991 甲酯、乙氧基丙酸乙酯等酯類;苯甲醚、乙基苄基醚、甲 酚甲基醚、二苯基醚、二苄基醚、苯乙醚、丁基苯基醚、 乙基苯、二乙基苯、戊基苯、異丙基苯、甲苯、二甲苯、 異丙基苯、三甲基苯等芳香族系有機溶劑等。 前述有機溶劑可單獨使用,或以2種以上之混合溶劑 形式使用亦可。 又,其中又以使用由丙二醇單甲基醚乙酸酯(PGMEA )與丙二醇單甲基醚(PGME)、乳酸乙酯(EL) 、r -丁 內酯爲佳。 又,以使用PGMEA與極性溶劑混合所得之混合溶劑 爲佳,其添加比(質量比)可依PGMEA與極性溶劑之相 溶性等作適當之決定即可,較佳爲1 : 9至9 : 1,更佳爲 2: 8至8: 2之範圍。 更具體而言,極性溶劑爲使用乳酸乙酯(EL )時, PGMEA: EL之質量比較佳爲1: 9至9: 1,更佳爲2: 8 至8 : 2。極性溶劑爲使用PGME時’ PGMEA : PGME之質 量比較佳爲1:9至9: 1,更佳爲2: 8至8:2’最佳爲3 :7 至 7 : 3。 又,(S )成份中,其他例如使用由PGMEA與EL中 選出之至少1種與r - 丁內酯所得混合溶劑爲佳。此時’ 混合比例中,前者與後者之質量比較佳爲70: 30至95: 5 〇 又,(S )成份,其他例如使用由PGMEA與PGME之 混合溶劑與r - 丁內酯所得之混合溶劑爲佳。此時’混合 -87- 200914991 比例,以前者對後者之質量比較佳爲99.9 : 0.1至80 : 20 ,以 99.9: 0.1 至 90: 10 爲更佳,以 99.9: 0.1 至 95: 5 爲最佳。 於前述範圍內時,可提高光阻圖型之矩形性。 (S )成份之使用量並未有特別限定,一般可配合塗 佈於基板等之濃度,塗膜厚度等作適當的選擇設定,一般 可於光阻組成物中之固體成份濃度爲2至20質量%,較佳 爲5至15質量%之範圍內使用。 本發明中,可使用上述通式(bl-14)所示之化合物 所形成之酸產生劑(B1 )。該(B 1 )成份,與芳基鍵結之 羥基,具有被三級烷基酯型,或烷氧烷基等縮醛型之酸解 離性基所保護之構造,該非曝光部中,其構造爲有任何變 化。因此,上述通式(b 1 -1 4 )所示之化合物,於光阻膜 之非曝光部中,對(A 1 )成份,可發揮出對鹼顯影液之溶 解抑止效果。 又,曝光部中,於受所產生之酸進行曝光後加熱( PEB)時,前述酸解離性基中,前述羥基由所構成之氧原 子解離,而生成鍵結於芳基之化合物,故對於(A1)成份 而言,推測其可發揮對鹼顯影液之溶解促進效果。 因此,推想可提高曝光部/非曝光部之高反差化。 基於以上之理由,本發明之光阻組成物爲正型光阻組 成物時,經由使基材成份與酸產生劑(前述(B 1 )成份) 組合使用結果’可改善光阻圖型形成之際的遮罩重現性’ 例如,可改善形成接觸孔(C/H )圖型之際的該通孔之正 -88- 200914991 圓性,提高直徑(CD )之均勻性(CDU ),改善遮罩誤差 因子(MEF ),具有優良之C/H圖型抜取性等,而提高微 影蝕刻特性。又,形成線路與空間之光阻圖型(L/S圖型 )之際,因MEF得到改善等,故可提高微影蝕刻特性。 隨後,本發明之光阻組成物,於含有浸潤式曝光步驟 之光阻圖型形成方法中,極適合作爲浸潤式曝光用光阻組 成物使用,而可得到良好之微影蝕刻特性,又,於含有形 成3層光阻層合物之步驟的光阻圖型形成方法中,亦適合 作爲形成上層光阻膜用之正型光阻組成物,而可得到良好 之微影蝕刻特性。 《光阻圖型之形成方法》 其次,將對本發明之第2實施態樣之光阻圖型之形成 方法作一說明。 本發明之光阻圖型之形成方法,爲包含使用上述本發 明之第1實施態樣之光阻組成物於基板上形成光阻膜之步 驟、使前述光阻膜曝光之步驟、使前述光阻膜顯影以形成 光阻圖型之步驟。 本發明之光阻圖型之形成方法,例如可依下述方式進 行。 即,首先,於支撐體上,將本發明之第1實施態樣之 光阻組成物使用旋轉塗佈器等進行塗佈後’於80〜150°C 之溫度條件下,進行40〜1 20秒間,較佳爲60〜90秒間 之塗佈後燒焙(post-apply bake ( PAB ))’再利用 ArF準 -89- 200914991 分子雷射光介由所期待之遮罩圖型進行選擇性曝光後,再 於80〜150°C之溫度條件下,進行40〜120秒間,較佳爲 60〜90秒間之曝光後燒焙(Post exposure bake,PEB)。其 次,將其使用鹼顯影液,例如0 . 1〜1 0質量%氫氧化四甲 基銨水溶液進行顯影處理,較佳爲使用純水進行洗滌後, 乾燥。又,必要時,於上述顯影處理後可進行燒焙處理( 後燒焙)。如此,即可得到忠實反應遮罩圖型之光阻圖型 〇 支撐體並未有特別限定,其可使用以往公知之物品, 例如電子零件用之基板,或於其上形成特定配線圖型之物 品等。更具體而言,例如砂晶圓、銅、鉻、鐵、銘等金屬 製之基板或,玻璃基板等。配線圖型之材料,例如可使用 銅、銘、鏡、金等。Deterioration in sensitivity), or the purpose of improving the resistive shape of the latent image formed by the pattern-wise exposure of the resist layer, etc. At least one compound (E) (hereinafter also referred to as (E) component) selected from the group consisting of acid or phosphorus oxyacids or derivatives thereof. An organic carboxylic acid such as acetic acid, malonic acid, citric acid, malic acid, succinic acid, benzoic acid, salicylic acid or the like is preferred. Phosphorus oxyacids such as phosphoric acid, Phosphonic acid, Phosphinic acid, etc., of which phosphonic acid is preferred. The oxo acid derivative of phosphoric acid, for example, an ester group obtained by substituting a hydrogen atom of the oxo acid with a hydrocarbon group, and the hydrocarbon group is, for example, an alkyl group having 1 to 5 carbon atoms or an aryl group having 6 to 15 carbon atoms. The phosphoric acid derivative is, for example, a phosphate such as di-η-butyl phosphate or diphenyl phosphate. Phosphonic acid derivatives such as dimethyl phosphonate, phosphonic acid-di-n-butyl ester, phenylphosphonic acid, diphenyl phosphonate, diphenyl phosphonate, and the like. Phosphinic acid derivatives such as phosphinates such as phenylphosphinic acid. (E) The components may be used singly or in combination of two or more. The component (E) is preferably an organic carboxylic acid, particularly salicylic acid. -85 - 200914991 (E) Ingredients For the 100 parts by mass of the component (A), it is generally in the range of from 1 to 5.0 parts by mass. The photoresist composition of the present invention may be further blended with an additive which is suitable for mixing, for example, an additive resin which can improve the properties of the photoresist film, a surfactant for improving coating properties, a dissolution inhibitor, a plasticizer, and a stabilizer. , colorants, halo inhibitors, dyes, and the like. [(S) component] The photoresist composition of the first embodiment of the present invention can be produced by dissolving a material in an organic solvent (hereinafter also referred to as (S) component). The (S) component is used as long as it can dissolve the components to be used to form a uniform solution. For example, one or two or more kinds of the above-mentioned conventionally known as a chemically amplified resist solvent can be used. For example, lactones such as r-butyrolactone, ketones such as acetone, methyl ethyl ketone, cyclohexanone, methyl-η-pentanone, methyl isoamyl ketone, and 2-heptanone; ethylene glycol, a polyhydric alcohol such as ethylene glycol, propylene glycol or dipropylene glycol; an ester-bonded compound such as ethylene glycol monoacetate, diethylene glycol monoacetate, propylene glycol monoacetate or dipropylene glycol monoacetic acid vinegar; a polyether or a compound having an ether bond, such as a monomethyl ether, a monoethyl ether, a monopropyl ether or a monobutyl ether; or a compound having an ether bond such as a monophenyl ether or a monophenyl ether; a derivative of a polyhydric alcohol [wherein, propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monomethyl ether (PGME) is preferred]; a cyclic ether such as dioxane; or methyl lactate, Ethyl lactate (EL), methyl acetate, ethyl acetate, butyl acetate, methyl pyruvate, ethyl pyruvate, methoxypropionic acid-86- 200914991 methyl ester, ethyl ethoxy propionate and other esters Category; anisole, ethylbenzyl ether, cresyl methyl ether, diphenyl ether, dibenzyl ether, phenyl ether, butylphenyl ether, ethylbenzene, diethylbenzene, Benzene, cumene, toluene, xylene, cumene, mesitylene and the like, aromatic organic solvents. These organic solvents may be used singly or in combination of two or more. Further, among them, propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monomethyl ether (PGME), ethyl lactate (EL), and r-butyrolactone are preferably used. Further, a mixed solvent obtained by mixing PGMEA with a polar solvent is preferred, and the addition ratio (mass ratio) may be appropriately determined depending on the compatibility of PGMEA with a polar solvent, etc., preferably 1:9 to 9:1. More preferably 2: 8 to 8: 2 range. More specifically, when the polar solvent is ethyl lactate (EL), the mass of PGMEA: EL is preferably from 1:9 to 9:1, more preferably from 2:8 to 8:2. When the polar solvent is PGME, the quality of PGMEA: PGME is preferably 1:9 to 9:1, more preferably 2:8 to 8:2', and most preferably 3:7 to 7:3. Further, among the components (S), for example, a mixed solvent of at least one selected from PGMEA and EL and r-butyrolactone is preferably used. At this time, in the 'mixing ratio, the former and the latter are preferably 70:30 to 95: 5 〇 and (S) components, and other mixed solvents obtained by using a mixed solvent of PGMEA and PGME and r - butyrolactone, for example. It is better. At this time, the ratio of 'mix-87-200914991' is better for the latter to be 99.9: 0.1 to 80: 20, 99.9: 0.1 to 90: 10 is better, and 99.9: 0.1 to 95: 5 is the best. . When it is within the above range, the rectangular shape of the photoresist pattern can be improved. The amount of the component (S) is not particularly limited. Generally, it can be appropriately selected in accordance with the concentration applied to the substrate, the thickness of the coating film, etc., and the solid concentration in the photoresist composition is generally 2 to 20 The mass% is preferably used in the range of 5 to 15% by mass. In the present invention, the acid generator (B1) formed by the compound represented by the above formula (bl-14) can be used. The (B 1 ) component and the aryl group-bonded hydroxyl group have a structure protected by a tertiary alkyl ester type or an acetal acid dissociable group such as an alkoxyalkyl group, and the non-exposed portion has a structure For any changes. Therefore, the compound represented by the above formula (b 1 -1 4 ) exhibits a dissolution inhibiting effect on the alkali developing solution on the (A 1 ) component in the non-exposed portion of the resist film. Further, in the exposed portion, when the acid generated is subjected to post-exposure heating (PEB), in the acid dissociable group, the hydroxyl group is dissociated from the formed oxygen atom to form a compound bonded to the aryl group. The component (A1) is presumed to exhibit a dissolution promoting effect on the alkali developer. Therefore, it is conceivable that the high contrast of the exposure portion/non-exposure portion can be improved. For the reason described above, when the photoresist composition of the present invention is a positive photoresist composition, the formation of the photoresist pattern can be improved by using the substrate component in combination with an acid generator (the aforementioned (B 1 ) component). Inter-mask reproducibility' For example, the positive-88-200914991 roundness of the through-hole at the time of forming the contact hole (C/H) pattern can be improved, and the uniformity (CDU) of the diameter (CD) can be improved. The mask error factor (MEF) has excellent C/H pattern picking and the like, and improves the lithography etching characteristics. Further, when the photoresist pattern (L/S pattern) of the line and the space is formed, the MEF is improved, and the lithography characteristics can be improved. Subsequently, the photoresist composition of the present invention is excellently used as a photoresist composition for immersion exposure in a photoresist pattern forming method including an immersion exposure step, and good lithographic etching characteristics can be obtained. In the photoresist pattern forming method including the step of forming a three-layer photoresist layer, it is also suitable as a positive-type photoresist composition for forming an upper photoresist film, and good lithographic etching characteristics can be obtained. <<Method of Forming Photoresist Pattern>> Next, a method of forming a photoresist pattern according to a second embodiment of the present invention will be described. The method for forming a photoresist pattern of the present invention includes a step of forming a photoresist film on a substrate by using the photoresist composition according to the first embodiment of the present invention, and exposing the photoresist film to a step of exposing the light. The step of developing the resist film to form a photoresist pattern. The method of forming the photoresist pattern of the present invention can be carried out, for example, in the following manner. In other words, first, the photoresist composition of the first embodiment of the present invention is applied to a support using a spin coater or the like, and then 40 to 120 at a temperature of 80 to 150 ° C. Post-apply bake (PAB)), preferably between 60 and 90 seconds, is reused after ArF quasi-89-200914991 molecular laser light is selectively exposed by the desired mask pattern. Post exposure bake (PEB) is carried out at a temperature of 80 to 150 ° C for 40 to 120 seconds, preferably 60 to 90 seconds. Then, it is subjected to development treatment using an alkali developer, for example, 0.1 to 10% by mass aqueous solution of tetramethylammonium hydroxide, preferably washed with pure water, and then dried. Further, if necessary, baking treatment (post-baking) may be performed after the above development treatment. Thus, the photoresist pattern of the faithful reaction mask pattern is not particularly limited, and a conventionally known article such as a substrate for an electronic component or a specific wiring pattern can be formed thereon. Items, etc. More specifically, for example, a metal wafer such as a sand wafer, copper, chromium, iron, or the like, or a glass substrate. For wiring pattern materials, for example, copper, inscription, mirror, gold, etc. can be used.

又,支撐體,例如亦可於上述基板上,設置無機系及 /或有機系之膜。無機系之膜,例如無機抗反射膜(無機 B ARC )等。有機系之膜,例如有機抗反射膜(有機BAR C )等。 曝光所使用之波長’並未有特別限定,其可使用ArF 準分子雷射、KrF準分子雷射、f2準分子雷射、EUV (極 紫外線)、V U V (真空紫外線)、E B (電子線)、X線、 軟X線等放射線進行。上述光阻組成物,以對KrF準分子 雷射、ArF準分子雷射、EB或EUV,特別是對ArF準分 子雷射爲有效。又,其對於浸潤式曝光亦爲有效。 -90- 200914991 【實施方式】 w下,將本發明以實施例作更具體之說明,但本發明 並不受下述實施例所限定。 (合成例1 ) &lt;化合物(1 )之合成&gt; 【化5 1】Further, for the support, for example, an inorganic or/or organic film may be provided on the substrate. An inorganic film such as an inorganic antireflection film (inorganic B ARC ) or the like. Organic film, such as organic anti-reflective film (organic BAR C). The wavelength used for exposure is not particularly limited, and an ArF excimer laser, a KrF excimer laser, an f2 excimer laser, an EUV (very ultraviolet ray), a VUV (vacuum ultraviolet ray), an EB (electron line) can be used. , X-ray, soft X-ray and other radiation. The above photoresist composition is effective for KrF excimer laser, ArF excimer laser, EB or EUV, especially for ArF quasi-molecular laser. Moreover, it is also effective for immersion exposure. [Embodiment] The present invention will be more specifically described by way of examples, but the present invention is not limited by the following examples. (Synthesis Example 1) &lt;Synthesis of Compound (1)&gt; [Chemical 5 1]

OHOH

於控制於2(TC以下之甲烷磺酸(60.75 g)中,少量緩 緩添加氧化磷(8.53g)與2,6-二甲基酚(8.81§)與二苯 基亞颯(12.2g)。於溫度控制爲is〜20°C中進行30分鐘 熟成後’升溫至40t再經2小時熟成。其後,將反應液滴 入冷卻至1 5 °C以下之純水(1 0 9 · 3 5 g )中。滴下結束後, 加入二氯甲烷(5 4.6 8 g ),攪拌後,回收二氯甲烷層。於 其他容器中加入20〜25 t之己烷( 386.86g),將二氯甲 烷層滴入。滴入結束後,於20〜25t下經30分鐘熟成後 ,經過濾而得到目的化合物(產率7 0 · 9 % )。 對所得化合物進行1 H-NMR分析。 1 Η-N RM ( D M S Ο - d 6、6 0 0 Μ Η z ) : δ ( ppm) =7.61- -91 - 200914991A small amount of phosphorus oxide (8.53g) and 2,6-dimethylphenol (8.81§) and diphenylarsenium (12.2g) were added slowly to a small amount of methanesulfonic acid (60.75 g) below 2 (TC). After the temperature is controlled to 30 ° C for 30 minutes, the temperature is raised to 40 t and then matured for 2 hours. Thereafter, the reaction is dropped into pure water cooled to 15 ° C or below (1 0 9 · 3). 5 g ). After the completion of the dropwise addition, dichloromethane (5 4.6 8 g) was added, and after stirring, the dichloromethane layer was recovered. 20 to 25 t of hexane (386.86 g) was added to the other vessel, and dichloromethane was added. After the completion of the dropwise addition, the mixture was aged at 20 to 25 t for 30 minutes, and then filtered to give the objective compound (yield 7 0 · 9 %). The obtained compound was subjected to 1 H-NMR analysis. 1 Η-N RM ( DMS Ο - d 6,6 0 0 Μ Η z ) : δ ( ppm) =7.61- -91 - 200914991

7_72 ( m,10H,phenyl ) ,7.14 ( S - 2H,Hc ) ,3.12 ( S ,3H,Hb ) ,2.22 ( s,6H,Ha )。 由上述結果得知,確認所得化合物具有下述所示構造 【化5 2】7_72 ( m, 10H, phenyl ) , 7.14 ( S - 2H, Hc ) , 3.12 ( S , 3H, Hb ) , 2.22 ( s, 6H, Ha ). From the above results, it was confirmed that the obtained compound had the structure shown below.

(合成例2 ) &lt;化合物(2 )之合成&gt; 【化5 3】(Synthesis Example 2) &lt;Synthesis of Compound (2)&gt;

OHOH

· (2) 將5.00g之化合物(1)溶解於25.0 0g之水與24.03 g 之二氯甲烷的混合溶液中。其後,少量緩緩添加2-萘基甲 氧基四氟乙烷磺酸鋰(4.2 8 g ),於2 5 °C下攪拌1小時。 反應結束後,將二氯甲烷溶液經水洗後,進行濃縮乾燥。 -92- 200914991 所得之粉體以己院分散洗浄後’進行減壓乾燥後’製得目 的化合物7.23g (產率90.2%)。 對所得化合物進行1 H - N M R、19 F _ N M R分析。 1H-NRM ( DMS 0-d6、600MHz ) : ¢5 (ppm) =7.97 ( s,1H,Hc ) ,7.94-7.91 ( m,3H,pheny 1 + naphthy 1 ), 7.83-7.81 ( m,2H,phenyl + naphthy 1 ) ,7.76-7.75 ( m, 8H , phenyl + naphthy 1 ) , 7.5 5-7.52 ( m , 3 H , pheny 1 + naphthy 1 ) ,7.496 ( s,2H,Hd ) ,5.21 ( s,2H ,Hb ) 2.24 ( s,6H,Ha )。 19F-NMR ( Acetone-d6、3 76MHz ) : &lt;5 (ppm) = -82.8 ,-1 1 5 . 8。 由上述結果得知,確認所得化合物具有下述所示構造(2) 5.00 g of the compound (1) was dissolved in a mixed solution of 25.0 0 g of water and 24.03 g of methylene chloride. Thereafter, a small amount of lithium 2-naphthylmethoxytetrafluoroethanesulfonate (4.2 8 g) was gradually added thereto, and the mixture was stirred at 25 ° C for 1 hour. After completion of the reaction, the dichloromethane solution was washed with water and concentrated to dryness. -92- 200914991 The obtained powder was washed with a dispersion in a home, and then dried under reduced pressure to obtain 7.23 g of a compound (yield: 90.2%). The obtained compound was subjected to 1 H - N M R, 19 F _ N M R analysis. 1H-NRM ( DMS 0-d6, 600MHz ) : ¢5 (ppm) =7.97 ( s,1H,Hc ) , 7.94 -7.91 ( m,3H,pheny 1 + naphthy 1 ), 7.83-7.81 ( m,2H, Phenyl + naphthy 1 ) , 7.76-7.75 ( m, 8H , phenyl + naphthy 1 ) , 7.5 5-7.52 ( m , 3 H , pheny 1 + naphthy 1 ) , 7.496 ( s, 2H, Hd ) , 5.21 ( s, 2H , Hb ) 2.24 ( s, 6H, Ha ). 19F-NMR (Acetone-d6, 3 76 MHz): &lt;5 (ppm) = -82.8, -1 1 5 . From the above results, it was confirmed that the obtained compound had the structure shown below.

(實施例1 )〈化合物(b 1 -1 4 -1 0 1 )之合成〉 -93- 200914991(Example 1) <Synthesis of Compound (b 1 -1 4 -1 0 1 )> -93- 200914991

將化合物(1 ) ( 1 2 · 1 g )溶解於二氯甲 水(6 0.4 g )中,於其中添加九氟-η - 丁烷磺 後,於室溫下攪拌1小時。於其後分液’經 洗、濃縮乾燥後,得前述化合物(1 )之陰 丁烷磺酸陰離子所取代之化合物1 6 · 5 g ° 6. lg)溶解於脫水四氫呋喃80.9g中’冰冷 於其中添加氫化鈉(〇 . 44 g )後,滴入2 -金 (2_2g)之四氫呋喃(4.4g)溶液。滴入結 室溫,經1小時攪拌後,將反應液滴入水中 二氯甲烷(90g )進行萃取。其後,將二氯 酸水洗浄,並進行水洗。將該二氯甲烷溶 150g)中,得目的化合物之白色粉體6.9g。 對所得化合物進行1H-NMR、19F-NMRj *H-NRM ( DMSO-d6 ' 400MHz) : δ 丨 7.88 ( m,1 OH,Ha-He ) ,7 _ 6 0 ( s,2 Η,Hf 2H,Hg ) ,3.88 ( s,1H,Hh ) ,2.33 ( s 1.46- 1.99 ( m,14H,Adamantane )。 烷(5 4.6 g )與 酸鉀(11.2g) 由將有機層水 離子經九氟-η -將該化合物( 至1 0 °C以下。 剛烷氯甲基醚 束後,升溫至 ,該溶液使用 甲烷層以稀鹽 液滴入己院( 子析。 〔ppm ) =7.76-),5.24 ( s , ,6H,Η1 ), -94 - 200914991 19F-NRM ( DMSO-d6、3 76MHz ) : δ (ppm) =-80.4 ,-114.6, -121.1 , -125.3° 由上述結果得知,確認所得化合物具有下述所示構造The compound (1) (1 2 · 1 g) was dissolved in dichloromethane (6 0.4 g), and then the mixture was stirred at room temperature for 1 hour. After the liquid portion is washed, concentrated and dried, the compound (1), which is substituted with the anion butanesulfonic acid anion of the above compound (1), is dissolved in 80.9 g of dehydrated tetrahydrofuran. After sodium hydride (〇. 44 g) was added thereto, a solution of 2-metal (2-2 g) in tetrahydrofuran (4.4 g) was added dropwise. The mixture was added dropwise to the mixture at room temperature, and after stirring for 1 hour, the reaction was dropped into dichloromethane (90 g) for extraction. Thereafter, the dichloro acid water was washed and washed with water. This dichloromethane was dissolved in 150 g of the title compound to obtain 6.9 g of white powder of the objective compound. The obtained compound was subjected to 1H-NMR, 19F-NMRj*H-NRM (DMSO-d6 '400 MHz): δ 丨 7.88 (m, 1 OH, Ha-He), 7 _ 6 0 (s, 2 Η, Hf 2H, Hg ) , 3.88 ( s, 1H, Hh ) , 2.33 ( s 1.46- 1.99 ( m, 14H, Adamantane ). Alkane (5 4.6 g ) and potassium acid (11.2 g) from the organic layer water ions through the nonafluoro-n - the compound (up to 10 ° C or less. After the bundle of cyclohexane chloromethyl ether, the temperature is raised until the solution is diluted with a methane layer into a house with a dilute salt (sub-analysis. [ppm] = 7.76-), 5.24 ( s , , 6H, Η 1 ), -94 - 200914991 19F-NRM (DMSO-d6, 3 76MHz) : δ (ppm) = -80.4, -114.6, -121.1, -125.3° Based on the above results, confirm the income The compound has the structure shown below

(實施例2 ) &lt;化合物(bl-14-201 )之合成〉 【化5 7】(Example 2) &lt;Synthesis of Compound (bl-14-201)> [Chem. 5 7]

於75ml之四氫呋喃溶液中添加5.00g之化合物(2 ) ,予以水冷。 -95- 200914991 於其中添加0.34g之氫化鈉後’滴入2-金剛烷氯甲基 醚(1.713g)之四氫呋喃(3.42ml )溶液。滴入結束後, 升溫至室溫,經1小時攪拌後’將反應液滴入水中’該溶 液以二氯甲烷(6 0.4 g )萃取。其後’二氯甲烷層以稀鹽 酸水洗浄,及進行水洗。將該二氯甲烷溶液濃縮乾燥後, 所得之粉體以己烷分散。其後’經減壓乾燥後得目的化合 物 4.2 7 g (產率 6 8 . 1 % )。 對所得化合物進行1H-NMR、19F-NMR分析。 *H-NRM ( DMSO-d6 ' 600ΜΗζ) : δ (ppm) =7.89 ( s,1H , He ) ,7.8 7-7.5 9 ( m,13H , phenyl + naphthyl ), 7.561 ( s , 2H , He ) , 7.54-7.5 2 ( m , 3H , phenyl + naphthyl ) ,5.23-5.21 ( d,4H,Hd ) , 3.87 ( s ’ 1H,Hf) ,2_33 ( s,6H,Ha ) ,1.9 9 - 1 .4 5 ( m,14 H,5.00 g of the compound (2) was added to a solution of 75 ml of tetrahydrofuran, and water-cooled. -95-200914991 After adding 0.34 g of sodium hydride thereto, a solution of 2-adamantanechloromethyl ether (1.713 g) in tetrahydrofuran (3.42 ml) was added dropwise. After the completion of the dropwise addition, the mixture was warmed to room temperature, and after stirring for 1 hour, the reaction was dropped into water. The solution was extracted with dichloromethane (6 0.4 g). Thereafter, the methylene chloride layer was washed with dilute hydrochloric acid water and washed with water. After the dichloromethane solution was concentrated and dried, the obtained powder was dispersed in hexane. Thereafter, it was dried under reduced pressure to give the title compound (4.2 g) (yield 68. 1%). The obtained compound was subjected to 1H-NMR and 19F-NMR analysis. *H-NRM (DMSO-d6 '600ΜΗζ) : δ (ppm) = 7.89 (s, 1H , He ) , 7.8 7-7.5 9 ( m, 13H , phenyl + naphthyl ), 7.561 ( s , 2H , He ) , 7.54-7.5 2 ( m , 3H , phenyl + naphthyl ) , 5.23-5.21 ( d,4H,Hd ) , 3.87 ( s ' 1H,Hf) , 2_33 ( s,6H,Ha ) ,1.9 9 - 1 .4 5 (m, 14 H,

Adamantane )。 19F-NMR- ( Acetone-d6、3 76MHz ) : δ (ppm ) =-82.9 ,-1 1 5.9。 由上述結果得知,確認化合物具有下述所示構造。 -96- 200914991 【化5 8】Adamantane). 19F-NMR-(Acetone-d6, 3 76MHz): δ (ppm) = -82.9, -1 1 5.9. From the above results, it was confirmed that the compound had the structure shown below. -96- 200914991 [Chem. 5 8]

(實施例3 ) &lt;化合物(bl-14-301 )之合成&gt; 【化5 9】(Example 3) &lt;Synthesis of Compound (bl-14-301)&gt; [Chem. 5 9]

於實施例2中,除將2-金剛烷氯甲基醚變更爲該莫耳 量之溴乙酸2-甲基-2-金剛烷以外,其他皆進行相同之反 應。 對所得化合物進行1H-NMR、I9F-NMR分析。 1 Η - N R M ( C D C 13、4 0 0 Μ Η ζ ) : δ ( ppm) =7.84 ( s, 1Η,Hf ) ,7.71-7.77 ( m &gt; 3H 1 Phenyl + Naphthyl ), 7.5 7-7.6 7 ( m,1 0 H,Phenyl + Naphthyl ) ,7.39-7.51 ( m -97- 200914991 ,3H,Phenyl + Naphthyl ) ,7.36 ( s,2H,Hd ) ,5.19 ( s ,2H,Hc) ,4.38 ( s,2H,Hb ) ,2.32 ( s,6H,Ha ), 1.69- 1 .9 7 ( m,11H,Adamantan ) ,1 .66 ( s,3H,He ) ,1 . 5 5 - 1 _ 5 8 ( d,3 H,Adamantan )。 19F-NMR(CDC13、400MHz) : 5 (p p m) : - 7 6 _ 8 7, -109.14。 由上述結果得知,確認化合物具有下述所示構造/In the second embodiment, the same reaction was carried out except that 2-adamantane chloromethyl ether was changed to the molar amount of 2-methyl-2-adamantane bromoacetate. The obtained compound was subjected to 1H-NMR and I9F-NMR analysis. 1 Η - NRM ( CDC 13 , 4 0 0 Μ Η ζ ) : δ ( ppm ) = 7.84 ( s, 1 Η, Hf ) , 7.71 - 7.77 ( m &gt; 3H 1 Phenyl + Naphthyl ), 7.5 7-7.6 7 ( m, 1 0 H, Phenyl + Naphthyl ) , 7.39-7.51 ( m -97- 200914991 , 3H, Phenyl + Naphthyl ) , 7.36 ( s, 2H, Hd ) , 5.19 ( s , 2H, Hc) , 4.38 ( s, 2H, Hb ) , 2.32 ( s, 6H, Ha ), 1.69- 1. 9 7 ( m, 11H, Adamantan ) , 1.66 ( s, 3H, He ) , 1. 5 5 - 1 _ 5 8 ( d , 3 H, Adamantan ). 19F-NMR (CDC13, 400MHz): 5 (p p m) : - 7 6 _ 8 7 - -109.14. From the above results, it was confirmed that the compound had the structure shown below /

(實施例4〜6,比較例1 )&lt;正型光阻組成物之製作&gt; 將表1所示各成份混合、溶解,以製作正型光阻組成 物。 -98- 200914991 【表1】 ㈧成份 (Β)成份 (D戚份 ⑸成份 實施例4 (ΑΗ [100] (Β)-1 [6.77] (D)-1 [0.10] ⑶-1 [2200] 實施例5 (Α)-1 ΠΟΟ] (Β)-2 [7· 10] ⑼-1 [0.10] (S)-1 [2200] 實施例6 (Α)-1 ΠΟΟ] (Β)-3 [6.90] (D)-1 [0.10] ¢)-1 [2200] 比較例1 (Α)-1 ΠΟΟ] (Β)-4 [4.94] 0))-1 to. 1〇] (S)-1 [2200] 表1中之各簡稱具有以下之意義。又’表1中之[]内 的數値爲添加量(質量份)° (A) -1:下述化學式(A) -1所示之聚合物° (B) -1:前述化學式(bl-14-101)所示之酸產生劑 (實施例1之化合物)。 (B ) -2 :前述化學式(bl-l4-2〇l )所示之酸產生劑 (實施例2之化合物)。 (B) -3:前述化學式(bl-14-301)所示之酸產生劑 (實施例3之化合物)。 (B) -4:三苯基鏑九氟-η-丁烷磺酸酯。 (D ) -1 :三- η-戊胺。 (S ) -1 : PGMEA/PGME = 6/4 (質量比)之混合溶劑 〇 又,(B)-l〜(Β)-4之添加量爲等莫耳量。 -99- 200914991 【化6 1】(Examples 4 to 6 and Comparative Example 1) &lt;Production of Positive Photoresist Composition&gt; Each component shown in Table 1 was mixed and dissolved to prepare a positive resist composition. -98- 200914991 [Table 1] (8) Ingredient (Β) Ingredients (D) (5) Ingredient Example 4 (ΑΗ [100] (Β)-1 [6.77] (D)-1 [0.10] (3)-1 [2200] Example 5 (Α)-1 ΠΟΟ] (Β)-2 [7· 10] (9)-1 [0.10] (S)-1 [2200] Example 6 (Α)-1 ΠΟΟ] (Β)-3 [ 6.90] (D)-1 [0.10] ¢)-1 [2200] Comparative Example 1 (Α)-1 ΠΟΟ] (Β)-4 [4.94] 0))-1 to. 1〇] (S)-1 [2200] Each of the abbreviations in Table 1 has the following meanings. Further, the number in the [] in Table 1 is the amount of addition (parts by mass) ° (A) -1: the polymer represented by the following chemical formula (A) -1 (B) -1: the aforementioned chemical formula (bl -14-101) The acid generator (compound of Example 1) shown. (B) -2 : an acid generator (compound of Example 2) represented by the aforementioned chemical formula (bl-l4-2〇l). (B) -3: an acid generator (compound of Example 3) represented by the aforementioned chemical formula (bl-14-301). (B) -4: Triphenylsulfonium nonafluoro-n-butanesulfonate. (D ) -1 : Tri-n-pentylamine. (S ) -1 : PGMEA/PGME = 6/4 (mass ratio) of mixed solvent 〇 Also, the addition amount of (B)-l~(Β)-4 is equal to the molar amount. -99- 200914991 [Chem. 6 1]

OH (A) -1 &lt;微影蝕刻特性之評估&gt; 使用所得之正型光阻組成物溶液形成光 以下之微影蝕刻特性。 [解析性、感度] 使用旋轉塗佈器將有機系抗反射膜組反 」(商品名,普利瓦科學公司製)塗佈於8 上,於熱壓板上進行205 °C、60秒鐘之燒焙 結果,形成膜厚89nm之有機系抗反射膜。 反射膜上,將上述所得之正型光阻組成物溶 佈器分別進行塗佈,並於熱壓板上以1 〇〇 t 件下進行預燒焙(PAB )處理’經乾燥後形 之光阻膜。 其次,於前述光阻膜上,使用旋轉塗佈 成用塗佈液(TSRC-002)(商品名,東京應 ),經由於9 0 °C、6 0秒鐘加熱後,形成膜J| -100- 阻圖型,評估 t 物「ARC2 9A 英吋之矽晶圓 ,並進行乾燥 隨後,於該抗 液使用旋轉塗 、6 0秒鐘之條 成膜厚1 2 0 n m 器將保護膜形 化工業公司製 :2 8 n m之頂塗 200914991 覆層(Top-coat)。 其次,使用A r F浸潤式曝光裝置N S R _ S 6 0 9 B (理光公 司製;ΝΑ (開口數)=1.07,2/3輪帶照明),將ArF準 分子雷射(193nm)介由通孔直徑(CD)爲75nm之通孔 以等間隔(間距1 3 1 nm )配置之具有通孔圖型之遮罩( bias Onm) ’對形成有頂塗覆層之前述光阻膜進行選擇性 照射。 以保護膜去除液(TS-Rememover-S)(商品名,東京 應化工業公司製)去除頂塗覆層,其後,於95 °C、60秒 間之條件下進行曝光後加熱(P E B )處理,再於2 3。(:下以 2.38質量%氫氧化四甲基銨(TMAH )水溶液「NMD-W」 (東京應化工業公司製)進行3 0秒鐘之顯影,其後以3 0 秒鐘’使用純水進行水洗,進行振動乾燥。 其結果得知,於前述光阻膜上,形成等距離(間距 13 1nm)配置有通孔直徑(CD)爲70nm之通孔所得之接 觸孔圖型(C/H圖型)。 又’並求取此時之最佳曝光量(感度:Eop,mJ/cm2 )。其結果’於實施例4爲61mJ/cm2,實施例5爲 8 5mJ/cm2 ’ 實施例 6 爲 57mJ/Cm2,比較例 1 爲 34mJ/cm2 [圖型形狀] 使用掃描型電子顯微鏡(商品名:S_922〇,日立製作 所公司製)觀察上述通孔之直徑70nm、間距丨3 i nm之 200914991 C/Η圖型結果’得知實施例4〜6之C/Η圖型之剝離性較 比較例1爲更佳。比較例1之C/H圖型,其圖型之一部份 無法剝離。 [遮罩誤差因子(MEF; Mask Error Factor)之評估] 於上述E0P中,使用口徑爲70nm、間距131nm作爲 標靶之遮罩圖型,與口徑75nm、間距1 3 1 nm作爲標靶之 遮罩圖型形成C/Η圖型,並依下述計算式求取MEF値。OH (A) -1 &lt;Evaluation of lithographic etching characteristics&gt; The resulting positive photoresist composition solution was used to form photolithographic etching characteristics. [Analysis and Sensitivity] The organic anti-reflection film set was applied to 8 on a hot platen at 205 ° C for 60 seconds using a rotary applicator (product name, manufactured by Privah Scientific Co., Ltd.). As a result of baking, an organic antireflection film having a film thickness of 89 nm was formed. On the reflective film, the positive-type photoresist composition dissolver obtained above is separately coated, and pre-baked (PAB) is performed on a hot plate at 1 〇〇t. Resistance film. Next, on the resist film, a coating liquid (TSRC-002) (trade name, Tokyo) was used, and after heating at 90 ° C for 60 seconds, a film J| was formed. 100- resistance pattern, evaluate the T material "ARC2 9A inch 矽 wafer, and dry it. Then use the spin coating for 60 seconds, and the film thickness of 1 20 nm will protect the film shape. Chemical Industry Co., Ltd.: Top coating of 200914991 coating on top of 2 nm. Secondly, using A r F immersion exposure apparatus NSR _ S 6 0 9 B (manufactured by Ricoh Co., Ltd.; ΝΑ (number of openings) = 1.07, 2/3 wheel illumination), ArF excimer laser (193nm) with a through-hole pattern mask arranged at equal intervals (pitch 1 3 1 nm) through a via having a via diameter (CD) of 75 nm (bias Onm) 'Selective irradiation of the above-mentioned photoresist film to which the top coating layer is formed. The top coating layer is removed by a protective film removal liquid (TS-Rememover-S) (trade name, manufactured by Tokyo Ohka Kogyo Co., Ltd.) Thereafter, the post-exposure heating (PEB) treatment was carried out at 95 ° C for 60 seconds, and then at 23. (under: 2.38 mass% tetramethylammonium hydroxide (TMAH) The aqueous solution "NMD-W" (manufactured by Tokyo Ohka Kogyo Co., Ltd.) was developed for 30 seconds, and then washed with pure water for 30 seconds, and subjected to vibration drying. As a result, it was found that the photoresist was On the film, a contact hole pattern (C/H pattern) obtained by a via hole having a via diameter (CD) of 70 nm is formed at an equidistant distance (pitch of 13 nm). Further, the optimum exposure amount at this time is obtained. (sensitivity: Eop, mJ/cm2). The result '61 mJ/cm2 in Example 4, 85 mJ/cm2 in Example 5', 57 mJ/cm2 in Example 6, and 34 mJ/cm2 in Comparative Example 1 [Graph shape Using a scanning electron microscope (trade name: S_922〇, manufactured by Hitachi, Ltd.), the results of the above-mentioned through-holes of 70 nm and the pitch 丨3 i nm of 200914991 C/Η pattern results were observed. The peeling property of the Η pattern is better than that of Comparative Example 1. In the C/H pattern of Comparative Example 1, one part of the pattern cannot be peeled off. [Evaluation of Mask Error Factor (MEF)] In the above E0P, a mask pattern having a diameter of 70 nm and a pitch of 131 nm as a target is used, and a aperture of 75 nm and a pitch of 13 1 nm are used as targets. Mask pattern formed C / Η pattern, and calculated according to the following equation is obtained MEF Zhi.

MEF= | CD75-CD70 I / I MD75-MD70 I 上述式中,CD75、CD7Q爲分別使用口徑75nm、70nm 作爲標靶之遮罩圖型所形成之C/Η圖型之實際口徑(nm )。又,MD75、MD7G分別爲該遮罩圖型作爲標靶之口徑 (nm) ,MD75=75,MD70=70。 MEF爲,相同之曝光量下,於固定間距狀態下,變更 遮罩尺寸(C/Η圖型中爲通孔直徑,線路與空間圖型中爲 線寬)之際時,顯示不同尺寸下遮罩圖型可如何忠實地重 現之參數,MEF之數値越接近1時,即表示遮罩重現性更 爲良好。評估之結果,確認實施例4〜6相較於比較例1 ’ 顯示出更良好之遮罩重現性。 [CD均勻性(CDU )評估] 於依上述EOP所得之C/Η圖型中,測定各C/Η圖型 -102- 200914991 中之25個通孔之CD’並求得由該結果所算出之標準 (σ)之3倍値(3σ)。依此方式求得之3σ,其數値 時,即表示形成於該光阻膜之各通孔的CD均勻性( )越高之意。 評估之結果得知,實施例4爲1 3 . 6 5 ’實施例 1 4.5 1,實施例6爲1 1 · 9 9,比較例1爲1 6.6 0。 [正圓性評估] 由上述EOP所得之C/H圖型的上方觀察,以使 長 SEM (日立製作所公司製,製品名:S-9220 )測 C/H圖型中之25個通孔之由該通孔之中心至24方向 緣爲止之距離,並求得由其結果算出之標準偏差(σ ) 倍値(3σ )。依此方式求得之3σ,該數値越小時, 示該通孔之正圓性越高之意。 評估之結果得知,實施例4爲5.5,實施例5爲4 實施例6爲4 · 1,比較例1爲5.2。實施例4與比較例 鄕等之正圓性,實施例5〜6與比較例1相比較時, 其具有更優良之正圓性。 由以上之結果得知,含有本發明之酸產生劑的光 成物’具有良好之圖型形狀,具有優良之MEF、CDU 圓性’故與含有以往之酸產生劑之光阻組成物相比較 確認其可得到良好之微影鈾刻特性。 (實施例7) &lt;化合物(bl-14-501) 偏差 越小 CDU 5爲 用測 定各 的外 之3 即表 .7 &gt; 1爲 得知 阻組 、正 時, (bl-14-503 -103- 200914991 )之合成 【化6 2】MEF= | CD75-CD70 I / I MD75-MD70 I In the above formula, CD75 and CD7Q are the actual apertures (nm) of the C/Η pattern formed by using mask patterns of 75 nm and 70 nm as targets, respectively. Further, MD75 and MD7G respectively have the mask pattern as the target aperture (nm), MD75=75, and MD70=70. MEF is the same exposure amount, when the mask size is changed in the fixed pitch state (the diameter of the through hole in the C/Η pattern, and the line width in the line and space pattern), the different sizes are displayed. How the mask pattern can faithfully reproduce the parameters, the closer the MEF number is to 1, the better the mask reproducibility. As a result of the evaluation, it was confirmed that Examples 4 to 6 showed better mask reproducibility than Comparative Example 1'. [CD uniformity (CDU) evaluation] In the C/Η pattern obtained by the above EOP, CD's of 25 through holes in each C/Η pattern-102-200914991 were measured and calculated from the results. The standard (σ) is 3 times 値 (3σ). The 3σ obtained in this way, when the number is 値, means that the CD uniformity ( ) formed in each of the through holes of the photoresist film is high. As a result of the evaluation, Example 4 was 1 3 . 6 5 'Example 1 4.5 1 , Example 6 was 1 1 · 9 9, and Comparative Example 1 was 1 6.6 0. [Positive roundness evaluation] From the top of the C/H pattern obtained by the above EOP, the long SEM (product name: S-9220, manufactured by Hitachi, Ltd.) was used to measure 25 through holes in the C/H pattern. The standard deviation (σ) times 値(3σ) calculated from the result is obtained from the distance from the center of the through hole to the direction of the 24 directional edge. The 3σ obtained in this way, the smaller the number, the higher the roundness of the through hole. As a result of the evaluation, it was found that Example 4 was 5.5, Example 5 was 4, Example 6 was 4·1, and Comparative Example 1 was 5.2. Example 4 and Comparative Example The roundness of ruthenium and the like, and Examples 5 to 6 were more excellent in roundness as compared with Comparative Example 1. From the above results, it is known that the photo-formed product containing the acid generator of the present invention has a good pattern shape and has excellent MEF and CDU roundness, so that it is compared with a photoresist composition containing a conventional acid generator. Confirm that it can obtain good lithography characteristics. (Example 7) &lt;Compound (bl-14-501) The smaller the deviation, the smaller the CDU 5 is, and the other is 3, that is, Table 7 &gt; 1 is the resistance group, timing, (bl-14-503) -103- 200914991 ) Synthesis [Chemistry 6 2]

使化合物(1 ) ( 4 g )溶解於二氯甲院(7 9 _8 g )中。 確認溶解後,添加碳酸鉀(6 ·8 7 g) ’添加溴乙酸2 -甲基- 2 -金剛烷(3.4 2 g )。於迴流下’反應2 4小時後,進行過 濾、水洗浄,以己烷晶析。所得之粉體經減壓乾燥結果’ 得目的化合物3.9 8 g (產率6 6 % )。 對該化合物,以1 H-NMR進行分析。其結果係如以下 所示。 ^-NRM ( CDC13 ' 600MHz ) : δ (ppm) =7.83-7.86 (m,4H,phenyl ) ,7.69-7.78 ( m &gt; 6H,phenyl ) ’ 7.51 (s,2H,Hd ) ,4.46 ( s,2H,He) ,2.39 ( s,6H,Ha ),2 _ 3 3 ( s,2H,Adamantane ) ,2_17 ( s,2H,Compound (1) (4 g) was dissolved in dichloromethane (7 9 _8 g). After confirming dissolution, potassium carbonate (6·8 7 g) was added to add 2-methyl-2-adamantane (3.4 2 g). After reacting for 24 hours under reflux, it was filtered, washed with water and crystallized from hexane. The obtained powder was dried under reduced pressure to give the title compound 3.9 8 g (yield: 6 6 %). The compound was analyzed by 1 H-NMR. The results are as follows. ^-NRM ( CDC13 ' 600MHz ) : δ (ppm) =7.83-7.86 (m,4H,phenyl ) , 7.69-7.78 ( m &gt; 6H,phenyl ) ' 7.51 (s,2H,Hd ) ,4.46 ( s, 2H, He) , 2.39 ( s, 6H, Ha ), 2 _ 3 3 ( s, 2H, Adamantane ) , 2_17 ( s, 2H,

Adamantane ) ,1.7 1 - 1.976 ( m,1 1H ’ Adamantane ) ’ 1.68 ( s,3H,Hb ) ,1.57-1.61 ( m &gt; 2H &gt; Adamantane) o 由上述結果得知,確認所得化合物中,爲含有下述所 -104- 200914991 示構造之化合物(bl_14-501 )。此外,於所得化合物中, 陽離子部之NMR數據中,含有與上述相同之化合物(bl-1 4- 5 02 )及(b卜1 4-5 03 )部份,爲經由離子滲透色層分析 之測定結果而確認。前述化合物之比例,化合物(b 1 - 1 4-501)爲 21.4mol%、化合物(bl-14-502)爲 ll_4mol%、 (b 1 - 1 4- 5 03 )爲 67.2mol%°Adamantane ) , 1.7 1 - 1.976 ( m,1 1H ' Adamantane ) ' 1.68 ( s,3H,Hb ) ,1.57-1.61 ( m &gt; 2H &gt; Adamantane) o From the above results, it is confirmed that the obtained compound is The compound (bl_14-501) having the structure shown in the following -104-200914991 is contained. Further, in the obtained compound, the NMR data of the cation portion contains the same compound (bl-1 4- 5 02 ) and (b Bu 1 4-5 03 ) as the above, and is analyzed by ion permeation chromatography. Confirmed by the measurement results. The ratio of the above compound, the compound (b 1 - 1 4-501) was 21.4 mol%, the compound (bl-14-502) was ll_4 mol%, and (b 1 - 1 4- 5 03 ) was 67.2 mol%.

(實施例8 ) &lt;化合物(bl-14-401 )之合成〉(Example 8) &lt;Synthesis of Compound (bl-14-401)>

【化6 4】 使化合物(b 卜 1 4 - 5 0 1 ) 2 1 · 4 m 〇 1%、化合物(b 1 -1 4 - -105- 200914991 502 ) 1 1.4mol%、 ( b 1 - 1 4 - 5 0 3 ) 6 7.2 m ο 1 % 之混合物 2 5 . 5 g 溶解於200g之純水中,於其中添加二氯甲烷(127.4g ) 及九氟-η-丁烷磺酸鉀(16.0g),於室溫下攪拌14小時。 其後,將二氯甲烷層分液後,進行稀鹽酸洗滌 '氨洗滌、 水洗滌等,經由將二氯甲烷層濃縮及乾固處理,得白色固 體之目的物(3 2 · 9 g )。 對所得化合物以1H-NMR、19F-NMR進行分析。 'H-NRM ( DMSO-d6 ' 400MHz) : &lt;5 ( ppm ) =7.75- 7.86 ( m,10H,ArH) ,7.61 ( s,2 H,A r H ) ,4.62 ( s ’ 2H &gt; CH2 ) ,2.31 (s,6H,CH3 ) ,1.49-1.97 (m,17H,[Chem. 6 4] Compound (b Bu 1 4 - 5 0 1 ) 2 1 · 4 m 〇 1%, compound (b 1 -1 4 - -105- 200914991 502 ) 1 1.4 mol%, ( b 1 - 1 4 - 5 0 3 ) 6 7.2 m ο 1 % of the mixture 2 5 . 5 g Dissolved in 200 g of pure water, to which dichloromethane (127.4 g) and potassium nonafluoro-η-butane sulfonate (16.0) were added. g), stirred at room temperature for 14 hours. Thereafter, the methylene chloride layer was separated, and then washed with dilute hydrochloric acid, ammonia washing, water washing, etc., and the methylene chloride layer was concentrated and dried to give a white solid object (3 2 · 9 g ). The obtained compound was analyzed by 1H-NMR and 19F-NMR. 'H-NRM ( DMSO-d6 ' 400MHz) : &lt;5 ( ppm ) =7.75- 7.86 ( m,10H,ArH) , 7.61 ( s,2 H,A r H ) ,4.62 ( s ' 2H &gt; CH2 ), 2.31 (s, 6H, CH3), 1.49-1.97 (m, 17H,

Adamantane )。 1 9 F-N RM ( D M S O - d 6、3 7 6 MHz ) : δ (ppm) =-77.8 ,-112.2 &gt; -118.7 &gt; -123.0 ° 由上述結果得知,確認化合物具有上述所示構造。 (實施例9 )〈化合物(bl-1 4-402 )之合成〉Adamantane). 1 9 F-N RM ( D M S O - d 6 , 3 7 6 MHz ) : δ (ppm) = -77.8 , -112.2 &gt; -118.7 &gt; -123.0 ° From the above results, it was confirmed that the compound had the structure shown above. (Example 9) <Synthesis of Compound (bl-1 4-402)>

【化6 5】【化6 5】

將化合物(b 1 -1 4 - 5 0 1 ) 2 1 . 4 m ο 1 %、化合物(b 1-14- -106- 200914991 5 0 2 ) 1 1 .4 m ο 1 % ' (bl-14-503) 67.2mol% 之混合物 8.93g 溶解於70.4g之純水中,於其中添加二氯甲烷(44.7g)及 三氟甲烷磺酸鉀(3 .1 2g ),於室溫下攪拌1 4小時。其後 ,將二氯甲烷層分液後,進行稀鹽酸洗滌、氨洗滌、水洗 滌等’經由將二氯甲烷層濃縮及乾固處理,得白色固體之 目的物(8.70g)。 對所得化合物以1H-NMR、19F-NMR進行分析。 1H-NRM ( DMSO-d6、4 00MHz ) : 5 (ppm) =7.74- 7· 86 ( m,1 OH ’ ArH ) ,7.60 ( s,2H,ArH ) ,4.62 ( s, 2H’CH2) ,2.31( s,6H,CH3) ,1.49-1.97 (m,17H,Compound (b 1 -1 4 - 5 0 1 ) 2 1 . 4 m ο 1 %, compound (b 1-14- -106- 200914991 5 0 2 ) 1 1 .4 m ο 1 % ' (bl-14 -503) 67.2 mol% of a mixture of 8.93 g was dissolved in 70.4 g of pure water, and dichloromethane (44.7 g) and potassium trifluoromethanesulfonate (3.12 g) were added thereto, and stirred at room temperature for 1 4 hour. Thereafter, the methylene chloride layer was separated, and then subjected to dilute hydrochloric acid washing, ammonia washing, water washing, etc., and the methylene chloride layer was concentrated and dried to give a white solid object (8.70 g). The obtained compound was analyzed by 1H-NMR and 19F-NMR. 1H-NRM (DMSO-d6, 4 00MHz): 5 (ppm) = 7.74 - 7· 86 ( m,1 OH ' ArH ) , 7.60 ( s, 2H, ArH ) , 4.62 ( s, 2H'CH2) , 2.31 (s,6H,CH3), 1.49-1.97 (m,17H,

Adamantane) 〇 19F-NMR ( DMSO-d6、376MHz ) : &lt;5 ( ppm ) =-75.2 o 由上述結果得知,確認化合物具有上述所示構造。 (實施例1 0〜1 7、比較例2 )&lt;正型光阻組成物之製 作&gt; 依表2所示各成份混合、溶解,以製作正型光阻組成 物。 -107- 200914991 【表2】 (A戚份 (B戚份 (D戚份 ⑸成份 實施例10 (A)-2 (B)-5 (D)-1 (S)-1 [100] [11.5] [1.2] [2200] 實施例11 (A)-3 ⑻-5 (D)-1 ⑸-1 [100] [11.5] [1-2] [2200] 實施例12 (A)-2 (A)-4 (B)-5 (D)-1 (S)-1 . [80] [20] [11.5] [1.2] [2200] 實施例13 (A)-2 (A)-4 (B)-5 (D)-1 (S)-1 [60] [40] [11.5] [1.2] [2200] 實施例14 (A)-2 (B)-1 (B)-6 (D)-1 (S)-1 [100] [9.6] [1.0] [1.2] [2200] 實施例15 (A)-2 (B)-1 (B)-6 (D)-1 ⑸-1 [100] [5. 6] [3. 0] [1.2] [2200] 實施例16 (A)-2 (B)-1 (B)-7 (D)-1 ⑸-1 [100] [9.2] [1.9] [1.2] [2200] 實施例17 ㈧-2 (B)-1 (B)-7 (D)-1 ⑸-1 [100] [6.9] [3.8] [1.2] [2200] 比較例2 (A)-2 (B)-8 (D)-1 (S)-1 [100] [8.0] [1.2] [2200] 表2中之各簡稱具有以下之意義。又,表2中之[]内 的數値爲添加量(質量份)。 (A) -2·下述化學式(A) -2所不之聚合物(Mw = 7000、Mw/Mn =1.8)。 (A ) -3 :下述化學式(A ) -2所示之聚合物(Mw = 1 0000 ' Mw/Mn = 2.0 )。 (A ) -4 :下述化學式(A ) -4所示之聚合物(Mw = 5 000 ' Mw/Mn= 1.5)。 (B ) -5 :前述化學式(bl-14-401 )所示之酸產生劑 (實施例8之化合物)。 -108- 200914991 :三苯基锍三氟甲烷磺酸酯。 '•二(1-萘基)苯基锍九氟-η-丁烷磺酸酯。 (Β ) 【化6 6】Adamantane) 〇 19F-NMR (DMSO-d6, 376 MHz): &lt;5 (ppm) = -75.2 o From the above results, it was confirmed that the compound had the structure shown above. (Examples 10 to 17 and Comparative Example 2) &lt;Production of Positive Photoresist Composition&gt; Each component was mixed and dissolved as shown in Table 2 to prepare a positive resist composition. -107- 200914991 [Table 2] (Part A) (Part B) (D) (5) Ingredient Example 10 (A)-2 (B)-5 (D)-1 (S)-1 [100] [11.5 [1.2] [2200] Example 11 (A)-3 (8)-5 (D)-1 (5)-1 [100] [11.5] [1-2] [2200] Example 12 (A)-2 (A) )-4 (B)-5 (D)-1 (S)-1 . [80] [20] [11.5] [1.2] [2200] Example 13 (A)-2 (A)-4 (B) -5 (D)-1 (S)-1 [60] [40] [11.5] [1.2] [2200] Example 14 (A)-2 (B)-1 (B)-6 (D)-1 (S)-1 [100] [9.6] [1.0] [1.2] [2200] Example 15 (A)-2 (B)-1 (B)-6 (D)-1 (5)-1 [100] [ 5. 6] [3. 0] [1.2] [2200] Example 16 (A)-2 (B)-1 (B)-7 (D)-1 (5)-1 [100] [9.2] [1.9] [1.2] [2200] Example 17 (8)-2 (B)-1 (B)-7 (D)-1 (5)-1 [100] [6.9] [3.8] [1.2] [2200] Comparative Example 2 (A) )-2 (B)-8 (D)-1 (S)-1 [100] [8.0] [1.2] [2200] Each of the abbreviations in Table 2 has the following meaning. Also, in [] in Table 2 The number of enthalpy is the amount of addition (parts by mass). (A) -2. The polymer of the following chemical formula (A) -2 (Mw = 7000, Mw / Mn = 1.8). (A) -3 : Polymer of formula (A)-2 (Mw = 1 0000 ' Mw/ Mn = 2.0 ) (A ) -4 : a polymer represented by the following chemical formula (A ) -4 (Mw = 5 000 ' Mw / Mn = 1.5). (B ) -5 : The aforementioned chemical formula (bl-14- 401) The acid generator (compound of Example 8) is shown. -108- 200914991: Triphenylsulfonium trifluoromethanesulfonate. '•Di(1-naphthyl)phenylphosphonium hexafluoro-η-butyl Alkane sulfonate. (Β) 【化6 6】

〈微影軸刻特性之評估&gt; 4·甲基苯基二苯基鏑九氟-η-丁烷磺酸酯。<Evaluation of lithography axising characteristics> 4. Methylphenyl diphenyl quinone nonafluoro-η-butane sulfonate.

使用所得之正型光阻組成物溶液形成光阻圖型,評估 以下之微影蝕刻特性。 [解析性、感度] 使用旋轉塗佈器將有機系抗反射膜組成物「ARC29」 (商品名’普利瓦科學公司製)塗佈於8英吋之矽晶圓上 ,於熱壓板上進行2 0 5 t:、6 0秒鐘之燒焙,並進行乾燥結 果’形成膜厚75nm之有機系抗反射膜。隨後,於該抗反 射膜上’將上述所得之正型光阻組成物溶液使用旋轉塗佈 器分別進行塗佈,並於熱壓板上以1 1 0 °C、6 0秒間之條件 下進行預燒焙(PAB )處理,經乾燥後形成膜厚120ηηι之 光阻膜。 其次,使用ArF浸潤式曝光裝置NSR-S 609B (理光公 司製;NA (開口數)=1.07,照明條件=X-p〇le·( -109- 200914991 0.78/0.97 ),偏光條件= w/P),將 ArF準分子雷射(The resulting resist pattern was formed using the resulting positive resist composition solution, and the following lithographic etching characteristics were evaluated. [Analytical property and sensitivity] The organic anti-reflection film composition "ARC29" (trade name "Puliva Scientific Co., Ltd.") was applied onto a 8 inch silicon wafer by a spin coater on a hot plate. The baking was performed at 2 0 5 t: for 60 seconds, and drying was carried out to form an organic anti-reflection film having a film thickness of 75 nm. Subsequently, the positive photoresist composition solution obtained above was coated on the anti-reflection film using a spin coater, and dried on a hot plate at 110 ° C for 60 seconds. The pre-baked (PAB) treatment is dried to form a photoresist film having a film thickness of 120 ηηι. Next, an ArF immersion exposure apparatus NSR-S 609B (manufactured by Ricoh Co., Ltd.; NA (number of openings) = 1.07, illumination condition = Xp〇le·(-109-200914991 0.78/0.97), polarizing condition = w/P), ArF excimer laser (

1 93nm )介由遮罩圖型(6%half-tone )進行選擇性照射。 隨後,於1 1 、6 0秒鐘之條件下進行曝光後加熱(PEB )處理,再於2 3 〇C下,使用2 · 3 8質量%氫氧化四甲基銨 (TMAH )水溶液(NMD-3 )(東京應化工業公司製)進 行4 0秒鐘之顯影,於其後之4 0秒間’使用純水進行水洗 ,進行振動乾燥。 其結果得知,無論使用任一正型光阻組成物所得之例 示中,皆形成線寬65nm、間距130nm之線路與空間光阻 圖型(L/S圖型)。 又,求取此時之最佳曝光量(感度:Eop,mJ/cm2 ) ,其結果如表3所示。 [遮罩誤差因子(MEF; Mask Error Factor)之評估] 於上述Ε ο p中,分別使用線寬之標IE尺寸爲6 1 n m、 6 3 nm ' 65nm、67nm、69nm之遮罩圖型,形成間距130nm 之L/S圖型。此時,算出以標靶尺寸(nm )作爲橫軸,使 用各遮罩圖型形成於光阻膜的線寬(nm )作爲縱軸進行標 記時直線之傾斜度作爲MEF。MEF (直線之傾斜度)其數 値越接近於1時,即爲遮罩重現性良好之意。所得結果係 如表3所示。 -110- 200914991 【表3】 實施例 10 實施例 11 實施例 12 實施例 13 實施例 14 實施例 15 實施例 16 實施例 17 比較例 2 E叩 (mJ/cm2) 27.0 29.9 28.8 31.6 29.0 26.5 32.5 38.0 23.5 MEF 3.29 3.3 3.49 3.43 3.76 3.69 3.22 3.28 3.92 由上述結果明確得知,確認使用含有本發明之酸產生 劑之實施例1 〇至1 7之光阻組成物,相較於比較例2之光 阻組成物可顯示出更佳之遮罩重現性。 111 -1 93 nm) Selective illumination via a mask pattern (6% half-tone). Subsequently, post-exposure heating (PEB) treatment was carried out under conditions of 1 1 and 60 seconds, and then 2 · 38 % by mass of aqueous solution of tetramethylammonium hydroxide (TMAH) was used at 2 3 〇C (NMD- 3) (manufactured by Tokyo Ohka Kogyo Co., Ltd.) was subjected to development for 40 seconds, and was washed with pure water for 40 hours thereafter, and subjected to vibration drying. As a result, it was found that the wiring and the space resist pattern (L/S pattern) having a line width of 65 nm and a pitch of 130 nm were formed in any of the examples obtained by using any of the positive resist compositions. Further, the optimum exposure amount at this time (sensitivity: Eop, mJ/cm2) was obtained, and the results are shown in Table 3. [Evaluation of Mask Error Factor (MEF)] In the above Ε ο p, the mask pattern of the line width IE is 6 1 nm, 6 3 nm ' 65 nm, 67 nm, 69 nm, respectively. An L/S pattern with a pitch of 130 nm is formed. At this time, the inclination of the straight line when the target size (nm) is plotted as the horizontal axis and the line width (nm) of each of the mask patterns formed on the photoresist film is plotted as the vertical axis is calculated as the MEF. The closer the MEF (the inclination of the line) to the number 1, the better the reproducibility of the mask. The results obtained are shown in Table 3. -110- 200914991 [Table 3] Example 10 Example 11 Example 12 Example 13 Example 14 Example 15 Example 16 Example 17 Comparative Example 2 E叩(mJ/cm2) 27.0 29.9 28.8 31.6 29.0 26.5 32.5 38.0 23.5 MEF 3.29 3.3 3.49 3.43 3.76 3.69 3.22 3.28 3.92 It is clear from the above results that it was confirmed that the photoresist composition of Example 1 to 17 containing the acid generator of the present invention was used as compared with the photoresist of Comparative Example 2. The composition shows better mask reproducibility. 111 -

Claims (1)

200914991 十、申請專利範圍 1 · 一種光阻組成物,其爲含有經由酸之作用而對鹼顯 影液之溶解性產生變化之基材成份(A )及經由曝光而產 生酸之酸產生劑成份(B )之光阻組成物, 其特徵爲,前述酸產生劑成份(B)爲含有下述通式 (b 1 -1 4 )所示之化合物所形成之酸產生劑(B 1 ), 【化1】 R7*· r8-s+ χ- 上9&quot; · · · (b 1 — 1 4) [式中,R7’’〜R9’’各自獨立表示芳基或烷基;R7”〜R9”中任 意2個可相互鍵結與式中之硫原子共同形成環;R7”〜R9’ 之中,至少1個爲氫原子之一部份或全部被烷氧烷基氧基 或烷氧羰基烷基氧基所取代之取代芳基;X·爲陰離子]。 2 .如申請專利範圍第1項之光阻組成物,其中,前述 烷氧烷基氧基爲下述逋式(bl4-l)所示 【化2】200914991 X. Patent Application No. 1 · A photoresist composition which is a substrate component (A) containing a change in solubility of an alkali developer via an action of an acid and an acid generator component which generates an acid by exposure ( The photoresist composition of B), wherein the acid generator component (B) is an acid generator (B 1 ) formed by a compound represented by the following formula (b 1 -1 4 ). 1] R7*·r8-s+ χ-上上9&quot; · · · (b 1 - 1 4) [wherein, R7''~R9'' each independently represent an aryl group or an alkyl group; any of R7"~R9" Two may be bonded to each other to form a ring together with a sulfur atom in the formula; at least one of R7" to R9' is a part or all of a hydrogen atom by an alkoxyalkyloxy group or an alkoxycarbonylalkyloxy group. The substituted aryl group substituted by the group; X. is an anion]. The photoresist composition according to claim 1, wherein the alkoxyalkyloxy group is represented by the following formula (bl4-l) [Chemical 2] R47R47 R49R49 [式中’R4 7及R48各自獨立爲氫原子或直鏈狀或支鏈狀之 烷基’ R4 9爲烷基,R4 8及R4 9可相互鍵結形成一個之環構 造亦可,其中’ R47及R48中至少1個爲氫原子]; -112- 200914991 前述烷氧羰基烷基氧基爲下述通式(bl4-2)所示 【化3】[In the formula, R4 7 and R48 are each independently a hydrogen atom or a linear or branched alkyl group. R 4 9 is an alkyl group, and R 4 8 and R 4 9 may be bonded to each other to form a ring structure, wherein ' At least one of R47 and R48 is a hydrogen atom]; -112- 200914991 The alkoxycarbonylalkyloxy group is represented by the following formula (bl4-2) [Chemical 3] (b 1 4-2) [式中’ R5()爲直鏈狀或支鏈狀之伸院基,R51爲酸解離性 基]。 3 _如申請專利範圍第1項之光阻組成物,其中,前述 基材成份(A )爲經由酸之作用而增大對鹼顯影液的溶解 性之基材成份。 4 _如申請專利範圍第3項之光阻組成物,其中,前述 基材成份(A)爲樹脂成份(A1),其具有含有酸解離性 溶解抑制基之丙烯酸酯所衍生之結構單位(a 1 )。 5 .如申請專利範圍第4項之光阻組成物,其中,前述 基材成份(A)尙具有含有含內酯之環式基的丙烯酸酯所 衍生之結構單位(a2)。 6. 如申請專利範圍第4項之光阻組成物,其中,前述 基材成份(A )尙具有含有含極性基之脂肪族烴基的丙烯 酸酯所衍生之結構單位(a3 ) ° 7. 如申請專利範圍第5項之光阻組成物’其中’前述 基材成份(A )尙具有含有含極性基之脂肪族烴基的丙稀 酸酯所衍生之結構單位(a3) ° 8 .如申請專利範圍第1項之光阻組成物’其含有含氮 -113- 200914991 有機化合物(D )。 9. 一種光阻圖型之形成方法,其爲包含使用申請專利 範圍第1至8項中任一項之光阻組成物於支撐體上形成光 阻膜之步驟、使前述光阻膜曝光之步驟,與使前述光阻膜 鹼顯影以形成光阻圖型之步驟。 10. —種如下述通式(bl-14)所示之化合物, 【化4】 R7&quot; R9&quot; r8-s+ χ- (b 1 - 1 4) [式中,R7’’〜R9’’各自獨立表示芳基或烷基;R7’’〜R9’’中任 意2個可相互鍵結與式中之硫原子共同形成環;R7’’〜R9’ 之中,至少1個爲氫原子之一部份或全部被烷氧烷基氧基 或烷氧羰基烷基氧基所取代之取代芳基;X’爲陰離子]。 1 1 ·如申請專利範圍第1 〇項之化合物,其中’前述烷 氧烷基氧基爲下述通式(bl4-l)所示 【化5】(b 1 4-2) [wherein R5() is a linear or branched extending matrix, and R51 is an acid dissociable group]. The photoresist composition according to the first aspect of the invention, wherein the substrate component (A) is a substrate component which increases the solubility to the alkali developer via the action of an acid. The photo-resist composition of claim 3, wherein the substrate component (A) is a resin component (A1) having a structural unit derived from an acrylate having an acid-dissociable dissolution inhibiting group (a) 1 ). 5. The photoresist composition of claim 4, wherein the substrate component (A) has a structural unit (a2) derived from an acrylate containing a lactone-containing cyclic group. 6. The photoresist composition according to claim 4, wherein the substrate component (A) has a structural unit derived from an acrylate having a polar group-containing aliphatic hydrocarbon group (a3). The photoresist composition of claim 5, wherein the aforementioned substrate component (A) has a structural unit derived from a acrylate containing a polar group-containing aliphatic hydrocarbon group (a3) ° 8 as claimed in the patent application. The photoresist composition of the first item contains the organic compound (D) containing nitrogen-113-200914991. A method for forming a photoresist pattern, comprising the step of forming a photoresist film on a support using the photoresist composition according to any one of claims 1 to 8, and exposing the photoresist film And a step of alkali developing the aforementioned photoresist film to form a photoresist pattern. 10. A compound of the following formula (bl-14), wherein R7&quot;R9&quot; r8-s+ χ- (b 1 - 1 4) [wherein R7''~R9'' Independently represents an aryl group or an alkyl group; any two of R7''~R9'' may be bonded to each other to form a ring together with a sulfur atom in the formula; at least one of R7''~R9' is one of hydrogen atoms a substituted aryl group partially or wholly substituted with an alkoxyalkyloxy group or an alkoxycarbonylalkyloxy group; X' is an anion]. A compound according to the first aspect of the invention, wherein the alkoxyalkyloxy group is represented by the following formula (bl4-l). [式中,R47及R48各自獨立爲氫原子或直鏈狀或支鏈狀之 烷基,R49爲烷基,R48及R49可相互鍵結形成一個之環構 200914991 造亦可,其中,R47及R48中至少1 f[ 前述烷氧羰基烷基氧基爲下述通 【化6】Wherein R47 and R48 are each independently a hydrogen atom or a linear or branched alkyl group, R49 is an alkyl group, and R48 and R49 may be bonded to each other to form a ring structure 200914991, wherein R47 and At least 1 f of R48 [the aforementioned alkoxycarbonylalkyloxy group is as follows] [式中,R5()爲直鏈狀或支鏈狀之伸 基]。 1 2 . —種酸產生劑,其特徵爲由 1 1項之化合物所形成。 丨爲氫原子]; 式(bl4-2 )所示 一2) :基,R51爲酸解離性 請專利範圍第1 0或 -115- 200914991 七、指定代表圖: (一) 、本案指定代表圖為:無 (二) 、本代表圖之元件代表符號簡單說明:無 八、本案若有化學式時,請揭示最能顯示發明特徵的 化學式: [化1][wherein, R5() is a linear or branched exudate]. An acid generator characterized by being formed of a compound of item 11.丨 is a hydrogen atom]; formula (bl4-2) shows a 2): group, R51 is acid dissociation, please patent range 10 or -115- 200914991 VII. Designated representative map: (1) For: No (2), the representative symbol of the representative figure is a simple description: No. 8. If there is a chemical formula in this case, please reveal the chemical formula that best shows the characteristics of the invention: [Chemical 1] (b 1 — 1 4) -5-(b 1 — 1 4) -5-
TW097121845A 2007-06-13 2008-06-11 Resist composition, method of forming resist pattern, compound and acid generator TWI383252B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007156556 2007-06-13
JP2007294429A JP5364256B2 (en) 2007-06-13 2007-11-13 Compound, acid generator, resist composition, and resist pattern forming method

Publications (2)

Publication Number Publication Date
TW200914991A true TW200914991A (en) 2009-04-01
TWI383252B TWI383252B (en) 2013-01-21

Family

ID=40358986

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097121845A TWI383252B (en) 2007-06-13 2008-06-11 Resist composition, method of forming resist pattern, compound and acid generator

Country Status (3)

Country Link
JP (1) JP5364256B2 (en)
KR (1) KR100962164B1 (en)
TW (1) TWI383252B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5364436B2 (en) * 2008-05-08 2013-12-11 東京応化工業株式会社 Resist composition, resist pattern forming method, novel compound, and acid generator
KR101660041B1 (en) 2008-11-28 2016-09-26 도오꾜오까고오교 가부시끼가이샤 Resist composition, method of forming resist pattern, novel compound, and acid generator
JP5544212B2 (en) 2009-04-27 2014-07-09 東京応化工業株式会社 Resist composition, resist pattern forming method, compound and method for producing the same, acid generator
US8318403B2 (en) * 2009-05-28 2012-11-27 Sumitomo Chemical Company, Limited Salt and photoresist composition containing the same
JP6009730B2 (en) * 2009-05-28 2016-10-19 住友化学株式会社 Salt and resist composition for acid generator
US8278023B2 (en) * 2009-05-28 2012-10-02 Sumitomo Chemical Company, Limited Salt and photoresist composition containing the same
JP5469920B2 (en) * 2009-05-29 2014-04-16 東京応化工業株式会社 Resist composition and resist pattern forming method
JP6027934B2 (en) 2013-03-29 2016-11-16 富士フイルム株式会社 Compound, actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and electronic device manufacturing method using these
US10088749B2 (en) * 2016-09-30 2018-10-02 Rohm And Haas Electronic Materials Llc Photoacid-generating compound and associated polymer, photoresist composition, and method of forming a photoresist relief image
JP7186516B2 (en) * 2018-05-28 2022-12-09 東京応化工業株式会社 Resist composition, resist pattern forming method, compound, and acid generator
JP7274839B2 (en) * 2018-09-07 2023-05-17 東京応化工業株式会社 Resist composition and resist pattern forming method
EP4159716A4 (en) 2020-05-29 2023-12-06 FUJIFILM Corporation Actinic-ray-sensitive or radiation-sensitive resin composition, pattern formation method, resist film, electronic device manufacturing method, compound, and compound production method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0311049A (en) * 1989-06-07 1991-01-18 Mitsubishi Gas Chem Co Inc Preparation of sulfonium compound
DE3924298A1 (en) * 1989-07-22 1991-02-07 Basf Ag NEW SULPHONIUM SALTS AND THEIR USE
DE3924299A1 (en) * 1989-07-22 1991-01-31 Basf Ag NEW SULPHONIUM SALTS AND THEIR USE
JP3198845B2 (en) * 1994-12-05 2001-08-13 信越化学工業株式会社 Chemically amplified positive resist material
JP3606291B2 (en) * 1995-06-29 2005-01-05 信越化学工業株式会社 Sulfonium salt
JP4012600B2 (en) * 1997-06-23 2007-11-21 富士通株式会社 Acid-sensitive polymer, resist composition, resist pattern forming method, and semiconductor device manufacturing method
KR100320773B1 (en) * 1999-05-31 2002-01-17 윤종용 photoresist compositions
US20030235775A1 (en) * 2002-06-13 2003-12-25 Munirathna Padmanaban Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds
JP4583790B2 (en) * 2003-06-26 2010-11-17 東京応化工業株式会社 Positive resist composition and resist pattern forming method using the same
US20050271974A1 (en) * 2004-06-08 2005-12-08 Rahman M D Photoactive compounds
JP2007065353A (en) * 2005-08-31 2007-03-15 Fujifilm Corp Photosensitive composition and pattern forming method using it
US7678528B2 (en) * 2005-11-16 2010-03-16 Az Electronic Materials Usa Corp. Photoactive compounds
JP5097442B2 (en) * 2007-05-22 2012-12-12 東京応化工業株式会社 Compound, acid generator, resist composition, and resist pattern forming method

Also Published As

Publication number Publication date
KR20080109629A (en) 2008-12-17
KR100962164B1 (en) 2010-06-10
JP2009019028A (en) 2009-01-29
TWI383252B (en) 2013-01-21
JP5364256B2 (en) 2013-12-11

Similar Documents

Publication Publication Date Title
TWI465844B (en) Resist composition, method of forming resist pattern, compound and acid generator
TWI578098B (en) Resist composition, method of forming resist pattern and polymeric compound
TWI391781B (en) Resist composition, method of forming resist pattern, novel compound, and acid generator
TWI410749B (en) Resist composition for immersion exposure, method of forming resist pattern using the same, and fluorine-containing compound
TWI464532B (en) Resist composition, method of forming resist pattern, compound and acid generator
TWI375124B (en) Pattern formation method
TW200914991A (en) Resist composition, method of forming resist pattern, compound and acid generator
TWI384325B (en) Resist composition, method of formimg resist pattern, novel compound and method of producing the same, and acid generator
TWI389922B (en) Polymer compound, positive resist composition and method of forming resist pattern
TWI464533B (en) Resist composition, method of forming resist pattern, and novel compound and acid generator
JP5557657B2 (en) Resist composition, resist pattern forming method, novel compound and acid generator
TW201003319A (en) Positive resist composition, method of forming resist pattern, and polymeric compound
TW201035119A (en) Resist composition, method of forming resist pattern, novel compound and acid generator
TW201137522A (en) Positive resist composition and method of forming resist pattern
TWI394741B (en) Compound, acid generator, resist composition, and method for formation of resist patterns
TW200910004A (en) Resist composition, method of forming resist pattern, compound and acid generator
TWI554528B (en) Resist composition, method of forming resist pattern
TWI424265B (en) Novel compound, manufacturing method thereof, acid generator, resist composition and method of forming resist pattern
TW200947127A (en) Positive resist composition and method of forming resist pattern
TWI494686B (en) Resist composition, method of forming resist pattern
TW200921280A (en) Positive resist composition and method of forming resist pattern
TW200821292A (en) Compound, acid generator, resist composition, and resist pattern forming method
TWI614230B (en) Compound, radical polymerization initiator, method of producing compound, polymer, resist composition, method of forming resist pattern
TWI380999B (en) Polymer compound, positive resist composition and resist pattern formation method
TWI498324B (en) Resist composition, method of forming resist pattern, polymer compound, compound